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G-quadruplex stabilising ligands are of interest as potential anti-cancer drugs. G-
quadruplexes are folded DNA structures which can form in guanine-rich regions of 
DNA or RNA, and stabilisation of these structures at telomeres can result in the 
inhibition of telomerase activity. In this thesis, Saccharomyces cerevisiae was used as a 
model to examine the in vivo cellular response to treatment with the G-quadruplex 
stabilising ligand TMPyP4. The findings indicate that the pentose phosphate pathway 
(PPP) is key for resistance to TMPyP4, since the absence of PPP genes resulted in 
increased sensitivity to treatment with the ligand. However, the TMPyP4-sensitivity 
exhibited by ppp∆ strains is most likely due to oxidative stress caused by the 
photosensitivity of the porphyrin. There are also potential links between PPP activity, 
the response to uncapped telomeres and the DNA damage response (DDR). The cdc13-
1 mutant strain, in which the telomere binding protein Cdc13 is defective, was used to 
explore these connections. Here, I demonstrate that deletion of key PPP genes results in 
suppression of the temperature-sensitive growth phenotype of cdc13-1. In addition, the 
activity of the enzyme which catalyses the initial step of the oxidative phase of the PPP, 
Zwf1, increases in cdc13-1 strains. Studies of Zwf1 activity in strains arrested in late 
anaphase and G1, however, suggest that the increase in Zwf1 activity is due to the phase 
of the cell cycle in which the strains are arrested, rather than the DDR. The work 
described here demonstrates that the PPP is intrinsically linked to the response to a 
variety of cellular stresses. Due to its role in the Warburg effect, a metabolic shift 
observed in tumour cells, examination of PPP function is important not only for the 
study of normal tissues but also immortal cancer cells, and lessons in budding yeast can 
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   1.1.1   The structure and function of telomeres 
The linear nature of eukaryotic chromosomes can result in replication and 
degradation issues in the terminal regions. These problems are circumvented by the 
presence of telomeres, which are found at the ends of all linear chromosomes and 
which protect against damage to genomic integrity (Blackburn, 1991). Telomeres 
are nucleoprotein structures, composed of both DNA and proteins, both of which 
play important roles in the protection of genomic stability. Telomeric DNA acts as a 
buffer, protecting coding DNA further away from the end of the chromosome from 
degradation (Blackburn, 1991). This degradation is a phenomenon called the end 
replication problem, the result of the fallibility of the DNA replication machinery, 
which occurs every time the cell undergoes replication and division (Olovnikov, 
1973; Watson, 1972; Olovnikov, 1971).  
 
The proteins which bind to or interact with telomeric DNA aid a second function of 
telomeres:  the prevention of recognition of the ends of chromosomes as double 
strand breaks (DSBs) (di Fagagna et al., 2004; Nugent et al., 1998). The 
resemblance of the terminal regions of linear chromosomes to DSBs means that 
without the protection afforded by telomere binding proteins, specific DNA damage 
responses and double strand break repair processes can be activated. Homologous 
recombination (HR) repairs DSBs by using similar or identical DNA, usually a sister 
chromatid, as a template for repair (Kim et al., 2005; Frank-Vaillant and Marcand, 
2002; Szostak et al., 1983). Non-homologous end joining (NHEJ), on the other 
hand, does not require a homologous template to repair the break and instead carries 
out the repair by directly ligating the broken ends together (Kim et al., 2005; Frank-
Vaillant and Marcand, 2002; Szostak et al., 1983). Since the ends of linear 
chromosomes resemble double strand breaks, many of the same components are 
involved in both the repair of DSBs and the processing of the telomere end (Nugent 




Whereas prokaryotes commonly encode their genome on circular chromosomes (and 
thereby evade the end replication problem), the majority of eukaryotic chromosomes 
are linear. The basic telomere function is conserved between most eukaryotic 
species; however, there is variation between species in the composition of the DNA 
element of the structure and the proteins associated with it (Figure 1.1). The multiple 
repeat sequences of which all telomeres are composed are guanine-rich, and most 
telomeres end in a single-stranded 3’ overhang (Henderson and Blackburn, 1989). 
However, significant variation is present between species in sequence structure, 
repeat number and the length of the telomere. In Homo sapiens telomeres are 
composed of the hexameric DNA sequence TTAGGG(n), a sequence conserved 
among vertebrates (Meyne et al., 1989; Moyzis et al., 1988). In yeast, such as the 
budding yeast Saccharomyces cerevisiae, the telomere is formed instead from 
multiple TG1-3 repeats (Greider and Blackburn, 1985; Szostak and Blackburn, 1982). 
Not all eukaryotic species use these repeating elements as telomeres; the fruit fly 
Drosophila melanogaster instead uses the retrotransposons HeT-A and TART to 
combat NHEJ and chromosomal instability (Biessmann and Mason, 1994; Levis et 
al., 1993; Biessmann et al., 1992).  
 
The 3’ overhang found at the end of most eukaryotic telomeres provides a substrate 
for telomerase binding, which may also have a role in recombination-dependent 
telomere maintenance (Wang and Blackburn, 1997; Lingner and Cech, 1996; 
Henderson and Blackburn, 1989). In some species, this 3’ overhang can fold back on 
itself and invade the corresponding strand to create a loop. This loop is found at the 
termini of telomeres of a broad range of species, such as Pisum sativum (peas), 
Trypanosoma brucei (a flagellate protozoan) and humans, and is known as the ‘t-
loop’ (Cesare et al., 2003; Muñoz-Jordán et al., 2001; Griffith et al., 1999). It is 
thought that this loop structure provides an extra level of protection and that this 
protection can be increased further by the presence of structures known as ‘d-loops’ 
(Griffith et al., 1999).  
 
As well as differences in telomeric structure, there is also interspecies variation in 
telomere length. For instance, telomeres in humans can be very long (from around 
15kb at birth) (Shay and Wright, 2005). In contrast, yeast telomeres are amongst the 























Figure 1.1: The structure of yeast and human telomeres 
(a) The nucleoprotein structure of telomeres in yeast. The 3’ overhang at the termini of 
chromosomes is bound by the CST complex; Cdc13 and the Cdc13-interacting factors 
Ten1 and Stn1. The heterodimeric Ku complex (Yku70/80) interacts with the double-
stranded region at the terminus of the telomere. Rap1 binds to double-stranded telomeric 
sequences and interacts with Rif1 and Rif2, which regulate telomere length. Rap1 also 
recruits the Sir2, Sir3 and Sir4 proteins present in the subtelomeric region. (b) The 
nucleoprotein structure of telomeres in humans. Three proteins resembling those in the 
yeast CST complex (CTC1, STN1 and TEN1) form a complex which associates with a 
fraction of telomeres. The 3’ overhang at the terminus of chromosomes is bound by POT1 
and TPP1. The double stranded region of human telomeres is bound by TRF1 and TRF2. 
TRF1 recruits TIN2 and TRF2 recruits Rap1 to the telomere, and TIN1 interacts with 
TPP1, tethering the single-stranded and double-stranded regions together and forming 
the six-protein Shelterin complex. Colour and shape of the proteins in the figure 
represents homology (if any) between the yeast and human forms. Adapted from Jain & 





at the end of the telomere and regulation of overhang length also varies. In yeast, the 
length of the 3’ overhang is affected by the cell cycle and in S phase it can stretch 
from anywhere between 50 bp and 100 bp in length (Wellinger et al., 1993). In 
mammalian systems, the 3’ overhang is present throughout the cell cycle (Makarov 
et al., 1997; McElligott and Wellinger, 1997). 
 
Adjacent to telomeric repeats at the ends of most (but not all) S. cerevisiae yeast 
chromosomes are regions known as Y’ elements (Walmsley et al., 1984; Chan and 
Tye, 1983). These elements are formed from 6500 bp repeat sequences, and up to 4 
tandem copies of these repeats make up the element.  Another subtelomeric repeat, 
the X sequence, is found at the end of all S. cerevisiae chromosomes. This has little 
sequence similarity or homology with the Y’ element. Variation between Y’ element 
number and X element length is demonstrated between chromosome ends. There can 
also be variable numbers of telomeric repeats between Y’ and X elements, and 
between tandem copies of the Y’ element (Louis and Haber, 1991; Walmsley et al., 
1984). The Y’ and X elements both contain ARSs (autonomously replicating 
sequences), which most likely function as chromosomal replication origins (Chan 
and Tye, 1983). The replication origins found in Y’ and X elements are densely 
packed together (around 6.5 kb apart), indicating potential co-regulation, and 
perhaps a role in ensuring the initiation of replication at telomeres (Chan and Tye, 
1983). Within the Saccharomyces genus, the Y’ elements are conserved; however, 
between species the hybridisation pattern of the telomeric sequences differs. 
Nevertheless, the closely related species can still mate and generate viable spores, 
suggesting that this change in telomeric sequence does not affect the conservation of 
telomeric function (Chan and Tye, 1983). 
 
 
   1.1.2   Telomerase and the elongation of telomeres 
The ‘end replication problem’ refers to the shortening of the chromosome upon 
DNA replication (Figure 1.2). It was independently described by Watson (Watson, 
1972) and Olovnikov (Olovnikov, 1973; Olovnikov, 1971) to explain the 
phenomenon of DNA loss upon the replication of linear chromosomes as a result of 
the fallibility of the DNA replication machinery. During DNA replication, a 5’ to 3’ 
polymerase is employed to generate newly synthesised strands of DNA and this 
 5 
 
polymerase, as indicated, can only operate in the 5’ to 3’ direction. This means that 
one strand of the chromosome can be replicated without disruption (known as the 
leading strand) and using just one primer. However, replication of the 
complementary strand can only be carried out in smaller sections, producing 
segments of DNA called Okazaki fragments. This is known as lagging strand 
synthesis and it requires multiple primers bound to the parent strand.  
 
Following replication, the primers are removed and through the action of the DNA 
polymerase, the gaps are filled in. However, removal of the terminal primer at the 
end of the lagging strand results in a 5’ gap and a 3’ overhang.  In the absence of 
telomerase, the result is a shortening of the chromosome which occurs each time the 
DNA replicates and the cell divides. Since no primer removal occurs at the terminal 
end of the leading strand, the chromosome end is left blunt. In order for telomere 
protection through the binding of capping proteins to occur, a 3’ overhang needs to 
be present; therefore, this blunt end requires processing (Figure 1.2). Without 
capping proteins, the end of the chromosome would be recognised as a double strand 
break (DSB) and initiate a DNA damage response (di Fagagna et al., 2003). To 
combat this, the C-rich strand at the blunt end is degraded by nucleases, such as the 
MRX (Mre11-Rad50-Xrs2) complex in budding yeast and the MRN (Mre11-Rad50-
Nbs1) complex in humans, leaving a G-rich overhang which can then be bound by 
ssDNA telomere binding proteins  (Faure et al., 2010).  
 
The shortening which occurs due to the end replication problem can be 
circumvented by the action of the enzyme telomerase. The 3’ telomeric overhang is 
bound by capping proteins such as Cdc13 in yeast and the TRF complex in humans 
(Smogorzewska and de Lange, 2004; Hughes et al., 2000; Lin and Zakian, 1996; 
Nugent et al., 1996). These proteins recruit telomerase to the ssDNA overhang and 
through the action of the reverse transcriptase, the 3’ strand is elongated. This means 
that an additional primer can bind to the elongated 3’ overhang, facilitating the 
action of the 5’ to 3’ polymerase, which fills in the gap on the lagging strand and 
prevents the loss of DNA due to the end replication problem.  A 3’ overhang still 
remains, which is bound by telomere capping proteins and prevents recognition of 





























Figure 1.2: The end replication problem and 3’ overhang generation 
 (a) Following DNA replication the removal of RNA primers leaves a 5’ gap at the 
end of the lagging strand. (b) The blunt end which results from leading strand 
synthesis is processed to generate the 3’ overhang necessary for telomere 




Composed of several subunits, the highly conserved reverse transcriptase telomerase 
uses an RNA template complementary to the nascent telomeric repeat sequence to 
elongate the 3’ overhang at the terminus of the telomere (Feng et al., 1995). In S. 
cerevisiae, this essential RNA template is called TLC1. TLC1 RNA is AC-rich, 
producing a TG-rich DNA elongation (Singer and Gottschling, 1994). The other 
yeast telomerase subunits are Est1, Est2 and Est3. EST2 encodes the subunit of 
telomerase which provides reverse transcriptase activity and along with TLC1 forms 
the catalytic core of telomerase (Lingner et al., 1997b). Est1 and Est3 on the other 
hand are dispensable for telomerase catalytic activity in vitro and instead play 
regulatory roles. For instance, Est1 provides a link between the 3’ end of ssDNA and 
the catalytic core of telomerase, and loss of Est1 leads to a progressive reduction in 
telomere length (Qi and Zakian, 2000; Evans and Lundblad, 1999; Lingner et al., 
1997a; Lundblad and Szostak, 1989). This link occurs through binding of Est1 to the 
ssDNA binding protein Cdc13 (also known as Est4), an interaction which is 
regulated negatively by Stn1 and positively by the Ku complex (Grandin et al., 
2000; Qi and Zakian, 2000; Evans and Lundblad, 1999). The interaction between 
Est1 and Cdc13 is essential for telomerase activity, as it recruits telomerase to 
chromosomal ends. The role of Est3 in the function of telomerase is yet to be 
defined, as it is not required for catalysis in vitro; however, in vivo it is required for 
telomere replication (Lingner et al., 1997a).  
 
There is homology between yeast and human telomerase subunits; for example, the 
human orthologue of the RNA template subunit TLC1 is known as TERC, or hTR 
(Feng et al., 1995). Est2, which has reverse transcriptase activity, is similar to TERT 
(or hTERT) in humans (Nakamura et al., 1997). hEST1a and hEST1b are Est1-like 
proteins found in humans which have also been shown to associate with telomeres 
(Reichenbach et al., 2003; Snow et al., 2003). However, no homologue of Est3 has 
yet been found. Telomerase in humans is only expressed in gametes, stem cells, and 
stem cell niches, and not in somatic cells, which have significantly shorter telomeres 
(Kim et al., 1994; De Lange et al., 1990). Despite the absence of telomerase in 
somatic human cells, a lack of correctly functioning telomerase in humans is 
associated with the disorder known as Cri du chat, which most commonly occurs 
following mutation of the catalytic subunit TERT (Zhang et al., 2003; Bryce et al., 




Telomerase activity is regulated by interactions with the telomere binding proteins. 
Through interactions with the Est1 subunit, the S. cerevisiae ssDNA binding protein 
Cdc13 mediates recruitment of telomerase to the 3’ overhang at the terminus of the 
telomere (Hughes et al., 2000; Qi and Zakian, 2000; Lin and Zakian, 1996; Nugent 
et al., 1996). Cdc13 also mediates the recruitment of telomerase to double strand 
breaks (DSBs) as part of its role in a process called ‘telomere healing’ (Zhang and 
Durocher, 2010; Bianchi et al., 2004). This recruitment results in the production of a 
de novo telomere within the chromosome, and can lead to a loss of coding DNA in 
the distal arm of the chromosome (Bianchi et al., 2004). Due to the loss of genomic 
DNA, this method of double-strand break repair is extreme, and is possibly an effort 
to combat a double strand break which cannot be repaired by the usual methods. 
Telomerase activity can also be regulated by the Ku complex. Ku interacts with the 
TLC1 subunit of telomerase throughout the cell cycle, an interaction which is 
lessened following telomere replication (Fisher et al., 2004; Stellwagen et al., 2003). 
In the absence of the Ku complex, the associations of Est2 and Est1 with the 
telomere are affected, and so a model is proposed where the Ku complex recruits 
inactive telomerase to the telomere in G1 and promotes its activity late in S phase 
(Fisher et al., 2004).  
 
 
   1.1.3   The role of telomere binding proteins 
Telomeres are bound by multiple binding proteins to form the nucleoprotein 
structure. These proteins have numerous roles in the protection of the telomere, 
telomere length maintenance and telomere positioning. In addition to its role in 
recruitment of telomerase, Cdc13 is also involved in preventing telomere 
degradation by exonucleases such as Exo1 (Zubko et al., 2004; Maringele and 
Lydall, 2002). In the absence of telomere capping, this degradation leads to 
activation of DNA damage response pathways and, ultimately, cell cycle arrest 
(Garvik et al., 1995). The capping of telomeres by Cdc13 is regulated by interactions 
with Stn1 and Ten1, which promote and prevent Cdc13 binding to the telomere 
respectively, and the three form the CST complex (Petreaca et al., 2007; Petreaca et 




Cdc13, along with Ten1 and the telomere capping protein Stn1, forms part of the 
CST complex (Grandin et al., 2000). Loss of Cdc13 is lethal; however, 
overexpression of STN1 can provide telomere capping in the absence of Cdc13 
(Petreaca et al., 2007; Petreaca et al., 2006). Stn1 and Ten1 also play essential roles 
in the regulation of telomere length. Stn1 negatively regulates telomerase activity by 
competing with Est1 for binding with Cdc13 (Chandra et al., 2001). Ten1, on the 
other hand, promotes the interaction between Cdc13 and telomerase, potentially 
through disrupting the efforts of Stn1 to displace Est1 (Chandra et al., 2001; Grandin 
et al., 2001). The N-terminus of Cdc13 is essential for the activity of the capping 
protein, as it interacts with other binding proteins (Hughes et al., 2000). Telomere 
capping also occurs through the binding of the Ku complex. This heterodimeric ring, 
which is composed of Yku70 and Yku80, binds to the double stranded region distal 
to the terminus of the chromosome (Milne et al., 1996). The Ku complex is involved 
in telomere length homeostasis, nuclear localisation of telomeres and telomeric 
silencing via interactions with Sir proteins (Martin et al., 1999; Boulton and 
Jackson, 1998; Boulton and Jackson, 1996a; Boulton and Jackson, 1996b). As 
mentioned previously in the chapter, the Ku complex interacts with the telomerase 
subunit TLC1 throughout the cell cycle (Fisher et al., 2004; Stellwagen et al., 2003). 
The complex also potentially regulates the recruitment of Est1 and Est2 to the 
telomere, and subsequently the activity of telomerase in S phase (Fisher et al., 2004; 
Stellwagen et al., 2003). Like Cdc13, the Ku complex also plays a role in the repair 
of double strand breaks in relocating to the site of DSBs and promoting repair 
through non-homologous-end-joining (NHEJ) (Smith and Jackson, 1999; Boulton 
and Jackson, 1996a; Boulton and Jackson, 1996b; Mages et al., 1996). In humans, 
the six-protein complex Shelterin also protects chromosomal ends against DNA 
damage response activation and activity (Palm and de Lange, 2008; De Lange, 
2005). There is little conservation of the Shelterin subunits in yeast; the only subunit 
which is present in S. cerevisiae is Rap1, which binds telomeric DNA directly, 
instead of depending on TRF2 for its telomeric localisation (Li and De Lange, 2003; 
Li et al., 2000) (Figure 1.1). In yeast, Rap1 associates with Rif1 and Rif2 to form a 
complex which binds telomeric double-stranded DNA repeats and inhibits NHEJ 
and telomere elongation by telomerase (Marcand et al., 2008; Levy and Blackburn, 




Homologues of both Cdc13 and the Ku complex are present at the telomeres in 
humans. POT1 encodes the functional homologue of Cdc13, with both proteins 
containing the OB-fold domains important for binding ssDNA and interacting with 
other binding proteins (Theobald and Wuttke, 2004). POT1 and Cdc13 play similar 
roles in capping the telomere and protecting chromosomal ends; however, a link 
between POT1 and the recruitment of telomerase in humans is less well known. The 
presence of POT1 alone does not increase telomerase activity, although in the 
absence of POT1, telomere elongation is reduced (Colgin et al., 2003). And the 
processivity of telomerase is increased when POT1 binds to TPP1, though the 
method by which this occurs is unclear (Wang et al., 2007). The Ku complex is also 
conserved in humans. The human form of the Ku complex, which is composed of 
the subunits Ku70 and Ku80 (equivalent to Yku70 and Yku80 in yeast respectively), 
plays similar roles to its yeast counterpart, primarily facilitating NHEJ (Smith and 
Jackson, 1999). DSBs in mammalian systems are predominantly repaired using this 
method.  
 
Due to their importance in the protection of telomeres, experiments involving Cdc13 
and the Ku complex can reveal aspects of telomere regulation, protection and 
function, and the response that occurs when capping is defective. However, as 
mentioned above, CDC13 is essential and its deletion causes the rapid accumulation 
of ssDNA at telomeres, cell cycle arrest and cell death (Zubko et al., 2004; Garvik et 
al., 1995; Lydall and Weinert, 1995). Nevertheless, its function and role in telomere 
capping can be studied through the use of the temperature-sensitive mutant cdc13-1. 
This mutant form is deficient in capping at temperatures over 26oC, though it can 
still recruit telomerase (Nugent et al., 1996; Garvik et al., 1995). Telomere 
uncapping in cdc13-1 leads to cell cycle arrest in G2-M. The role of the Ku complex 
at the telomere can also be studied using the temperature-sensitive null mutant 
yku70∆ (Barnes and Rio, 1997; Feldmann et al., 1996). In contrast to cdc13-1, 
telomere uncapping occurs at the higher temperature of around 36oC in yku70∆ 
strains. Uncapping brought about by temperature sensitivity in both strains results in 
the initiation of DNA damage responses. Using a combination of techniques, such as 
gene deletion and overexpression studies, the response to telomere uncapping can be 





   1.1.4   Telomeres, DSBs and the DNA damage response (DDR) 
The dysfunction or loss of telomeric binding proteins leads to the initiation of the 
DNA damage response (DDR). Uncapping caused by loss of Cdc13 function at 
telomeres or the absence of Yku70 leads to exposure of the terminus of the 
chromosome This is recognised as a double strand break (DSB), and the response to 
uncapped telomeres resembles the response to DSBs with a few key exceptions. 
Following the detection of a DSB, the MRX (Mre11-Rad50-Xrs1) complex binds to 
and processes the break, generating a 3’ overhang (D'Amours and Jackson, 2002). 
However, if the MRX complex is absent ssDNA may still be generated, though this 
generation is delayed (Diede and Gottschling, 2001). The 3’ ssDNA is possibly 
generated in the absence of the MRX complex by Exo1, a 5’ to 3’ exonuclease. The 
3’ overhang at the break is bound by the RPA complex and recognised by ATR (in 
humans) or Mec1 and Ddc2 (in yeast), which recruit HR proteins to the break (Zou 
and Elledge, 2003). The Ddc1-Rad17-Mec3 complex (the 9-1-1 complex in humans) 
is loaded onto DNA by the Rad24/Rfc2-5 (replication factor C-like complex with 
Rad24) clamp loader and enhances Mec1-dependent checkpoint activation (Majka et 
al., 2006). Rad9, along with the activities of Rad53 and Chk1, transmits the DNA 
damage signal which results in cell cycle arrest at G2-M (Sweeney et al., 2005; 
Gilbert et al., 2001). 
 
The response to telomere uncapping differs from the response to double strand 
breaks in that MRX does not play a role in resection of the C-rich strand to generate 
a 3’ overhang; rather, the MRX complex may play more of a protective role in 
telomere capping (Foster et al., 2006; Tsukamoto et al., 2001). Following a shift of 
cdc13-1 strains to restrictive temperatures, the uncapped telomere is detected as a 
DSB with a short 3’ overhang (Figure 1.3). The initial step of the response to 
uncapping is the loading of the Ddc1-Mec3-Rad17 sliding clamp by Rad24/Rfc2-5 
(Green et al., 2000; Venclovas and Thelen, 2000). This clamp, along with a helicase, 
processes the telomere, producing a substrate which is recognised by the 
Mec1/Rad53/Dun1-dependent checkpoint pathway (Maringele and Lydall, 2002). 
Exo1 (possibly along with another, unknown, nucleases) processes the telomere 
further still, leaving a 3’ overhang (Maringele and Lydall, 2002). This long ssDNA 
overhang initiates the Rad9/Mec1/Chk1- and Pds1-dependent checkpoint pathway 
































Figure 1.3: Telomere uncapping and the DNA damage response 
(a) Following a shift to restrictive temperature, telomere capping in cdc13-1 strains 
is defective and leads to the generation of a long single-stranded 3’overhang. The 
presence of this overhang initiates the Mec/Rad53/Dun1-dependent and 
Rad9/Mec1/Chk1- and Pds1-dependent checkpoint pathways and leads to cell cycle 
arrest. (b) A shift to restrictive temperature in yku70∆ strains leads to the generation 
of a 3’ overhang, the activation of the Rad9/Mec1/Chk1- and Pds1-dependent 






























cascade, prompting cell cycle arrest in G2-M.   
 
In yku70∆ strains the response to telomere uncapping due to a dysfunctional Ku 
complex involves similar processes – the uncapped telomere is recognised as a DSB, 
the 3’ ssDNA overhang is extended and the 5’ strand is processed by the 
exonuclease Exo1 (Maringele and Lydall, 2002). However, there are differences 
between the response to telomere uncapping in cdc13-1 strains and the response to 
uncapping in yku70∆ strains. For instance, following telomere uncapping in yku70∆ 
strains, Rad24 and the Ddc1/Mec3/Rad17 sliding clamp are not required for Exo1 
recruitment and the Mec1/Rad53/Dun1-dependent checkpoint pathway is not 
initiated, although it has been shown that Rad53 is activated at 37oC at very low 
levels in yku80∆ mutants (Maringele and Lydall, 2002; Teo and Jackson, 2001). 
However, Exo1 is still recruited to the uncapped telomere and the 3’ overhang 
produced by the activity of the exonuclease activates the Rad9/Mec1/Chk1- and 
Pds1-dependent pathway (Figure 1.3) (Maringele and Lydall, 2002). In addition to 
regulating the transcription of downstream effectors, the DNA damage response also 
regulates activity at the uncapped telomere. Exo1 activity at unprotected telomeres is 
inhibited by its checkpoint-dependent phosphorylation, mediated by Rad17, Rad24, 
Rad9, Rad23 and Mec1 (Morin et al., 2008). This potentially limits ssDNA 
production at uncapped telomeres, which therefore limits DNA damage checkpoint 
activation and so acts as a negative feedback loop (Morin et al., 2008). 
 
 
   1.1.5   The DDR and nucleotide production  
Downstream of the Rad53 and Chk1 pathways are various effectors of the DNA 
damage response and it is the change in activity of these effectors which results in an 
arrest in cell division. The downstream DNA damage response is widespread and 
varied, and can affect the transcription of a number of genes. Some of the effectors 
of Dun1 and Pds1 include transcription factors and transcriptional repressors, which 
regulate the genome-wide transcriptional response to telomere uncapping. For 
instance, activation of Dun1 leads to an alteration in ribonucleotide reductase (RNR) 
activity through a variety of pathways and processes (Elledge et al., 2005; Reichard, 
1988). Upon activation as part of the DNA damage response, Dun1 phosphorylates 
the transcriptional repressor Crt1, which prevents the transcription of genes that 
 15 
 
encode the RNR subunits (Huang et al., 1998; Huang and Elledge, 1997; Zhou and 
Elledge, 1993). This targets the transcriptional repressor for degradation and allows 
expression of RNR2, RNR3 and RNR4, and leads to an increase in RNR transcript 
concentration (Fu et al., 2008).  
 
RNR activity is also regulated by Dun1 via the degradation of Sml1 (Zhao and 
Rothstein, 2002). Sml1 binds to the large subunit of ribonucleotide reductase, Rnr1, 
and suppresses activity of the enzyme (Zhao et al., 2000; Chabes et al., 1999; Zhao 
et al., 1998). Dun1 phosphorylates Sml1, targeting it for degradation and allowing 
RNR to catalyse the conversion of ribonucleotides to the deoxyribonucleotides, 
which are in turn used in the synthesis of DNA. In addition to transcriptional 
changes and degradation of inhibitors, RNR activity is also promoted through the 
redistribution of Rnr2 and Rnr4, which move from the nucleus to the cytoplasm (An 
et al., 2006). This redistribution is mediated by the Mec1/Rad53/Dun1 checkpoint 
kinase pathway and occurs in response to DNA damage, including when cdc13-1 
cells are shifted to non-permissive temperatures (Yao et al., 2003). Therefore, as part 
of the DNA damage response there is a robust stimulation of RNR production and 
activity via the increased expression of RNR subunits and the removal of 
suppression by Sml1.  
 
 
   1.1.6   Longevity and cancer 
A lack of telomerase activity in cells, either due to mutation or lack of expression  
(such as seen in human somatic cells) can lead to progressive telomere shortening 
upon cell division due to the end replication problem (as discussed in Chapter 1.1.2) 
(Harley et al., 1990). In 1973, Olovnikov proposed that the shortening of telomeres 
eventually results in cell death, and that this shortening may play a role in the entry 
of cells into a senescent state (Olovnikov, 1973). All human cells possess the ability 
to produce telomerase, but not all express the necessary genes for its synthesis. Only 
embryonic cells and stem cells express telomerase, allowing them to divide 
repeatedly without shortening of the telomeres (Wright et al., 1996). Somatic cells, 
in contrast, do not express telomerase and so lose a terminal fragment of telomeric 
DNA upon each cell division. The telomere is finite, which means that once the 
telomere has been lost, the coding DNA is exposed to degradation. At this point, the 
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cell reaches its replicative limit, stops dividing and enters senescence. Studies into 
ageing have investigated whether the telomeres found in cells of elderly subjects are 
shorter than those of their younger counterparts and found that, in the majority, this 
is the case (Allsopp et al., 1992; Harley et al., 1990). Additionally, telomeres from 
patients with premature ageing syndromes appear to be far shorter than those of 
people of the same age without the disease (Blasco, 2005). However, there can be a 
large amount of heterogeneity between the subjects with regards to the original 
length of the telomeres, which subsequently affects telomere length even after 
several cell divisions (Allsopp et al., 1992).  
 
The concept of the role of telomere shortening in ageing originated from tissue 
culture experiments, in which human fibroblast cells only divide a certain number of 
times, and then ceased to divide further. The Hayflick Limit is the number of times a 
cell can divide before entering a senescent state (Hayflick and Moorhead, 1961). 
This ‘limit’ is named after the scientist who, upon studying human fibroblast cell 
cultures in vitro, discovered that cells have a finite replicative capacity. It is thought 
that this number of divisions is linked to telomere shortening, and that once the 
telomere reaches a critical length, the Hayflick Limit has been reached. Human 
fibroblast cells can undergo ~60 population doublings in vitro before entering 
senescence – a highly stable state (Figure 1.4). At this stage, the cell cycle is arrested 
by tumour suppressors such as p53 and retinoblastoma (RB) protein (Artandi and 
DePinho, 2000; Hara et al., 1991; Shay et al., 1991). If the functionality of these 
tumour suppressors is compromised (for example by tumour viruses) the checkpoint 
is bypassed and cells can divide once more, with the capacity for division limited to 
around 20-30 divisions. This stage is known as ‘crisis’ and is accompanied by a high 
spontaneous mutation rate. Any spontaneous mutations in the DNA are not dealt 
with because of a lack of cell cycling and dysfunction of the associated checkpoints 
which usually protect the cell from damage. These mutations can lead to the 
expression of proteins not typically expressed in normal cells and this means that 
telomerase can potentially be expressed in these cells in crisis. This is rare, occurring 
in about 1 in 10 million human cells (Wright and Shay, 1992). New telomerase 
activity can lead to the elongation of critically short telomeres and the resumption of 
cell division. If a random mutation leads to the activation of telomerase, the cells can 
exit the crisis state and become ‘immortal’, dividing indefinitely and unchecked. 
 
Figure 1.4: Replicative capacity, replicative senescence and cancer
Human somatic cells have a finite replicative capacity (between 60-80 population 
doublings in culture) due to telomere shortening. Telomeres shorten until they reach 
a critcal length between 4-6kb and cell-cycle arrests irreversibly (blue line). Cells can 
continue to divide indefinitely if telomerase is activated before senescence (green). If 
the p53 and RB1 pathways are suppressed then cells continue to divide (orange). 
Telomerase activation before end protection is lost prevents genomic instability (light 
pink); otherwise the complete loss of end protection results in telomeric crises, cell 
death and genomic instability (dark pink). The accumulation of mutation means that 
activation of telomerase at this point results in clones carrying multiple mutations 
with the ability to escape cell death, and these cells are predisposed to oncogenic 




This is one of the proposed mechanisms for the proliferation of cancerous cells and 
the initiation of tumour growth (Harley et al., 1994).  
 
Telomerase is commonly a target for anti-cancer drugs. When activity of the reverse 
transcriptase is prevented in the immortal cells found in tumours, the spread of 
cancerous cells can be slowed or even stopped (Hahn et al., 1999). Most of these 
drugs target hTERT (the human equivalent of yeast Est2) due to its catalytic activity 
(Shay and Wright, 2006). However, a number of compounds are under investigation 
as potential anti-cancer drugs due to their ability to inhibit telomerase via alternative 
mechanisms. Ligands which bind to and stabilise nucleic acid structures known as 
G-quadruplexes have been shown to prevent the action of telomerase and are 
effective against cancer cell lines (Mikami-Terao et al., 2009; Mikami-Terao et al., 


























1.2.1   G-quadruplex structure and location 
Due to the chemical structure of nucleotides, hydrogen bonds can form between the 
bases which make up DNA and RNA. Bonding between bases can lead to the 
formation of complex structures within nucleic acid sequences. Guanine (Figure 
1.5a) is a derivative of purine and forms a pair with cytosine through three hydrogen 
bonds. However, multiple guanines can also bind together, forming structures such 
as G-quartets and G-quadruplexes. A G-quartet in DNA and RNA is formed when 
four guanine bases in close proximity interact through Hoogsteen hydrogen bonding, 
forming a planar structure (Williamson et al., 1989; Gellert et al., 1962). The 
stacking of several G-quartets together results in the formation of a higher structure 
known as a G-quadruplex (Williamson et al., 1989). The presence of a cation (for 
example potassium) within the central channel of this quadruplex can stabilise the 
structure (Figure 1.5b) (Guschlbauer et al., 1990). The structure of the G-quadruplex 
is dependent on the number of consecutive guanine bases (Figure 1.5c, adapted from 
(Guo, 2008)). For instance, a quadruplex formed from a single strand where four 
distinct runs of guanine bases are in close proximity is called an intramolecular 
quadruplex (Wang and Patel, 1994; Williamson et al., 1989). Conversely, a 
tetramolecular quadruplex is formed from four individual strands containing a single 
run of guanines (Wang and Patel, 1993; Sen and Gilbert, 1988). Bimolecular 
quadruplexes are formed from two separate guanine-rich strands (Kang et al., 1992; 
Sundquist and Klug, 1989). Other bases, such as thymine, are able to form 
equivalent quartet structures; however, they are significantly less stable and cannot 
form the channels required for the stabilising cation (Balasubramanian et al., 2011). 
 
A sequence which holds the potential to form a quadruplex is known as a putative 
quadruplex sequence (PQS). Huppert & Balasubramanian (2005) identified a rule 
for PQS prediction based on primary DNA sequence for investigating the prevalence 
of PQSs within the genome. The research lead to the proposition of the Folding Rule 
- ‘A sequence of the form d(G3+N1-7G3+N1-7G3+N1-7G3) will fold into a quadruplex 





















































Figure 1.5: G-quadruplex structure and formation
(a) The structure of guanine. (b) Hydrogen bonds form between four proximal guanines 
to form a G-quartet. G-quartets stack to form G-quadruplexes. (c) G-quadruplexes can be 







and near-physiological conditions are 100 mM KCl and 10 mM Tris-HCl (pH 7.4) 
(Huppert and Balasubramanian, 2005). 
 
 
1.2.2   Prevalence, conservation and role of G-quadruplexes 
Using the above folding rule, an algorithm (the quadparser algorithm) was 
developed which could identify PQSs in genomic DNA. This algorithm counts both 
G-rich and C-rich patterns (‘G-patterns’ and ‘C-patterns’) since in theory a G-
quadruplex could be formed in a complementary strand (Huppert and 
Balasubramanian, 2005). The algorithm found a large number of sequences within 
the human genome with G-quadruplex-forming potential, and that as many as 
376,000 quadruplexes could potentially exist at the same time (which is unlikely to 
occur, due to the dynamic equilibrium between quadruplexes and other DNA 
structures) (Huppert and Balasubramanian, 2005). The PQSs identified are spread 
throughout the genome. Regions of DNA with G-quadruplex-forming potential have 
unsurprisingly been identified within telomeres, due to the guanine-rich nature of 
telomeric regions (Huppert and Balasubramanian, 2005). The quadruplex-forming 
motif has also been indentified in non-telomeric regions of DNA, most interestingly 
in promoter regions. Indeed, quadruplex-forming sequences are highly prevalent in 
human gene promoters, with >40% of annotated genes containing one or more 
promoter quadruplexes (Huppert and Balasubramanian, 2007). One specific 
promoter region with quadruplex forming potential has garnered a considerable 
amount of interest. An extremely stable G-quadruplex structure has been found to 
form within the promoter region of human c-MYC, an oncogene linked to cell 
proliferation and inhibition of differentiation, and which is therefore associated with 
a number of cancers (Ambrus et al., 2005; Siddiqui-Jain et al., 2002). G-
quadruplexes can also form within the promoter regions of human VEGF (vascular 
endothelial growth factor), KRAS proto-oncogene and human BCL2 (Cogoi and 
Xodo, 2006; Dai et al., 2006a; Dai et al., 2006b; Sun et al., 2005).  
 
Since the expression of oncogenes is linked to malignant transformation, the 
presence of G-quadruplexes in their promoters regions may offer important 
information on how their expression is regulated (Dexheimer et al., 2006). It has 
been proposed that since G-quadruplex structures can potentially form within 
 22 
 
promoter regions and their presence is transient due to their dynamic behaviour, 
quadruplexes have a role to play in the regulation of gene expression (Hershman et 
al., 2008; Huppert and Balasubramanian, 2007; Siddiqui-Jain et al., 2002). G-
quadruplexes can also form within RNA, and therefore have an additional link to the 
regulation of gene expression. RNA G-quadruplexes can inhibit translation in vivo – 
for instance, a highly conserved RNA G-quadruplex in the 5’-UTR of the mRNA of 
the human zinc-finger protein Zic-1 represses protein synthesis in eukaryotic cells 
(Arora et al., 2008). Similarly, an RNA G-quadruplex has been found in the 5’-UTR 
of the human NRAS oncogene which has the ability to modulate the translation of 
the mRNA (Kumari et al., 2007). Sequences with the potential to form G-
quadruplexes are well conserved, particularly in promoter regions. An in silico study 
of human, chimpanzee, rat and mouse promoters found G-quadruplex-forming 
motifs to be highly prevalent near transcription starts sites (Verma et al., 2008). The 
study also found high levels of conservation between species, with >700 
orthologously related promoters in human, mouse and rat containing sequence with 
quadruplex-forming capabilities (Verma et al., 2008).  
 
 
1.2.3   G-quadruplexes and telomeres 
In humans and other vertebrates, the highest occurrence of regions with the potential 
to form G-quadruplexes is in the guanine-rich telomeres (Huppert, 2008). G-
quadruplexes have been identified in the telomeric regions of a number of organisms 
including Stylonychia lemnae, Tetrahymena and Oxytricha nova, in spite of 
differences in telomeric sequence (Schaffitzel et al., 2001; Wang and Patel, 1995; 
Balagurumoorthy and Brahmachari, 1994; Wang and Patel, 1994; Blackburn, 1991; 
Henderson et al., 1987). Human telomeric G-quadruplexes have been found to form 
spontaneously in vitro under physiological conditions and are relatively stable 
(Balagurumoorthy and Brahmachari, 1994). Antibodies against telomeric G-
quadruplex DNA have been used to determine whether G-quadruplexes can form in 
vivo, and experiments in Stylonychia found strong signals for anti-parallel G-
quadruplexes (Schaffitzel et al., 2001). In the study, single-chain antibody fragments 
(scFvs) antibodies specific for Stylonychia telomeric G-quadruplex DNA were 
selected in vitro by ribosome display, then used to probe Stylonychia macronuclei 
and micronuclei (Schaffitzel et al., 2001). Through in situ immunofluorescence 
 23 
 
experiments, specific antibody binding to the macronucleus was observed using the 
scFv antibody Sty49, (Schaffitzel et al., 2001). Other methods of in vivo quadruplex 
detection in a number of organisms include use of highly fluorescent compounds 
and ligands which bind tightly to G-quadruplexes (Yang et al., 2009; De Cian et al., 
2008; Neidle and Parkinson, 2008). G-quadruplexes are not permanent nucleic acid 
structures and they exist in equilibrium between the G-quadruplex form and single 
stranded form. The formation and resolution of G-quadruplexes is likely to be 
tightly regulated. TEBPα and TEBPβ are telomere binding proteins which bind to 
the 16-nucleotide G-overhang in Oxytricha, with TEBPα binding specifically to the 
overhang and TEBPβ dimerising with TEBPα (Gray et al., 1991; Gottschling and 
Zakian, 1986). Telomere binding proteins, TEBPs, found in Stylonychia lemnae, 
also cooperate to regulate the formation of G-quadruplexes, and the in vivo 
formation of the structures is regulated by TEBPβ (Paeschke et al., 2005).  
 
Links between telomere-associated proteins and G-quadruplex maintenance have 
also been noted in other organisms. Rap1, which has a role in telomere maintenance 
in yeast, binds to and promotes the formation of intermolecular quadruplexes  in 
vitro (Giraldo and Rhodes, 1994). The highly conserved telomere binding protein 
POT1, on the other hand, prevents the formation of G-quadruplexes at telomeres, 
which in turn promotes the action of telomerase (Zaug et al., 2005; Lei et al., 2003). 
G-quadruplexes can also be removed through the action of helicases – for example, 
the yeast helicase Sgs1 and human WRN and BLM helicases (which all bind G-
quadruplexes with high affinity via conserved RQC domain) all have potent G-
quadruplex unwinding abilities in vitro (Huber et al., 2006; Fry and Loeb, 1999; Sun 
et al., 1999; Sun et al., 1998). The RQC domain of Sgs1 in S. cerevisiae can stabilise 
G-quadruplexes and can compensate for the dysfunction of the essential telomere 
binding protein Cdc13 (Smith et al., 2011). The temperature sensitivity of cdc13-1 
strains is suppressed when the RQC domain is over-expressed in SGS1 null mutants. 
This phenotypic suppression can also be achieved through over-expression of STM1, 





1.2.4   G-quadruplex binding ligands and cancer 
Monovalent cation-mediated G-quadruplex formation at telomeres can negatively 
regulate the action of telomerase in vivo (Zahler et al., 1991). Since around 85% of 
all human cancers are linked to telomerase activity regulation, the stabilising of G-
quadruplexes has been under scrutiny for many years as an option for anti-cancer 
therapeutics (Neidle and Read, 2000; Kim et al., 1994). As described above, the 
presence of G-quadruplex structures can be transient, existing in equilibrium 
between a folded- and an unfolded-form. If the G-quadruplex structure were to be 
stabilised, this could potentially provide a method of permanently preventing 
telomerase activity.  Inhibition of telomerase activity by ligand-mediated G-
quadruplex stabilisation was first demonstrated using 2,6-diamidodianthraquinone 
(Sun et al., 1997). Therefore a number of G-quadruplex binding ligands are under 
investigation for their efficacy in inhibiting telomerase activity with a view to 
treating cancer.  
 
Both synthetic and natural agents can act as ligands which bind G-quadruplexes. 
Many ligands which have so far demonstrated G-quadruplex binding abilities 
contain a core polyaromatic ring. For instance, compounds such as those belonging 
to the acridine family, which contain this polyaromatic ring, have a high affinity but 
low selectivity for duplex DNA, utilising base stacking and intercalation (Read et 
al., 2001; Harrison et al., 1999; Read et al., 1999). Other families of G-quadruplex 
stabilising compounds which contain polyaromatic heterocyclic ring systems include 
porphyrins, perylenes and anthraquinones (Neidle and Balasubramanian, 2007; 
Kerwin, 2000; Neidle and Read, 2000). The best characterised G-quadruplex 
binding ligand is the trisubstituted acridine BRACO-19, which has the ability to 
interact with three G-quadruplex grooves due to the compound’s three side arms 
(Moore et al., 2006; Schultes et al., 2004). Studies in vivo demonstrate that BRACO-
19 can cause telomere shortening and significant changes in telomerase catalytic 
activity (Burger et al., 2005).  
 
Many G-quadruplex binding ligands are of interest in the development of anti-cancer 
drugs, mainly due to the role of G-quadruplexes in the inhibition of telomerase 
activity. G-quadruplex binding ligands have already demonstrated efficacy against 




TMPyP4 (5,10,15,20-tetratkis-(N-methyl-4-pyridyl)-21,23-H-porphyrin). TMPyP4 
is a cationic porphyrin, which requires the binding of a metal ion to function. It has a 
high affinity but low selectivity for quadruplex nucleic acids (Freyer et al., 2007; 
Ren and Chaires, 1999). It has already been shown to inhibit telomerase in vitro and 
is effective against some cancer cell lines, such as MX-1 mammary tumours and PC-
3 human prostate carcinomas (Mikami-Terao et al., 2009; Mikami-Terao et al., 
2008; Grand et al., 2002). TMPyP4 also affects the c-MYC oncogene-dependent 
transcription of several genes including TERT, which encodes the human homologue 
of the S. cerevisiae telomerase reverse transcriptase subunit Est2 (Mikami-Terao et 
al., 2009; Mikami-Terao et al., 2008; Grand et al., 2002). Treatment with TMPyP4 
induces the elevated transcription of a number of oxidative stress response genes in 
human cell lines (Grand et al., 2002). Another G-quadruplex binding ligand under 
investigation as an effective cancer treatment is the pentacyclic acridine RHPS4 
(Cookson et al., 2005). Whereas TMPyP4 has the ability to both intercalate between 
adjacent G-tetrads and also stack onto the external G-quartet, RHPS4 strongly 
interacts with the two external G-quartets of the G-quadruplex, a complex which has 
been solved by NMR (Wei et al., 2006; Phan et al., 2005; Gavathiotis et al., 2003; 
Gavathiotis et al., 2001; Haq et al., 1999). Studies have shown that RHPS4 inhibits 
cell proliferation of human melanoma lines in a dose-dependent manner during short 
term treatment, and acts in a telomere-length independent manner to cause telomere 
dysfunction (Leonetti et al., 2004). The compound is also effective against uterus 
carcinoma cells, MCF-7 breast cancer cells and has an anti-metastatic effect on 
human melanoma xenografts in mice (Leonetti et al., 2008; Phatak et al., 2007; 
Cookson et al., 2005). RHPS4 triggers a rapid and potent ATR-dependent DNA 
damage response at telomeres in human cell lines and leads to the displacement of 
hTERT (the catalytic subunit of telomerase) from the nucleus, as well as 
chromosome fusions (Phatak et al., 2007; Salvati et al., 2007). Although no G-
quadruplex binding ligands are in use currently as anti-cancer drugs, several (for 
example, Quarfloxin) have entered phase II clinical trials on cancer patients 










1.3  The Pentose Phosphate Pathway (PPP) 
 
1.3.1   Cancer cell metabolism and the pentose phosphate pathway 
Highly proliferating cells, such as those found in tumours, require increased 
concentrations of nucleotides in order to replicate DNA and rapidly progress 
through the cell cycle. The most widely acknowledged alteration to cellular 
metabolism in cancer cells is the production of energy through glycolysis followed 
by the fermentation of lactic acid in the cytosol (aerobic glycolysis), instead of 
oxidation of pyruvate in mitochondria. This alteration in metabolism is also known 
as the Warburg effect and the existence of an oxidative pathway for glucose-6-
phosphate metabolism was first demonstrated in the 1930s (Dickens, 1938; Warburg 
and Christian, 1937; Lipmann, 1936; Warburg et al., 1935). Since aerobic glycolysis 
is an inefficient method of ATP generation (generating only 2 ATPs per molecule of 
glucose, compared to oxidative phosphorylation generates up to 36 ATPs per 
glucose molecule), the advantage that the Warburg effect confers on cancer cells is 
unclear. It has been suggested that the changes in metabolism favour the production 
of cellular components required for rapid division and proliferation (Vander Heiden 
et al., 2009). This includes nucleotides and amino acids, the precursors of which 
(ribose-5-phosphate and erythrose-4-phosphate) are generated by the pentose 
phosphate pathway (PPP) (Figure 1.6). The PPP (which is also known as the 
phosphogluconate pathway or the hexose monophosphate shunt) is also a source of 
NADPH, which is required for nucleic acid production and fatty acid synthesis.  
 
In cancer cells, around 85% of pentoses incorporated into DNA are provided by the 
PPP (Raïs et al., 1999). Activity of the glycolytic enzyme pyruvate kinase is 
modulated in response to growth factor signalling which occurs in cancer cells 
(Christofk et al., 2008a; Christofk et al., 2008b), which may promote flux into the 
PPP. Flux into the PPP can also be affected by the expression of a p53-inducible 
regulator of glycolysis and apoptosis known as TIGAR, the expression of which 
leads to a reduction in ROS levels (Bensaad et al., 2006). TIGAR expression results 
in the inhibition of phosphofructokinase, which redirects glucose towards the PPP 
(Bensaad et al., 2006). The first step of the oxidative phase of the PPP is catalysed 


























































































Figure 1.6: NAD+ biosynthesis, NAD+ phosphorylation and the PPP in yeast
NAD+ biosynthesis and the pentose phosphate pathway (PPP) are linked through the 
action of the NAD+ kinases Utr1 and Yef1 (Reaction 2). The different colours represent 
different stages or process of the pathways: for instance, the oxidative and non-oxidative 
phases of the PPP. Red numbers indicate reactions which will be referred to throughout 













in Figure 1.6). It has been demonstrated that an increase in G6PDH activity can be 
observed in tumour cells, correlating with an upregulation of the PPP in response to 
the increased requirement for NADPH and nucleotides (Jonas et al., 1992). An 
increase in G6PDH activity favours proliferation and survival, since it results in 
increased concentrations of both NAPDH (for protection against the strong oxidative 
environment encountered by tumour cells) and ribose-5-phosphate (for production 
of nucleotides for increased proliferation). G6PDH activity can be controlled by 
p53, which binds to the enzyme and prevents it from forming dimers (Jiang et al., 
2011). Loss of p53 activity (frequently associated with the development of many 
cancers) removes this inhibition and can therefore favour tumour growth. 
 
In non-transformed tissues, most of the ribose-5-phosphate necessary for nucleotide 
biosynthesis is generated through the oxidative phase of the PPP. However, in 
tumour cells the non-oxidative phase may also be an important source of the 
nucleotide precursor (Langbein et al., 2006; Boros et al., 2000; Cascante et al., 
2000). Accompanying an increase in PPP flux, transaldolase (TA) expression is 
increased in many tumours (Samland and Sprenger, 2009; Lam et al., 2002). 
Transaldolase catalyses the conversion of erythrose-4-phosphate and sedoheptulose-
7-phosphate to glyceraldehyde-3-phosphate and fructose-6-phosphate (Reaction 9 in 
Figure 1.6). Interestingly, there are links between the overexpression of certain 
isoforms of key PPP genes and various cancers. In humans, the transketolase family 
includes two transketolase-like proteins (TKTL1 and TKTL2) as well as 
transketolase (TK). Transketolases catalyse several steps of the non-oxidative phase 
of the PPP (Reactions 8 and 10 in Figure 1.6). The TKTL form of the human 
transketolase demonstrates very low activity in normal, untransformed cells; 
however, in cancer tissues, TKTLs are present and active, and work at a higher basal 
rate than TK (Coy et al., 2005). TKTL1 is over-expressed in a range of cancer cell 
lines, from invasive colon and urethelial tumours to uterine cervix cancer cells 
(HeLa) (Chen et al., 2009; Krockenberger et al., 2007; Langbein et al., 2006). Their 
expression also correlates with tumour progression in addition to proliferation rate 
(Langbein et al., 2008; Krockenberger et al., 2007; Langbein et al., 2006). Due to 
their over-expression in malignant tissues and the role of the PPP tumour 
development, TKTLs can be thought of as proto-oncogenes (Langbein et al., 2008; 




1.3.2   The PPP and conservation between species 
The pentose phosphate pathway is linked to glycolysis and gluconeogensis via 
glucose-6-phosphate and the intermediates fructose-6-phosphate and 
glyceraldehyde-4-phosphate which are produced by the pathway (Figure 1.6). In S. 
cerevisiae, the majority of glucose is fed into glycolysis, with as little as ~15% of 
glucose diverted through the PPP under normal growth conditions (Frick and 
Wittmann, 2005). This proportion can change due to various stresses, such as the 
presence of reactive oxygen species (ROS) and blockage of glycolysis through 
inactivation of key enzymes such as glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and phosphofructokinase (Ralser et al., 2007; Bensaad et al., 2006; Ralser 
et al., 2006). In higher organisms the activity of the enzymes which drive the 
oxidative phase of the PPP can be altered by changes in nutritional and hormonal 
conditions (Tomlinson et al., 1988; Back et al., 1985; Eggleston and Krebs, 1974). 
The PPP is well conserved between species; as in yeast, 80-90% of glucose 
oxidation in humans takes place via glycolysis, with the remaining 10-20% 
occurring via the PPP (Wamelink et al., 2008). The strong conservation of the 
pathway suggests that it plays an important and necessary role in cellular 
metabolism.  
 
The main roles of the PPP stem from its products. As noted above in Chapter 1.3.1, 
the PPP is a source of NADPH, ribose-5-phosphate and erythrose-4-phosphate. The 
first step of the oxidative phase of the pathway is the predominant source of cellular 
NADPH, the alternative sources in yeast being the third step in oxidative phase of 
the PPP (catalysed by 6-phosphogluconate dehydrogenase, 6PGDH), and the 
activity of the  cytosolic acetaldehyde dehydrogenase Adh1. The latter enzyme 
contributes to NADPH generation to a lesser extent than the reactions of the PPP; 
80%  of the total NADPH required under normal conditions in budding yeast is 
generated by the first step of the PPP, with the remainder being produced by the 
activity of Adh1 (Celton et al., 2012).  NADPH is an essential cellular reducing 
agent, maintaining the redox balance and protecting against the harmful effects of 
oxidative damage. NADPH is also important for fatty acid biosynthesis, where it is 
used in the conversion of acetyl-CoA and malonyl-CoA into palmitate in a reaction 
catalysed by fatty acid synthetase (FAS) (Wakil et al., 1983). The non-oxidative 
phase of the PPP produces ribose-5-phosphate and erythrose-4-phosphate. The 
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former is a precursor for purine ribonucleotide biosynthesis and latter can be used to 
generate amino acids such as tyrosine, phenylalanine and tryptophan. Deletion of 
genes key to both phases of the pentose phosphate pathway in yeast is lethal. For 
instance, a strain which harbours null mutations for both the glucose-6-phosphate 
dehydrogenase ZWF1 and the transketolase TKL1 is not viable (Deutscher et al., 
2006). Since NADPH can still be produced in zwf1∆ strains (Grabowska and 
Chelstowska, 2003), the lethality which occurs in the double mutant may be due to 
the lack of ribose-5-phosphate, which would otherwise be generated by either 
branch of the PPP (see Figure 1.6). 
 
 
1.3.3   The oxidative phase of the PPP 
The pentose phosphate pathway is composed of two independent phases – the non-
reversible oxidative phase, and the fully reversible non-oxidative phase (Figure 1.6). 
NADPH is generated in the first step of the oxidative phase of the PPP, in which 6-
phospho-gluconolactone is produced from glucose-6-phosphate, reducing NADP+ to 
NADPH in the process. The NADPH-generating first step of the oxidative phase of 
the PPP is rate-limiting and is catalysed by glucose-6-phosphate dehydrogenase 
(G6PDH, Zwf1 in S. cerevisiae). Human and yeast G6PDH demonstrate 47% 
homology in terms of amino acid sequence (Kletzien et al., 1994). G6PDH is 
constitutively expressed and is considered to have an important housekeeping 
function. In humans the G6PDH gene is X-linked (hence its constitutive expression), 
but its activity is regulated in specific tissues (Kletzien et al., 1994). For instance, 
hepatic G6PDH activity can increase in response to the presence of insulin, 
glucocorticoids and carbohydrates in the diet (Kletzien and Berdanier, 1993). It has 
also been shown that dietary fat can decrease the induction of G6PDH activity 
(Katsurada et al., 1989; Tomlinson et al., 1988).  
 
G6PDH activity is predominantly regulated by the NADP+/NADPH ratio. In human 
erythrocytes, the affinity of G6PDH for NADP+ increases from low to high when the 
concentration of NADP+ is increased, a result which may be explained by the 
presence of multiple NADP+ binding sites within the enzyme (Luzzatto, 1967). 
NADPH inhibits G6PDH by competing with NADP+ for binding sites, but it may 
also enhance the affinity of the remaining binding site(s) for NADP+ (Luzzatto, 
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1967). NADP+ is also necessary for stabilising G6PDH in the proper conformation, 
a property which NADPH lacks; therefore an increase in NADPH concentration 
results in a destabilising effect (Kotaka et al., 2005; Au et al., 2000). These 
alterations in affinity and stability caused by the NADP+/NADPH ratio can 
potentially result in 30-50 fold changes in the NADPH-producing capacity of 
G6PDH (Holten et al., 1976). Other means of G6PDH regulation are by the binding 
of MgCl2 and, in Xenopus laevis and human cell lines, by the binding of a heat 
shock protein (Cosentino et al., 2010). G6PDH deficiency in humans results in 
haemolytic anaemia and is the most widespread enzyme deficiency in the world - a 
prevalence which correlates with areas inhabited by populations historically exposed 
to endemic malaria (Nkhoma et al., 2009). This is thought to be due to defective 
NADPH-regenerating systems in red blood cells of sufferers, which is an 
unfavourable environment for Plasmodia development (Cappellini and Fiorelli, 
2008). 
 
In addition to NADPH, the oxidative phase of the PPP also generates H2O and CO2. 
The 6-phospho-gluconolactone generated in the first step of the pathway is 
hydrolysed in a reaction catalysed by 6-phospho-gluconolactonase (6PGL, Sol3 and 
Sol4 in yeast) to produce 6-phospho-gluconate (Reaction 4 in Figure 1.6). This 
reaction is spontaneous, but is accelerated by the action of 6PGL. It is thought that 
this enzyme prevents the conversion of 6-phospho-gluconolactone into the γ form, 
which cannot spontaneously hydrolyse, and instead accelerates the hydrolysis of the 
δ form of the lactone (Miclet et al., 2001). In Plasmodium falciparum, G6PDH and 
6PGL activities are combined in the same enzyme (Clarke et al., 2001). The 6-
phosphogluconate generated by 6-phospho-gluconolactone hydrolysis is in turn 
decarboxylated by 6-phosphogluconate dehydrogenase (6PGDH, Gnd1 and Gnd2 in 
yeast) to produce ribulose-5-phosphate and more NADPH, along with carbon 
dioxide and water (Reaction 5 in Figure 1.6). The resulting ribulose-5-phosphate 
feeds into the reversible non-oxidative phase of the pathway. 
 
 
1.3.4   The non-oxidative phase of the PPP 
In the non-oxidative phase of the pathway, the pentose carbon backbone from two 
ribulose-5-phosphate molecules is rearranged to produce sugars which feed back 
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into glycolysis. This effectively creates a cycle; indeed, the PPP is sometimes 
referred to as the pentose phosphate cycle, especially in early literature. However, 
several of the intermediates produced in these rearrangements are also important 
precursors to biological molecules; ribose-5-phosphate and erythrose-4-phosphate, 
as described earlier, are the precursors of purine nucleotides and certain amino acids 
respectively. The ribulose-5-phosphate which feeds into the non-oxidative phase of 
the PPP from the oxidative phase is converted to xylulose-5-phosphate and ribose-5-
phosphate by the action of Rpe1 and Rki1 respectively (Reactions 6 and 7 in Figure 
1.6). The human homolog of Rki1, the yeast ribose-5-phosphate ketol-isomerase, is 
known as RPI. RPI deficiency results in progressive leukoencephalopathy (Huck et 
al., 2004; Van der Knaap et al., 1999). Xylulose-5-phosphate and ribose-5-
phosphate are rearranged and inter-converted to generate fructose-6-phosphate, 
glyceraldehyde-3-phosphate, sedoheptulose-7-phosphate and erythrose-4-phosphate 
(Reactions 8, 9 and 10 in Figure 1.6). Reactions of the non-oxidative phase of the 
pentose phosphate pathway are catalysed by transketolase (Tkl1/2 in yeast) and 
transaldolase (Tal1). Deficiency of human transaldolase (TALDO) is associated with 
liver disease (Wamelink et al., 2008).  
 
Because of the reversible nature of the reactions of the non-oxidative phase of the 
PPP, flux can occur in either direction, from glycolysis or from the oxidative phase 
of the pathway. This means that ribose-5-phosphate, the precursor for nucleotide 
biosynthesis, can be manufactured via either route. Indeed, the two differing phases 
of the PPP can be regulated separately, depending on whether there is a necessity for 
the reducing power NADPH or the nucleotide precursor ribose-5-phosphate 
(Clasquin et al., 2011). It has been found recently that one of the intermediates of the 
non-oxidative phase of the PPP, sedoheptulose-7-phosphate, can be produced 
through the action of Shb17 in symphony with transketolase activity (Clasquin et al., 
2011). This can favour ribose-5-phosphate production since it increases the 
availability of intermediates for generation of the purine nucleotide precursor.  
 
 
1.3.5   The PPP and the oxidative stress response 
The reductive capacity of NADPH is used to reduce antioxidants so that they can 
participate in the response to oxidative stress. Oxidative stress occurs when the 
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levels of reactive oxygen species (ROS) (produced during respiration by the 
mitochondria, for example) are high (Chance et al., 1979). The oxidative stress 
response lowers ROS levels and ROS-induced damage. One major element of the 
oxidative stress response is the action of antioxidants such as glutathione (GSH), 
which terminate the chain of oxidation reactions caused by the presence of free 
radicals such as ROS. GSH, for example, is oxidised to form glutathione disulphide 
(GSSG) upon reducing ROS. GSSG is returned to its reduced form of GSH by the 
action of glutathione reductase (GSR). GSR itself is reduced by NADPH. As 
mentioned above, cellular NADPH is predominantly generated by the first step of 
the oxidative phase of the PPP (Celton et al., 2012). NADPH is also used to reduce 
the flavoenzyme thiroredoxin reductase, which in turn keeps the redox proteins 
thiroredoxins in a reduced state.  The oxidation of NADPH to NADP+ through these 
reactions decreases the NADPH/NADP+ ratio. As described above (Chapter 1.3.3), 
this alteration in the ratio can affect G6PDH activity, since NADPH enforces an 
inhibitory effect on the enzyme. Therefore a reduction in NADPH levels, for 
instance, through the oxidative stress response, results in an increase in NADP+ 
concentration, which increases the affinity of G6PDH for NADP+ and increases 
G6PDH activity, which in turn generates more NADPH.  
 
Flux through the PPP in response to oxidative stress can also increase via the 
inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Tdh1-3 in 
yeast) (Ralser et al., 2007; Grant et al., 1999). High levels of ROS inactivate 
GAPDH, which blocks glycolysis and redirects carbohydrate flux into the PPP 
(Ralser et al., 2007; Grant et al., 1999). In this way, GAPDH inactivation acts as a 
metabolic switch to counteract oxidative stress. In addition to this metabolic 
switching, the transcription of PPP genes also increases in response to oxidative 
stress, through the action of the transcription factor Stb5 (Larochelle et al., 2006). 
Studies into other oxidative stress responses have found that the cytosolic 
superoxide dismutase (Sod1) and the pentose phosphate pathway play overlapping 
roles in protection against the presence of reactive oxygen species (ROS). The 
overexpression of the transketolase-encoding gene TKL1 suppresses sod1∆ 
phenotypes in a Zwf1-dependent manner, proposed to be caused by an increase in 
flux through the PPP (Slekar et al., 1996). The pentose phosphate pathway and 
oxidative stress seem intrinsically linked, especially through transcriptional 
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regulation, and studies have shown that PPP activity alone in response to oxidative 
stress can actually influence further transcriptional alterations (Krüger et al., 2011).  
 
 
1.3.6   The PPP and nucleotide production  
The ribose-5-phosphate produced in the non-oxidative phase of the pentose 
phosphate pathway can either continue through this pathway, resulting in the 
production of glycolytic intermediates such as glyceraldehyde-3-phosphate and 
fructose-6-phosphate, or go on to produce nucleotides. The latter occurs through the 
action of phosphoribosylpyrophosphate synthetase and ribose-phosphate 
pyrophosphokinases, which use ribose-5-phosphate to produce phosphoribosyl 
pyrophosphate (PRPP), which is then metabolised further to make nucleotides. 
There are multiple reactions involved in the production of nucleotides (dNTPs); 
however, the rate-limiting reaction in the production of all dNTPs is catalysed by 
ribonucleotide reductase (RNR). RNR catalyses the formation of 
deoxyribonucleotides from ribonucleotides. Reduction of RNR by thioredoxin (itself 
reduced by NADPH) stimulates RNR enzyme activity (Holmgren, 1989). Since 
ribonucleotide reductase also indirectly requires reduction by NADPH to function, 
this means there are two ways in which nucleotide production is linked to the 
pentose phosphate pathway.  
 
Yeast ribonucleotide reductase is a class 1 RNR and is proposed to be an α2β2 
tetramer, composed of a large subunit and a small subunit (Sjöberg, 1997). The 
larger α2 subunit (R1) houses the active site and, during normal growth, consists of a 
homodimer of Rnr1; however, under DNA damage conditions RNR3 expression is 
induced strongly, leading to the hypothesis that Rnr3 expression may increase total 
RNR activity (Domkin et al., 2002). The smaller β subunit (R2) is composed of a 
Rnr2/Rnr4 heterodimer (Chabes et al., 2000). As described previously in Chapter 
1.1.5, the expression of all of the RNR genes can be induced following DNA 
damage, and this alteration in expression is mediated by Dun1, an effector of the 
DNA damage response (Huang and Elledge, 1997; Elledge, 1996; Zhou and Elledge, 
1993). RNR3 is most significantly upregulated, with up to a 100-fold increase in 
expression. Dun1 additionally regulates RNR activity by targeting its inhibitor, 
Sml1, for degradation (Zhao and Rothstein, 2002). Ribonucleotide reductase activity 
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can also be regulated allosterically by nucleotide concentration, in which a high 
level of dATPs inhibits the action of RNR by dATP feedback inhibition (Chabes et 
al., 2003). Research has found that RNR activity (and therefore the concentration of 
nucleotides) is under tight regulation – too few dNTPs, and DNA repair is 
compromised, but too many, and random mutations can occur (Kumar et al., 2011; 
Kumar et al., 2010; Chabes et al., 2003).  
 
Cells can balance the demands of redox homeostasis and biosynthesis placed on the 
PPP through the use of riboneogenesis. Clasquin et al. reported that a 
thermodynamically driven pathway which converts PPP intermediates into ribose-5-
phosphate without NADPH production is present in yeast (Clasquin et al., 2011). 
This pathway, termed riboneogenesis, can increase ribose-5-phosphate production 
when the relative demand for ribose compared to the demand of NADPH is high 
(Clasquin et al., 2011). Riboneogenesis requires the action of Shb17, which 
catalyses the committed reaction of the pathway, along with the activities of Tkl1 
and Rki1 (Clasquin et al., 2011). SHB17, TKL1 and RKI1 expression correlate across 
the yeast metabolic cycle, suggesting that they act together to produce ribose 
(Clasquin et al., 2011). SHB17 and TKL1 expression also anticorrelates with ZWF1 
expression, which suggests that riboneogenesis and the oxidative phase of the PPP 




1.3.7   Other key roles of the PPP 
An increase in PPP activity is also observable in ageing cells and in age-related 
conditions, such as age-linked neurological disorder Alzheimer’s disease. Studies 
into the disease have found that the activities of both G6PDH and 6PGDH, which 
catalyse the NADPH-producing steps of the PPP (Reactions 3 and 5 in Figure 1.6), 
increase in the inferior temporal cortex of patients with Alzheimer’s (Palmer, 1999). 
Age-related increases in the activity of G6PDH and 6PGDH have also been 
observed in the brains of rats (El-Hassan et al., 1981). It is thought that an increase 
in age correlates with an increase in the prevalence of oxidative stress; therefore 
modulating the pentose phosphate pathway may provide protection against age-
related diseases (Finkel and Holbrook, 2000). However, the relationship between the 
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pentose phosphate pathway and lifespan is a complicated one and is not yet 
thoroughly understood (Ralser et al., 2007).  
 
The PPP also plays a role in embryonic development and growth. G6PDH activity 
controls the levels of ROS the embryo is exposed to; ROS levels which are 
controlled at a low level trigger the proper differentiation and growth of the placenta 
and trophoblast during the first trimester (Ufer et al., 2010). G6PDH activity is also 
linked to the differentiation of specific tissues, such as cardiomyocytes, and the 
control of ROS levels is also important in fertility in the maturation of spermatozoa 
(Chung et al., 2010; Perl et al., 2006). G6PDH activity appears to have many 
physiological roles, and deficiency in the enzyme can lead to problems with cell 
growth and signalling, the response to viral infections and can increase susceptibility 
to degenerative diseases, as well as haemolytic anaemia (as discussed in the Chapter 
1.3.3) (Ho et al., 2007). The pentose phosphate pathway is also of interest to the 
wine making industry. S. cerevisiae usually poorly assimilates gluconate (which is 
metabolised by the PPP) when cultured on the substrate. Strains with increased flux 
through the PPP exhibit metabolic changes, including higher fermentation rates and 
reduced acetate production, which are advantageous to the wine-making process 


















1.4 Aims and objectives 
 
The aims and objectives of my project were to investigate the effect of treating yeast 
with the G-quadruplex binding ligand TMPyP4. Due to its ability to bind G-
quadruplexes and interact with telomerase, I expected to find that deletion of key 
telomere- and telomerase-related genes would alter the sensitivity of Saccharomyces 
cerevisiae to TMPyP4 and that this would provide some indication as to its 
mechanism at telomeres.  
 
I also aimed to study the gene deletions which caused an increased sensitivity to this 
molecule more closely, including their interaction with telomeres in the absence of 
TMPyP4, specifically the relationship with telomere capping, through study of the 


















2 Materials and Methods 
 
2.1 Robotics and in silico methods 
 
2.1.1   Yeast culture conditions 
The single gene deletion collection was stored at -80
o
C in 384-well plates (Greiner 
BioOne) in 15% glycerol (Tong and Boone, 2005). Yeast strains were cultured in 
complete synthetic media (CSM) with appropriate amino-acids and G418 (final 




2.1.2   Plate filling 
Rectangular, single chamber, SBS footprint plates (omnitrays; Nunc Thermo Fisher 
Scientific) were filled with 35 ml molten agar media using a Perimatic GP 
peristaltic pump (Jencons (Scientific) Limited, Leighton Buzzard, UK) fitted with a 
foot switch. 96-well plates (non bar-coded; Greiner Bio-One Ltd.) were filled with 
liquid media or distilled H2O (200 µl per well) using a Wellmate plate-filler with 
stacker (Matrix Technologies, Thermo Fisher Scientific). 
 
 
2.1.3   Robotics 
Solid agar to solid agar pinning was performed on a Biomatrix BM3-SC robot (S&P 
Robotics Inc., Toronto, Canada) using either 384-pin (1 mm diameter) or 1536-pin 
(0.8 mm diameter) pintools. Inoculation from solid agar to liquid media was 
performed on the Biomatrix BM3-SC robot using a 96-pin (1 mm diameter) pintool. 
Dilution and spotting of liquid cultures onto solid agar plates was performed on a 
Biomek FX robot (Beckman Coulter (UK) Limited, High Wycombe, UK) equipped 
with a pintool magnetic mount and a 96-pin (2 mm diameter) pintool (V&P 





2.1.4   Growth assays 
Liquid-to-solid agar 384-format robotic spot tests were performed as described 
previously (Addinall et al., 2008). Briefly, colonies were inoculated from the solid 
agar single gene deletion collection plates into 96-well plates containing 200 μl 
CSM supplemented with G418 media in each well (see Robotics, above). The 
cultures were grown to saturation for 3 days, without shaking, at 23°C. Cultures 
were resuspended, diluted approximately 1/100 in 200 μl H2O and spotted onto 
solid CSM and CSM supplemented with 100 µM TMPyP4 (in H2O), 1.5 mM H2O2, 
100 mM HU (in H2O) or 200 µM RHPS4 (in 1% DMSO) plates.  
 
 
2.1.5   Plate incubation and photography 
The plates were incubated at 30
o
C for 5 days in an S&P robotics automated 
integrated imager and incubator and photographed at 6 hour intervals. The spImager 
camera (a Canon EOS Rebel T3i) was used in fully manual mode. Using S&P 
robotics RoboSoft software, the plate number, batch number and a time stamp (date 
in year, month, day and time in hour, minute, second) were incorporated as the 
image name (e.g K000012_030_001_2011-10-17_17-06-15.JPG). 
 
 
2.1.6   Image analysis 
The image analysis tool Colonyzer was used to quantify cell density from captured 
photographs (Lawless et al., 2010). Colonyzer corrects for lighting gradients, 
removing spatial bias from density estimates. It is designed to detect cultures with 
extremely low cell densities, allowing it to capture a wide range of culture densities 
after dilute spotting on agar. Colonyzer is available under GPL at 
http://research.ncl.ac.uk/colonyzer. Modelling of fitness was carried out as 
described in Addinall et al. (2011). 
 
 
2.1.7   Microarray analysis 
The Affymetrix Cell Intensity (CEL) files generated in the Greenall microarray 
(accession number E-MEXP-1551) were downloaded from ArrayExpress, data was  
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normalised using RMA (Robust Multiple-array Average) in GeneSpring GX 10.0, 
and at each time point the average wild type intensity was used as the baseline 
control (i.e. cdc13-10 – wt0, cdc13-160 – wt60) (Greenall et al., 2008; Parkinson et 
al., 2007; Grewal and Conway, 2000). Normalised data was subjected to the 
unpaired T-test (with an asymptotic p-value computation) and data was corrected 
using the Bonferroni family-wise error rate (FWER). Genes with p-value < 0.05 and 
a log2 fold change between wild type and cdc13-1 ≥ 2 were classed as differentially 
expressed.  
 
CEL files were uploaded to CARMAweb and normalised by RMA (Rainer et al., 
2006). The moderated t-statistic (using the Bioconductor limma package) was used 
to calculate p-values and the Bonferroni correction was applied. Genes with p-value 




2.1.8   GO analysis 
GO Analysis was carried out using the GOstat bioinformatics tool (Beißbarth and 
Speed, 2004). Data was analysed using a Fisher's Exact Test, Benjamini & 

















2.2 Yeast protocols 
 
2.2.1   Yeast strains 
Table 2.1 lists the yeast strains that were used in this study. The majority of the 
yeast strains used were based on the W303 S. cerevisiae background. All contain 





 ssd1-d2 RAD5. 
 




640 MATa  R. Rothstein 
1096 MATa  chk1::HIS3 D. Lydall 
1108 MATa  cdc13-1-int D. Lydall 
1195 MATα  cdc13-1-int D. Lydall 
1255 MATa  rad9::HIS3 cdc13-1-int D. Lydall 
1256 MATα  rad9::HIS3 cdc13-1-int D. Lydall 
1273 MATα  exo1::LEU2 D. Lydall 
1320 MATa  rad53::HIS3 sml1::KanMX4 D. Lydall 
1569 MATα rad52::TRP1 D. Lydall 
2641 MATα  chk1::HIS3 cdc13-1-int D. Lydall 
2787 MATα  yku70::LEU2 D. Lydall 
3001 MATα  R. Rothstein 
5441 MATα  rad9::HIS3 D. Lydall 
5514 MATa  pho86::KANMX D. Lydall 
5541 MATa  tkl1::KANMX D. Lydall 
5543 MATa  tkl1::KANMX cdc13-1-int D. Lydall 
5544 MATa  tkl1::KANMX cdc13-1-int D. Lydall 
5547 MATa  tkl1::KANMX rad9::HIS3 cdc13-1-int D. Lydall 
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5548 MATa  tkl1::KANMX rad9::HIS3 cdc13-1-int D. Lydall 
5549 MATα  rpe1::KANMX  D. Lydall 
5550 MATα  rpe1::KANMX  D. Lydall 
5557 MATa  zwf1::KANMX D. Lydall 
5558 MATα  zwf1::KANMX D. Lydall 
5559 MATα  zwf1::KANMX cdc13-1-int D. Lydall 
5560 MATa  zwf1::KANMX cdc13-1-int D. Lydall 
5561 MATa  zwf1::KANMX rad9::HIS3 cdc13-1-int D. Lydall 
5625 MATa  tal1::KANMX rad9::HIS3 cdc13-1-int D. Lydall 
5708* MATα  tal1::KANMX cdc13-1-int D. Lydall 
5709* MATα  tal1::KANMX cdc13-1-int D. Lydall 
5710* MATa  tal1::KANMX cdc13-1-int D. Lydall 
5711* MATα  tal1::KANMX  D. Lydall 
5775 MATa  bar1::hisG cdc15-2-int  D. Lydall 
6345* MATa  yku70::LEU2 tkl1::KANMX 2787 x 5541 
6346* MATα  yku70::LEU2 tkl1::KANMX 2787 x 5541 
6816 MATa  rad53::HIS3 sml1::URA3 cdc13-1-int D. Lydall 
6930 MATa  rad24::TRP1 D. Lydall 
7076 MATα  rad53::HIS3 sml1::URA3 cdc13-1-int D. Lydall 
7105 MATa  bar1::hisG cdc15-2-int D. Lydall 
7428* MATa  zwf1::NATMX 
5557 transformed 
with NatMX 
7429* MATa  zwf1::NATMX 
5557 transformed 
with NatMX 
7440* MATa  zwf1::NATMX tal11::KANMX 7428 x 5708  
7442* MATα  zwf1::NATMX tal11::KANMX cdc13-1-int 7428 x 5708  
7443* MATa  zwf1::NATMX tal11::KANMX cdc13-1-int 7428 x 5708  
7444* MATα  zwf1::NATMX cdc13-1-int 7428 x 5708  
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7445* MATa  zwf1::NATMX cdc13-1-int 7428 x 5708 
7502* MATα  tal11::KANMX rad53::HIS3 sml1::URA3 cdc13-1-int 6816 x 5708 
7506* MATa  tal11::KANMX chk1::HIS3 cdc13-1-int 5708 x 1096 
7507* MATα  tal11::KANMX chk1::HIS3 cdc13-1-int 5708 x 1096 
7515* MATα  tkl11::KANMX rad53::HIS3 sml1::URA3 cdc13-1-int 7076 x 5541 
7518* MATa  tkl1::KANMX chk1::HIS3 cdc13-1-int 5541 x 2641 
7519* MATα  tkl1::KANMX chk1::HIS3 cdc13-1-int 5541 x 2641 
7554* MATa  tal11::NATMX 
5711 transformed 
with NatMX 
7565* MATα  tal11::KANMX rad53::HIS3 sml1::URA3 cdc13-1-int 6816 x 5708 
7570* MATα  tal11::NATMX tkl1::KANMX yku70::LEU2 7554 x 6346 
7571* MATa  tal11::NATMX tkl1::KANMX yku70::LEU2 7554 x 6346 
7572* MATα  tal11::NATMX tkl1::KANMX 7554 x 5543 
7574* MATα  tal11::NATMX tkl1::KANMX cdc13-1-int 7554 x 5543 
7575* MATa  tal11::NATMX tkl1::KANMX cdc13-1-int 7554 x 5543 
7576* MATa  tal11::NATMX yku70::LEU2 7554 x 6346 
7577* MATα  tal11::NATMX yku70::LEU2 7554 x 6346 
7578* MATa  tal11::NATMX cdc13-1-int 7554 x 5543 
7579* MATα  tal11::NATMX cdc13-1-int 7554 x 5543 
7580* MATa  tkl11::KANMX rad53::HIS3 sml1::URA3 cdc13-1-int 7076 x 5541 
7684* MATa  tkl11::NATMX 
5544 transformed 
with NatMX 
7711* MATα  tal1::NATMX rpe1::KANMX 7578 x 5549 
7717* MATa  tkl1::NATMX rpe1::KANMX 7684 x 5549 
7721* MATα  tkl1::NATMX 7684 x 5549 
DDY179 MATa/MATα  cdc13-1/CDC13 rad9::HIS3/RAD9 D. Lydall 
 






2.2.2   Plasmids 
Plasmids used in this study are listed in Table 2.2. Plasmids were stored at -20
o
C in 
1 x TE.  
  
Plasmid Details Source 
pDL1155 Plasmid used to switch from kanMX 
cassette to natMX cassette 
p4339 (provided by 
C. Boone) 
pDL1042 Plasmid for amplification of kanMX6 
cassette by PCR 
pFA6a-kanMX6 
(Longtine et al., 
1998) 
        Table 2.2: Plasmids used in this study 
 
2.2.3   Oligonucleotides 
Oligonucleotides used in this study were purchased from Sigma-Aldrich, stored at  
-20
o
C in 1 x TE and are listed in the table below: 
 
Oligo Sequence Target 
1606 TCAGCATCCATGTTGGAATT KanMX  
1802 GGTCCACCGGCACCT NatMX  
1877 GGCGCGTCTTAATTTTCTTC PIF1 
1878 TCGTTCCAGGATAAAGGACTG PIF1 
1937 TGGCGAATTCTTCAATGTACG ZWF1 
1939 TCCGTTCGCAATCTCTCGA TKL1 
1951 TTGTCAACTCGTCAAGTCAC TAL1 
   
    Table 2.3: Oligos used in this study 
 
 
2.2.4   Enzymes 
Enzymes used in this study are all listed below. The buffers supplied with the 
enzymes were used in conjunction. 
  
Enzyme Buffer Source 
EcoRI EcoRI buffer New England Biolabs 
   








2.2.5   Kits 
Kits used in this study are all listed below 
 
Kit Source 
XL1-blue sub-cloning grade competent cells Stratagene 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick Gel Extraction Kit Qiagen 
  

























2.2.6   Recipes for yeast media 
 
YEP 
Yeast Extract/Peptone (YEP) media used in experiments consisted of 1% Yeast 
Extract (w/v), 2% Bacto Peptone (w/v) and 50 mg/ml adenine in water, along with 
either 2% dextrose, galactose or raffinose as a carbon source. For 1 L of media of 
YEPD (yeast extract/peptone/dextrose), 10 g Yeast Extract and 20 g Bacto 
Peptone was added to 985 ml of water, then autoclaved and cooled to 60
o
C, before 
the addition of 50 ml sterile dextrose solution, (40% w/v) and 15 ml sterile 
adenine solution (0.5% w/v). 
 
Dropout media 
Nutritional selective media was composed as follows: 0.13% dropout amino acid 
powder, 0.17% yeast nitrogen base, 0.5% ammonium sulphate and 2% bacto agar, 
2% dextrose as the carbon source. In order to confer selective pressure, different 
quantities of amino acids were added to the media. Table 2.6 below indicates the 
amino acid combinations needed to generate the appropriate selection. 
 
 
Amino acid Amount (g) 
Adenine 2.5 
L-arginine (HCl) 1.2 
L-aspartic acid 6.0 
L-glutamic acid (monosodium salt) 6.0 
L-histidine 1.2 
L-leucine 3.6 


















For 1 L of Luria-Bertani Broth (LB Broth), 5 g Yeast Extract and 10 g Bacto 
Peptone, and 10 g NaCl was added to 985 ml of water, then autoclaved and 
cooled to 60
o




For 1 L of SOC media, 5 g Yeast Extract and 20 g Bacto Peptone, 0.5 g NaCl, 2.5 






The above recipes were also used to generate agar plates of the media. In addition, 
20 g of Bacto Agar was added to the liquid media prior to autoclaving, giving a 
final concentration of 20 g/L. To generate plates containing a selective marker, 
filter sterilised antibiotics (Geneticin (G418) and Nourseothricin-dihydrogen 
sulphate (CloNAT)) were added, to give a final concentration of 200 μg/ml. 
 
 
2.2.7   Isolating genomic DNA from yeast 
The appropriate yeast strains were grown to saturation overnight in YEPD media, 
then spun at 13,000 rpm for 1 minute. The resulting pellet was resuspended in 250 
μl of 0.1 M EDTA (pH 7.5), 1:1000 β-mercaptoethanol and 2.5 mg/ml zymolyase 
20T, before incubation at 37
o
C for 1 hour until spheroplasted. 55 μl of miniprep 
mix (0.25 M EDTA (pH 8.5), 0.5 M Tris base, 2.5% SDS) was added, and then 
samples were mixed by vortexing before incubation at 65
o
C for 30 minutes. 63 μl of 
5 M KAc was added, then samples were mixed by vortexing before incubation on 
ice for 30 minutes. Samples were spun at 13,000 rpm for 20 minutes, supernatants 
transferred to a new tube containing 720 μl of 100% ethanol and spun at 13,000 rpm 
for 10 minutes. After being drained thoroughly, 130 μl 1xTE containing 1 mg/ml 
RNAase A was added to the pellet and samples were incubated at 37
o
C for 35 
minutes. 150 μl isopropanol was added and samples were spun at 13,000 rpm for 20 
minutes. After draining, samples were washed with 70% ethanol (100 μl, 5 minute 
spin), aspirated and air dried for 30 minutes, before being resuspended in 40 μl 1 x 
 48 
 
TE, with incubation overnight at 37
o




2.2.8   Transformation of E. coli 
Bacterial transformations were carried out using XL1-blue Sub-cloning grade 
competent cells. Plasmid extractions from transformed bacterial cultures were 
carried out using a QIAprep Spin Miniprep Kit. The transformations were carried 
out as per the provided protocol. 
 
 
2.2.9   Restriction digests 
Digestion mixtures used in restriction digests were as follows:  
 
Component Concentration Volume (μl) 
DNA - 5 
Enzyme - 1 
Buffer 10x 2 
BSA 100x 0.5 
H2O - 12 
   
         Table 2.7: Composition of the restriction digest reaction mixture 
 
Digestions were carried out at 37
o
C for an hour to overnight. 
 
 
2.2.10   Disruption of ORFs with KanMX or NatMX 
The appropriate deletion strain was taken from the Boone Synthetic Deletion 
Library (single gene deletion, with KanMX in place of the ORF, in the S288C 
background) and grown at 23
o
C on a YEPD agar plate containing the antibiotic 
G418 (Tong and Boone, 2005). The KanMX marker was amplified using primers 
designed to anneal 500 bp upstream and 500bp downstream of the deleted gene 
(where applicable). In absence of the appropriate deletion strain in the Boone 
Synthetic Deletion library, the KanMX cassette was amplified from the pFA6a-
KanMX6 plasmid. The amplification was confirmed using gel electrophoresis, and 




To replace the KanMX cassette with the NatMX cassette, marker switching was 
used. The TA::MX4-natR switcher cassette was excised from the p4339 plasmid by 
digestion with EcoRI, isolated using gel electrophoresis and gel extraction using the 
QIAquick Gel Extraction Kit (Qiagen). The cassette was then transformed into 
strains carrying the KanMX cassette  as below (Chapter 2.2.12).  
 
 
2.2.11   PCR and gel electrophoresis 
For PCR, the ExTaq, ExTaq 10x Buffer and dNTPs were supplied by Takara. 
Oligonucleotides used were designed using Invitrogen Primer Design software and 
supplied by Sigma Aldrich. The PCR reaction mixture used in this study was as 
follows: 
 
Component Final Concentration Volume (μl) 
Template - 1 
Forward Primer 0.3 μM 0.5 
Reverse Primer 0.3 μM 0.5 
dNTPs 0.25 mM 4.8 
ExTaq (5 units/μl) 0.05 units/μl 0.5 
ExTaq Buffer 1x 5 
H2O - 37.7 
   
      Table 2.8: Composition of the PCR reaction mixture  
 




C) Time (mins) Cycles 
95 5 1 
94 1 
35 55 1 
72 5 
72 20 1 
4 Hold - 
           Table 2.9: PCR Conditions 
 
Gel electrophoresis was carried out using 0.8% agarose gel (0.48 g Electran 
Agaraose (VWR International), 60 ml 1x TAE buffer, 10 μl of SYBR SAFE). The 
gel tank contained 1xTAE buffer. 6X blue loading buffer (0.25% bromophenol blue, 
0.25% xylene cyanol, 15% ficoll, 120 mM EDTA pH 8.0 in dH20) was added to 
DNA samples to a final concentration of 1X. 5 μl 1 kb DNA Ladder (250 μg) 
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(Invitrogen) was run alongside samples to indicate band size. Electrophoresis was 
conducted at 80V for 45 minutes to 1 hour depending on the size of band being 
detected. Visualisation of gels was carried out using the Fuji LAS 4000 imager. Any 
gel extraction under taken was carried out by excising the correct band from the gel 




2.2.12   Lithium acetate transformation of yeast cells 
Transformations of yeast strains by PCR products or plasmids were carried out 
using a LiAC transformation protocol. PCR products were initially purified by the 
following protocol to generate transforming DNA: 
  
   40 μl   PCR product 
   0.8 μl   0.5 M EDTA 
   4 μl   3 M NaAc pH 5.2 
   120 μl   Isopropanol 
  
The mixture was precipitated at -20
o
C for 10 minutes, before being spun in a 
centrifuge for 10 minutes at 13,000 rpm. The pellet was washed with 500 μl 70% 
ethanol, spun again for 10 minutes at 13,000 rpm, the supernatant removed and the 
ethanol evaporated off, before resuspension in 10 μl dH2O. 
  
25 ml of fresh YEPD was inoculated with cells from a saturated overnight culture of 
the recipient yeast strain, and incubated at 23
o
C until the cell count doubled twice, 
confirmed by cell count using a haemocytometer, and the equation: 
  
                            25       x    No. of cells counted   x   10
4
 
                    No. of grids 
  
The yeast culture was spun in a centrifuge to yield a pellet of yeast cells, then 
washed with 50 ml dH2O, followed by a wash with 5 ml LiAc/TE (10 mM Tris-Cl, 
0.1 mM EDTA, 0.1 M LiAc, pH 7.5), before being resuspended in 1 ml of LiAc/TE. 
Transforming DNA was added to 100 μl of yeast suspension, along with 10 μl of 
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Salmon sperm DNA (10 μg/μl). 700 μl of 40% PEG in LiAc/TE (8 ml 50% PEG, 1 
ml 10 x LiAc, 1 ml 10 x TE) was added and then vortexed to mix, before incubating 
at 30
o
C for 30 minutes. Following incubation, 70 μl DMSO was added and then heat 
shocked at 42
o
C for 15 minutes. The reaction was then chilled on ice for 1-2 
minutes, before being spun at 6000 rpm for 3 minutes, resuspended in 1 x TE and 
plated onto appropriate selective medium. Plates were incubated at 23
o
C for 2-3 
days (or until colonies appeared) before colony purification to select for transformed 
yeast. 
  
When transforming yeast strains with plasmids, the same protocol was followed, 
apart from the purification step of the transforming DNA. Instead, 5 μl of plasmid 
was added directly to the yeast suspension, along with Salmon sperm DNA. 
 
 
2.2.13   Strain verification 
The genotype of generated strains was verified using PCR. Reverse primers which 
bound downstream of the start codon of the marker cassette (~ 500 bp into the 
KanMX cassette, ~ 200 bp into the NatMx cassette) were used in conjunction with 
forward primers which bound within the region upstream of the deleted gene. The 
presence of a band of around 800 bp indicated correct transformation and location of 
the cassette. Wild type strains and, where possible, original S288C versions of the 
gene deletion strains, were tested as negative and positive controls respectively. 
 
 
2.2.14   Mating of haploids, sporulation and tetrad scoring 
Diploid strains were generated through mating of two strains of opposite mating 
type (MATa x MATα). Mating occurred through streaking of the strains together on 
a YEPD plate and incubation at 23
o
C overnight. Successful diploid strains were 
identified using selection on plates containing the appropriate marker or lacking the 
appropriate amino acid which diploid strains were able to grow but haploid parent 
strains were not. Selection plates were incubated at 23
o
C overnight and the process 




Diploid yeast strains were grown to saturation overnight in 2 ml of YEPD at 23
o
C 
then spun at 13,000 rpm for 1 minute. The pellet was washed in dH2O twice then 
resuspended in 2 ml 1% KOAc and incubated for 2-3 days at 23
o
C. Sporulated yeast 
culture were spun down and washed with dH2O twice, then resuspended in 1 ml 
dH2O, and stored at 4
o
C. 1.2 μl glusulase (DuPont NEN Research Products) was 
added to a 50 μl aliquot of the sporulated yeast suspension and incubated at 30oC for 
12 minutes. The digested spores were placed on ice and 1 ml dH2O added. 50 μl of 
the digested spores were spread on a YEPD plate and dissected using a Microtec 
tetrad microscope. The plates were incubated at 23
o
C for 2-3 days, before the tetrads 




Plates were replicated using velvets onto appropriate selective media for 
identification of genotype and mating type, assessed by mating with MATa and 
MATα strains. Growth was scored after 2-3 days incubation at 23oC (or 36oC, when 
identifying temperature-sensitive cdc13-1 strains) to determine genotype. Haploids 
with the desired phenotype were stored in 15% glycerol at -80
o




2.2.15   Spot test growth assays 
Yeast strains were grown to saturation in 2 ml YEPD media at 23
o
C overnight. 
Saturated cultures were serially diluted 5-fold in fresh YEPD in a 96-well plate. 
Yeast cultures were then transferred onto solid agar YEPD plates (or appropriate 
media plates) using a sterilised 48-pin replica plating tool (Sigma), and left to dry. 
The plates were then placed at a range of temperatures for several days, determined 











2.3 G6PDH assay 
 
2.3.1   Culture inoculation and time course 
150 μl saturated cultures were inoculated in 120 ml fresh YEPD and incubated 
overnight at 23
o
C at 180 rpm.  Total cell number was counted using a 
haemocytometer and cells were diluted in fresh YEPD to a 120 ml culture at 8 x 10
6
 
cells/ml. Flasks were returned to 23
o
C for 2-2.5hrs or until cell density reached 1.5 x 
10
7
 cells/ml. Total bud numbers were counted, 1 x 3 ml and 1 x 1 ml samples of 
cultures were taken (T = 0) and cultures divided into two flasks and diluted in fresh 
YEPD to 100 ml cultures at 8 x 10
6
 cells/ml. In temperature-dependent experiments, 
one flask was returned to 23
o
C and one flask was placed at 36
o
C. In α-factor 
dependent experiments, α-factor (Sigma; 1:25,000 dilution of 5 x 10-4 M; 0.842 
mg/ml in H2O stock) was added to a concentration of 20 nM. 1 x 3 ml and 1 x 1 ml 
samples of cultures were taken 15, 60, 120, 180 and 240 minutes after dilution and 
the start of incubation. Total bud numbers were counted after 90 and 180 minutes 
and cultures diluted in fresh YEPD to 100 ml cultures at 8 x 10
6
 cells/ml. Where 
applicable, the α-factor concentration was maintained at 20 nM. 
 
 
2.3.2   Protein extraction 
Cells were harvested from 3 ml samples by low-speed centrifugation at 3,000 rpm 
for 3 minutes. The cell pellet was washed with cold 5 ml 10 mM potassium 
phosphate buffer (pH 7.5) containing 2 mM EDTA, then resuspended in 1 ml of the 
same buffer and transferred to a 1.5 ml eppendorf tube. Cells were harvested by 
low-speed centrifugation, the supernatant aspirated then stored at -80
o
C 
immediately. To extract the cell lysates, the pellet was thawed on ice then 
resuspended in 100 μl cold 100 mM potassium phosphate buffer (pH 7.5) containing 
2 mM MgCl2 and 1 mM DTT and transferred to a 2 ml screw cap tube. 200 μl 0.5 
mm glass beads were added to the screw cap tube, then cells were lysed using a 
ribolyser (5.5 for 30 seconds). Samples were stored on ice for ~2 minutes then lysis 
repeated. Cell breakage was checked under a microscope. Using scissors, the lids 
were removed from 1.5 ml eppendorf tubes. The 2 ml screw cap tubes were 




at 2,000 rpm for 2 minutes. The screw cap tubes were removed and eppendorf lids 
were replaced. Cell debris was separated out by high-speed centrifugation (13,200 
rpm for 10 minutes) and the supernatant transferred to a fresh 1.5 ml eppendorf. 
Protein concentration of supernatant was determined using Bradford assay 
(Bradford, 1976) and samples diluted to 200 μg/ml using 100 mM potassium 
phosphate buffer (pH 7.5) containing 2 mM MgCl2 and 1 mM DTT. Cell extract 





2.3.3   Enzymatic assays 
Enzyme assays were carried out in triplicate to determine average reading. Assay 
buffer was prepared as below: 
 
Reagent Stock concentration Volume (μl) Final concentration 
Cell extract 200 μg/ml 15 30 μg/ml  
dH2O - 68.5 - 
Tris HCl (0.5 M) 500 mM 10 50 mM 
MgCl2 (1 M) 1 M 0.5 5 mM 
NADP
+
 (0.04 M) 40 mM 1 0.4 mM 
G-6-P (0.1 M) 100 mM 5 5 mM 
Total Volume - 100 - 
    
 Table 2.10: G6PDH reaction mixture 
 
15 μl cell extract (or 15 μl H2O) and 80 μl assay buffer were added per well to 96-
well plate. Absorbance at 340 nm was measured in a FLUOstar plate reader (BMG 
Labtech) at 37
o
C. 5 μl glucose-6-phosphate was added to each well using a 
multichannel pipette and the plate was tapped to mix. Absorbance was measured at 
340 nm after 1, 5 and 10 minutes. Average absorbance was calculated and specific 







2.3.4   Determination of cell cycle position 
1 ml samples of cultures were spun at top speed (13,200 rpm) for 1 minute. Cell 
pellets were then washed with 1 ml H2O then resuspended in 200 μl 70% ethanol 
and incubated at room temperature for 1 hour. Samples were washed twice with 1 
ml H2O and resuspended in 200 μl DAPI (4',6-diamidino-2-phenylindole, Sigma) in 
H2O. Samples were sonicated for 6 seconds at an amplitude of 5 microns and 8 μl 
aliquot was examined under a fluorescence microscope (Nicon eclips 50i, 40x 
objective). A multicounter was used to counter the proportion of 100 cells in each 
cell cycle stage, following the below classification system, taken from (Zubko et al., 




Cell cycle analysis. Classifications are 1: no bud, single cell, single nucleus. 2: Bud < 
50% diameter of mother cell. Single nucleus. 3: Bud > 50% diameter of mother cell. 













3 The pentose phosphate pathway protects against 




G-quadruplexes are nucleic acid structures which can form within guanine-rich 
regions of DNA and RNA. As described in Chapter 1.2, G-quadruplexes have been 
predicted to form in key regions of the chromosome such as the centromeres, 
promoter regions and the G-rich telomeres. Stabilising G-quadruplexes through the 
binding of ligands has consequences for transcription and can prevent the action of 
telomerase (Mikami-Terao et al., 2009; Mikami-Terao et al., 2008; Grand et al., 
2002). For this reason, G-quadruplex-stabilising ligands are under investigation for 
their potential use as anti-cancer drugs.  
  
One such G-quadruplex binding ligand is the cationic porphyrin TMPyP4 
(5,10,15,20-tetratkis-(N-methyl-4-pyridyl)-21,23-H-porphyrin). It is thought that 
TMPyP4 binds to the outside of the G-quadruplex and stabilises the folded nucleic 
acid structure as shown in Figure 3.1a (Wei et al., 2006; Phan et al., 2005; Haq et 
al., 1999). TMPyP4 has been shown to act against certain cancer cell lines, such as 
retinoblastoma cells, MX-1 mammary tumours and PC-2 human prostate 
carcinomas (Mikami-Terao et al., 2009; Mikami-Terao et al., 2008; Grand et al., 
2002). It has also been demonstrated that TMPyP4 has the ability to inhibit 
telomerase in vitro. The presence of TMPyP4 also affects the c-MYC oncogene-
dependent transcription of several genes including TERT, the human homologue of 
the S. cerevisiae telomerase subunit Est2 (Grand et al., 2002).  
  
In order to study the mechanisms of TMPyP4 action and the effect of TMPyP4 
treatment at the cellular level, I studied the responses of a genome-wide single 
deletion library of budding yeast strains to the presence of the G-quadruplex binding 
ligand. I hoped that studying the differential sensitivity to TMPyP4 of deletion 
































Figure 3.1: Structure and binding locations of two G-quadruplex binding ligands
The chemical structure of (a) TMPyP4 and (b) RHPS4 and the predicted binding sites 
of the ligands to compatible G-quadruplex conformations.
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proven ability to bind G-quadruplexes and inhibit telomerase activity, I expected to 
find a trend towards telomere-, telomerase- or DNA damage response-related 
deletions displaying differential sensitivity towards the G-quadruplex binding 
ligand.  
 
In addition to screening the gene deletion collection for TMPyP4-sensitivity, I also 
screened for sensitivity to RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-
kl]acridinium methosulfate), another G-quadruplex binding ligand (Cookson et al., 
2005). RHPS4 is a pentacyclic acridine and binds to G-quadruplexes in a different 
manner and location compared with TMPyP4 (Figure 3.1b) (Gavathiotis et al., 2003; 
Gavathiotis et al., 2001). RHPS4 has also demonstrated efficacy against cancer cell 
lines, such as MCF-7 breast cancer cells and uterus carcinoma cells (Phatak et al., 
2007; Cookson et al., 2005). Therefore, I wanted to discern whether there was any 
correlation or similarities between gene deletion strains which were sensitive to the 
two G-quadruplex binding ligands, in order to try and elucidate a common 
























3.2.1   G-quadruplexes location and TMPyP4-sensitivity in S. cerevisiae 
The sequence necessary for potential G-quadruplex formation was determined by 
Huppert and Balasubramanian (2005). Their Folding Rule states: “A sequence of the 
form d(G3+N1-7G3+N1-7G3+N1-7G3) will fold into a quadruplex under near-
physiological conditions.” The quadparser computer algorithm was developed to 
rapidly analyse genomic data and identify regions in which G-quadruplexes could 
emerge (potential quadruplex sequences, PQSs) (Huppert and Balasubramanian, 
2005). Data on the location of PQSs within the S. cerevisiae genome was 
downloaded from the quadruplex.org database, including the genomic coordinates, 
strand and sequence for each PQS (Wong et al., 2010a; Wong et al., 2010b), and 
using this data, the relative positions of regions with G-quadruplex forming potential 
within the yeast genome were plotted (Figure 3.2). The algorithm identified 11 
PQSs proximal to the telomeric regions of 7 yeast chromosomes, and 27 PQSs 
spread throughout the rest of the genome (Wong et al., 2010a). Unlike studies of the 
human genome, in which G-quadruplex forming sequences were found in the 
promoter of c-MYC, few to none of these non-telomeric PQSs seem to be located in 
the promoter regions of key genes (Huppert and Balasubramanian, 2005; Seenisamy 
et al., 2004; Grand et al., 2002). The identification of PQSs within the S. cerevisiae 
genome indicate that it is appropriate to test a ligand targeted to these sequences in 
yeast. 
 
I aimed to study the differential sensitivity of single gene deletion strains to the G-
quadruplex binding ligand TMPyP4, in order to determine mechanism of the 
ligand’s action, targets and the cellular response to TMPyP4. A small scale test with 
several gene deletion strains in the W303 background indicated that exposure to 100 
μM TMPyP4 resulted in a growth defect (Figure 3.3). Therefore I tested the 






















Figure 3.2: Relative positions of predicted sites of G-quadruplex formation 
Location of putative quadruplex sequences (PQSs) within the S. cerevisiae genome. 
Arrows indicate PQSs, where down arrows = Watson, up arrows = Crick, pale arrows 
represent predicted telomeric PQSs and circles denote centromeres. Data taken from the 
quadruplex.org database (Wong et al., 2010a)
Figure 3.3: Treatment with TMPyP4 causes a reduction in growth
Strains were grown to saturation in YEPD before a 5-fold serial dilution and pinning onto 











YEPD + 100μM TMPyP4
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3.2.2   A genome-wide screen found TMPyP4-sensitive yfg∆ strains 
Using a genome-wide collection of around 4,300 S. cerevisiae gene deletion strains 
(yfg∆, your favourite gene deletion, which indicates any of the viable systematic 
gene deletions), I screened for differential sensitivity to TMPyP4. Figure 3.4a 
demonstrates how variable the TMPyP4-sensitivity was from strain to strain. Plate 
10 (of 15) contained the second most sensitive deletion strain, ccs1∆ (highlighted in 
pink) which as demonstrated in the figure grew on control media but failed to grow 
on media containing TMPyP4. However other strains, such as asc1∆ (highlighted in 
blue) grew on both media. The screen was replicated four times and quantitative 
fitness analysis (QFA) was performed by Conor Lawless as described by Addinall et 
al. (2011). Briefly, the fitness of each individual culture in the screen was deduced 
through time course photography of the agar plates and image processing and data 
analysis, followed by calculation of maximum doubling rate (MDR) and maximum 
doubling potential (MDP) of the single deletion mutant strains by fitting logistic 
growth model parameters to growth curves (Figure 3.4b). Strain fitness was defined 
as the product of MDP and MDR (Fitness, F, population doublings2/day).  
 
When comparing the fitness of each deletion strain on media supplemented with 
TMPyP4 with fitness on media lacking the compound (Figure 3.4c), it can be 
observed that the presence of TMPyP4 causes a reduction in growth across the 
population. Each point on the graph represents a single deletion mutant. The dashed 
grey line indicates equal growth on both control media and media containing 
TMPyP4, and the solid grey line indicates expected fitness based on the population 
model (linear regression). There is a clear difference between the two lines, which 
indicates around 40% reduction in growth across the population when exposed to 
TMPyP4 in comparison to growth on media lacking the ligand. However, it is worth 
noting that a proportion of this 40% reduction observed is a result of the difference 
in agar colour between control and TMPyP4 plates, due to the colour of the 
compound.  
 
The vertical distance of the points on the graph from the expected fitness linear 
regression model can be used to estimate the fitness differential (FD) for each yfg∆. 
Studying the data in closer detail, I used an arbitrary cut-off of FD ≥ 0.5 to define 
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Figure 3.4: Image analysis and statistical modelling of the genome-wide screen 
Image analysis and calculation of the growth fitnesses of single deletion strains on 
control media (CSM) and CSM containing 100 μM TMPyP4. Five different gene 
deletion strains are highlighted throughout the figure to demonstrate the 
methodology. (a) Plate 10 of 15 of the genome-wide screen grown on CSM and 
CSM containing 100 μM TMPyP4. Images were taken after 3 days incubation at 
30oC. Circles highlight the position of the five gene deletion strains on CSM and 
TMPyP4 plates. (b) Image analysis of individual replicate cultures determined cell 
density of the four genes highlighted in (a) and the logistic growth model was fitted 
to each culture density time-series. Average maximum Doubling Rate (MDR) and 
Maximum Doubling Potential (MDP) were determined from the fitted curves. (c) 
The growth fitness (Fitness, F, population doublings2/day) of ~4,300 single gene 
deletion mutants on control media compared with the growth fitness on media 
containing 100 μM TMPyP4. Fitness = product of maximum doubling rate (MDR) 
and maximum doubling potential (MDP) of the single deletion mutant strains. Each 
point on the graph represents a single deletion mutant. Dashed grey line denotes 
equal growth on CSM and CSM containing 100 μM TMPyP4. Solid grey line 
denotes expected fitness based on the population model (linear regression). Blue 










with a FD ≤ -0.5 as enhancing the TMPyP4-induced fitness defect. Using these 
parameters, 76 gene deletions were classified as TMPyP4-resistant and 107 gene 
deletions were defined at TMPyP4-sensitive by the genome-wide screen.   
 
 
3.2.3   19 null mutations cause TMPyP4-sensitivity 
In order to confirm the results of the genome-wide study, the high-throughput screen 
was repeated by Stephanie Merchan using the same single deletion library and 
growth conditions; however, a simpler method of fitness analysis was used (carried 
out by Darren Wilkinson), based on single time-point data. This end-point assay 
provided another 4 replicates of the screen and therefore a large amount of data for 
each gene deletion strain. The fitness definition used in the second screen differed 
from the one carried out in the analysis of data from the first screen, since the fitness 
for each yfg∆ in the second screen was calculated from cell density estimate from 
the final time point. Therefore, I defined TMPyP4 tolerance in the second screen as 
final fitness differential (FFD). Arbitrary cut-offs were again used to define 
TMPyP4-resistant and –sensitive strains (FFD ≥ 0.25 and FFD ≤ -0.2 respectively).  
 
The results from the two screens were compared (Figure 3.5), and there were a 
number of genes which, when deleted, resulted in increased sensitivity or resistance 
to the porphyrin in both screens (Table 3.1). 19 null mutations resulted in increased 
sensitivity to TMPyP4 and two null mutations resulted in reduced sensitivity to the 
G-quadruplex binder in both screens. Therefore repetition of the screen provided a 
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Fitness Differential (FD) on TMPyP4
Figure 3.5: Comparison of screen data reveals TMPyP4-sensitive strains 
Correlation plot of fitness differential values from two genome-wide screens for 
TMPyP4-sensitivity (correlation = 0.066). Genes in red (bottom left-hand corner) were 
found to increase TMPyP4-sensitivity when deleted according to both experiments (FD 
≤ -0.5 in the initial screen and FFD ≤ -0.2 in the follow-up screen). Genes in green (top 
right-hand corner) were found to decrease TMPyP4-sensitivity when deleted according 
to both experiments (FD ≥ 0.5 in the initial screen and FFD ≥ 0.25 in the follow-up 
screen). Blue lines denote FD thresholds.
ORF Gene SGD Description
Sensitive
YMR038C CCS1 Copper chaperone for superoxide dismutase Sod1p, involved in oxidative stress protection
YJL120W YJL120W Dubious open reading frame unlikely to encode a protein; partially overlaps the verified gene YJL121C/RPE1
YPR074C TKL1 Transketolase, similar to Tkl2p; catalyzes reactions in the pentose phosphate pathway
YJL121C RPE1 D-ribulose-5-phosphate 3-epimerase, catalyzes a reaction in the non-oxidative part of the pentose-phosphate pathway
YLR200W YKE2 Subunit of the heterohexameric Gim/prefoldin protein complex involved in the folding of alpha-tubulin, beta-tubulin, and actin
YNL241C ZWF1 Glucose-6-phosphate dehydrogenase (G6PD), catalyzes the first step of the pentose phosphate pathway
YKL212W SAC1 Phosphatidylinositol phosphate (PtdInsP) phosphatase involved in hydrolysis of PtdIns[4]P
YPL241C CIN2 GTPase-activating protein (GAP) for Cin4p; tubulin folding factor C involved in beta-tubulin (Tub2p) folding
YHR178W STB5 Transcription factor, involved in regulating multidrug resistance and oxidative stress response
YOR349W CIN1 Tubulin folding factor D involved in beta-tubulin (Tub2p) folding
YKL211C TRP3 Bifunctional enzyme exhibiting both indole-3-glycerol-phosphate synthase and anthranilate synthase activities
YLR371W ROM2 GDP/GTP exchange factor (GEF) for Rho1p and Rho2p
YML007W YAP1 Basic leucine zipper (bZIP) transcription factor required for oxidative stress tolerance
YLR138W NHA1 Na+/H+ antiporter involved in sodium and potassium efflux through the plasma membrane
YGL026C TRP5 Tryptophan synthase, catalyzes the last step of tryptophan biosynthesis
YLR047C FRE8 Protein with sequence similarity to iron/copper reductases, involved in iron homeostasis
YML124C TUB3 Alpha-tubulin; associates with beta-tubulin (Tub2p) to form tubulin dimer, which polymerizes to form microtubules
YML035C AMD1 AMP deaminase, tetrameric enzyme that catalyzes the deamination of AMP to form IMP and ammonia
YCR034W FEN1 Fatty acid elongase, involved in sphingolipid biosynthesis
Resistant
YBL089W AVT5 Putative transporter, member of a family of seven S. cerevisiae genes (AVT1-7) related to vesicular GABA-glycine transporters
YJL172W CPS1 Vacuolar carboxypeptidase yscS; expression is induced under low-nitrogen conditions
Table 3.1: TMPyP4-sensitive and -resistant gene deletion strains
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3.2.4   TMPyP4-sensitive gene deletion strains include PPP-related genes 
Gene Ontology (GO) analysis of the 19 null mutations which resulted in higher 
sensitivity to TMPyP4 than the rest of the population revealed that over-represented 
terms include the pentose phosphate shunt, nucleotide metabolic process and 
tryptophan biosynthetic process (Table 3.2).  
 
Table 3.2: GO analysis of TMPyP4-sensitive gene deletion strains 
 
Over 25% of the genes which, when deleted, cause TMPyP4-sensitivity encode 
proteins with links to the pentose phosphate pathway (PPP): ZWF1, RPE1, TKL1, 
YJL120W and STB5. Zwf1, the yeast glucose-6-phosphate dehydrogenase (G6PDH), 
catalyses the initial rate-limiting step of the oxidative phase of the PPP (Reaction 3 
in Figure 1.6) and plays an important role in the response to oxidative stress through 
NADPH production in the reaction it catalyses. RPE1 encodes Rpe1, a D-ribulose-5-
phosphate 3-epimerase, and the reaction it catalyses forms one of the steps linking 
the oxidative and non-oxidative phases of the PPP together (Reaction 6 in Figure 
1.6). YJL120W is a dubious open reading frame which partially overlaps with the 
RPE1 gene and therefore may confer its sensitivity upon deletion due to disruption 
of Rpe1 expression. TKL1 encodes the transketolase Tkl1, which plays a major role 
in the non-oxidative phase of the PPP (Reactions 8 and 10 in Figure 1.6). 
Upregulation of a mutant form of the human transketolase, TKTL1, is linked with 
various cancers (Chen et al., 2009; Krockenberger et al., 2007; Langbein et al., 
2006).  
 
The transcription of many PPP genes is regulated by Stb5, a transcription factor 
encoded for by STB5 which is involved in multidrug resistance and the oxidative 
stress response (Cadière et al., 2010; Larochelle et al., 2006). The precursor for 
nucleotide synthesis, ribose-5-phosphate, is produced by the PPP (by reactions 7 and 
8 in Figure 1.6). Amd1 catalyses the deamination of AMP to form IMP and 
ammonia, and therefore may be involved in regulation of intracellular adenine 
Gene Ontology Term Genes annotated to the term p-value 
Pentose phosphate shunt RPE1, ZWF1, TKL1 3.60E-04 
Heterocycle metabolic process TRP5, RPE1, TRP3, ROM2, AMD1, ZWF1, TKL1 5.20E-04 
Nucleotide metabolic process RPE1, ROM2, AMD1, ZWF1, TKL1 4.07E-03 
Tryptophan biosynthetic process TRP5, TRP3 9.21E-03 
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nucleotide pools. This provides a further link between the PPP and sensitivity to 
TMPyP4, and therefore this sensitivity could either be due to the nucleotide 
production process, the oxidative stress response or an as yet unknown process. 
 
The pentose phosphate pathway is not the only functionally related group of deletion 
strains that were found through the screen to be TMPyP4-sensitive. The deletion of 
YKE2, TUB3, CIN1 and CIN2, all of which are involved in tubulin folding and 
microtubule formation, also caused TMPyP4-sensitivity. YKE2 encodes a subunit of 
the heterohexameric Gim/prefolding protein complex which is involved in the 
folding of alpha-tubulin, beta-tubulin and actin (Siegers et al., 1999; Geissler et al., 
1998). TUB3 is one of two alpha-tubulin encoding genes (the other being TUB1). 
Alpha- and beta-tubulin form tubulin heterodimers, which polymerise to form 
microtubules. Cin1 (the homolog of mammalian cofactor D) and Cin2 (the tubulin 
cofactor C homolog) are involved in folding of the beta-tubulin Tub2 (Feierbach et 
al., 1999; Hoyt et al., 1997; Stearns et al., 1990). Cin2 also acts as a GTPase-
activating protein (GAP) for Cin4 (Veltel et al., 2008). The mechanisms by which 
tubulin processing responds to G-quadruplex binding are unclear. Tubulin 
polymerisation or stabilisation of microtubules can arrest cells in mitosis, and 
therefore some anti-cancer agents target tubulin (Li and Sham, 2002). TMPyP4, 
along with other G-quadruplex binding ligands, induces elongated chromosomes 
incapable of separating in anaphase (Izbicka et al., 1999). Deletion of key 
microtubule formation genes may therefore exacerbate difficulties in chromosome 
segregation, resulting in increased TMPyP4-sensitivity.   
 
The deletion of CCS1 and YAP1, genes which both encode proteins with roles in the 
oxidative stress response (a copper chaperone for the superoxide dismutase Sod1 
and a transcription factor which regulates anti-oxidant gene expression, 
respectively) also causes sensitivity to TMPyP4 (Moye-Rowley, 2002; Gasch et al., 
2000; Culotta et al., 1997). Additionally, deletion of genes involved in tryptophan 
biosynthesis (TRP3 and TRP5) also induces a fitness differential on media 
supplemented with TMPyP4. The remaining sensitive genes in Table 3.1 encode 
proteins involved in phosphatidylinositol (PtdInsP) biosynthesis (SAC1), GDP/GTP 
exchange for Rho1 and Rho2 (ROM2), Na+/H+ transport (NHA1), iron homeostasis 
(FRE8) and fatty acid elongation (FEN1). Interestingly, I did not observe any 
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telomere- or DNA damage response-related genes amongst those which displayed 
differential sensitivity to TMPyP4 in both screens; instead, the results from the 


































3.2.5   ppp∆ strains are sensitive to TMPyP4 in the W303 background 
The data from the genome-wide screen suggest that there is a link between pentose 
phosphate pathway (PPP) dysfunction and sensitivity to TMPyP4. The major roles 
of the PPP in eukaryotes are in the production of NADPH and in ribose-5-phosphate 
generation. Therefore, I wanted to explore the PPP and its link with TMPyP4 
further. In order to confirm the results from the genome-wide screen, I carried out a 
serial dilution spot test of ppp∆ strains in the W303 background (Figure 3.6a), which 
differs from the background used in the screen (S288C). As observed in the high-
throughput screen, deletion of RPE1, ZWF1 and TKL1 resulted in sensitivity to 
TMPyP4. I also tested the sensitivity of a tal1∆ strain, which, according to the 
screen data, is not TMPyP4-sensitive. TAL1 encodes the transaldolase Tal1 which 
catalyses a reaction in the non-oxidative phase of the PPP (Reaction 9 of Figure 
1.6). My spot test confirmed that TAL1 deletion does not cause TMPyP4-sensitivity. 
This may be due to the role of Tal1 in the PPP, which may not be essential for the 
resistance to the G-quadruplex binding ligand, or deletion of the gene does not result 
in the metabolic changes necessary to cause TMPyP4-sensitivity. Additionally, not 
all ppp∆ strains are sensitive to the same oxidants (Krüger et al., 2011) 
Alternatively, the functional transaldolase homologue Nqm1 may compensate for 
the lack of transaldolase activity due to TAL1 deletion (Huang et al., 2008).  
 
I hypothesised that the sensitivity to TMPyP4 exposure caused by deletion of PPP-
related genes is due to disruption of the metabolic pathway. I therefore hypothesised 
that combining several ppp∆ mutations in the same strain should not alter the 
sensitivity to TMPyP4. If the TMPyP4-sensitivity caused by deleting RPE1, ZWF1 
and TKL1 were due to differing methods, rather than PPP dysfunction, one would 
expect to see an increase in sensitivity upon combining PPP gene deletions. Figure 
3.6a demonstrates that deleting several PPP genes together in the same strain and 
growing them in the presence of TMPyP4 results in similar fitnesses to the 
equivalent single deletion strains. In addition, deletion of TAL1 in several of these 
strains does not suppress sensitivity to the G-quadruplex binding ligand. For 
instance, tal1∆ rpe1∆ demonstrates the same TMPyP4-sensitivity as rpe1∆ alone, 
which implies that TAL1 deletion does not provide resistance to TMPyP4 treatment. 
This suggests that the sensitivity to TMPyP4 is caused by disruption of the same 
pathway – the PPP – rather than alternative reasons, and the lack of alteration in 
…… 
Figure 3.6: TMPyP4-sensitivity of ppp∆ strains and telomere capping mutants
(a) Spot test for TMPyP4-sensitivity of ppp∆ strains in the W303 background. Strains 
were grown to saturation in YEPD before a 5-fold serial dilution and pinning onto plates 
containing and lacking 100 μM TMPyP4. Plates were incubated at 30oC for 3 days. (b) 
Spot test for cdc13-1 sensitivity to TMPyP4. Strains were cultured, pinned and incubated 



























TMPyP4 sensitivity in multiple PPP gene deletion strains suggests that any major 
disruption to the operation of the pentose phosphate pathway is sufficient to cause 
sensitivity to the G-quadruplex binding ligand.   
 
Treatment with TMPyP4 can affect telomere biology due to preventing the action of 
telomerase (Mikami-Terao et al., 2009; Mikami-Terao et al., 2008). The hypothesis 
is that this is due to the stabilising effect TMPyP4 has upon binding to G-
quadruplexes, which can in theory occur at telomeres. Research has suggested that 
stabilised G-quadruplexes can alter telomere biology and the response to telomere 
uncapping (Smith et al., 2011). As described in Chapter 1, Cdc13 is a protein which 
binds to the single stranded DNA (ssDNA) found at the end of telomeres in S. 
cerevisiae, capping them and preventing their recognition as double strand breaks 
(DSBs). When the capping ability of Cdc13 is disrupted, such as through the 
temperature sensitivity of the cdc13-1 mutant strain, a DNA damage response 
occurs, resulting in cell cycle arrest. cdc13-1 is deficient in telomere capping at 
restrictive temperatures (above 26oC). In a 2011 paper, Smith et al. describe how 
stabilising G-quadruplexes can rescue the temperature sensitivity of the telomere 
capping mutant cdc13-1 at semi-permissive temperatures (Smith et al., 2011). G-
quadruplexes were stabilised by over-expressing STM1, by treating yeast with a G-
quadruplex binding molecule or by overexpressing the HF1 single-chain antibody 
(scFv). This reportedly had the effect of improving the growth of temperature-
sensitive cdc13-1 strains at up to 30oC.  
 
I therefore decided to test whether exposure of cdc13-1 to TMPyP4 at permissive 
and semi-permissive temperatures would alter the growth phenotype of the mutant 
strain. The data reported by Smith et al. (2011) suggest that an improvement in 
cdc13-1 growth at semi-permissive temperatures should be observed if TMPyP4 
were stabilising G-quadruplexes at telomeres. Figure 3.6b demonstrates that there is 
no improvement in the growth of cdc13-1 at 26oC when treated with TMPyP4. The 
mutant strains do display a slight reduction in growth on media containing TMPyP4 
at 26oC – however, the fact that a reduction in growth is also observed upon 
exposure to the porphyrin at a permissive temperature of 23oC suggests that this 
apparent increase in sensitivity is due to a slight sensitivity of the mutant strain to 




in the genome-wide screen upon TMPyP4-treatment (see Figure 3.3) therefore this 
is not entirely surprising. The results of this experiment therefore suggest that either 
the G-quadruplex stabilising effect of TMPyP4 at telomeres is not sufficient for 
temperature sensitivity suppression, or that the presence of TMPyP4 has additional 
































3.2.6   A genome-wide screen found TMPyP4- and H2O2-sensitive yfg∆ strains 
The pentose phosphate pathway is important for protection against oxidative stress 
(Juhnke et al., 1996; Slekar et al., 1996). This is because the first step of the 
oxidative phase of the pathway is the main source of the reducing equivalent 
NADPH (Reaction 3 in Figure 1.6). NADPH plays a key role in the antioxidant 
system, since it is used to reduce glutathione reductase, thioredoxin and other 
antioxidants. Therefore strains which lose the ability to produce NADPH through 
the PPP are sensitive to the presence of reactive oxygen species (ROS) (Juhnke et 
al., 1996). In my screen I found that deletion of several key members of the PPP 
results in an increase in sensitivity to TMPyP4. In addition, two of the TMPyP4-
sensitive gene deletions uncovered by the screen were ccs1∆ and yap1∆ both of 
which have important roles in the oxidative stress response, as a copper chaperone 
to the superoxide dismutase Sod1 and a transcription factor required for oxidative 
stress tolerance respectively (Moye-Rowley, 2002; Gasch et al., 2000; Culotta et al., 
1997). If the sensitivity to TMPyP4 exhibited by ccs1∆ were due to its role as a 
chaperone to Sod1, I would expect a sod1∆ strain to display similar sensitivity to 
TMPyP4. However, since the library used in the genome-wide experiment does not 
include a sod1∆ strain, this could not be confirmed through the high-throughput 
screen. 
 
In order to determine whether the deletion strains which are sensitive to TMPyP4 
are also sensitive to the presence of reactive oxygen species, I carried out a genome-
wide screen of the single deletion library for mutant strains which were sensitive to 
1.5 mM hydrogen peroxide (H2O2). When comparing the results from the TMPyP4 
screen with those of the H2O2 screen, I found that 15 gene deletion strains were 
sensitive to both treatments (Figure 3.7a and Table 3.3). The same five PPP-related 
genes which were sensitive to TMPyP4 were also sensitive to H2O2. This is also true 
for YAP1, SAC1, AMD1 and FEN1 deletions. In order to confirm these results in the 
W303 background, I carried out a serial dilution spot test of ppp∆ strains on media 
with or without 1.5 mM H2O2 or 100 μM TMPyP4 (Figure 3.7b). As observed in the 
screen, the PPP gene deletion mutants were sensitive to the presence of hydrogen 
peroxide. The data from the TMPyP4 and H2O2 screens suggest that the sensitivity 
shown by ppp∆ strains to TMPyP4 is due to an oxidative stress response taking 
place upon treatment with the G-quadruplex binder. This is potentially due to the 
….. 
Figure 3.7: ppp∆ strains are TMPyP4- and H2O2-sensitive
(a) Correlation plot of fitness differential values from genome-wide screens for TMPyP4- 
and  H2O2-sensitivity (correlation = 0.033). Genes in red (bottom left-hand corner) were 
found to increase sensitivity to both TMPyP4 and H2O2 when deleted (FD ≤ -0.5). Genes 
in green (top right-hand corner) were found to decrease sensitivity to both TMPyP4 and 
H2O2 when deleted (FD ≥ 0.5). Blue lines denote FD thresholds. (b) Spot test for 
TMPyP4- and H2O2-sensitivity of ppp∆ strains in the W303 background. Strains were 
grown to saturation in YEPD before a 5-fold serial dilution and pinning onto 
indicated media. Plates were incubated at 30oC for 3 days.
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ORF Gene SGD Description
Sensitive
YJL121C RPE1 D-ribulose-5-phosphate 3-epimerase, catalyzes a reaction in the non-oxidative part of the pentose-phosphate pathway
YLR192C HCR1 Involved in translation initiation as a substoichiometric component (eIF3j) of translation initiation factor 3 (eIF3)
YJL120W YJL120W Dubious open reading frame unlikely to encode a protein; partially overlaps the verified gene YJL121C/RPE1
YPR074C TKL1 Transketolase, similar to Tkl2p; catalyzes reactions in the pentose phosphate pathway
YLR218C YLR218C Twin Cx(9)C protein involved in cytochrome c oxidase assembly or stability
YLR056W ERG3 C-5 sterol desaturase, catalyzes the introduction of a C-5(6) double bond into episterol
YDR207C UME6 Key transcriptional regulator of early meiotic genes, binds URS1 upstream regulatory sequence
YKL212W SAC1 Phosphatidylinositol phosphate (PtdInsP) phosphatase involved in hydrolysis of PtdIns[4]P
YEL013W VAC8 Phosphorylated and palmitoylated vacuolar membrane protein that interacts with Atg13p
YHR178W STB5 Transcription factor, involved in regulating multidrug resistance and oxidative stress response
YML007W YAP1 Basic leucine zipper (bZIP) transcription factor required for oxidative stress tolerance
YML035C AMD1 AMP deaminase, tetrameric enzyme that catalyzes the deamination of AMP to form IMP and ammonia
YER042W MXR1 Methionine-S-sulfoxide reductase, involved in the response to oxidative stress
YNL241C ZWF1 Glucose-6-phosphate dehydrogenase (G6PD), catalyzes the first step of the pentose phosphate pathway
YCR034W FEN1 Fatty acid elongase, involved in sphingolipid biosynthesis
Resistant
YDL062W YDL062W Dubious open reading frame unlikely to encode a protein; partially overlaps uncharacterized ORF YDL063C
YPL172C COX10 Catalyzes the first step in the conversion of protoheme to the heme A prosthetic group required for cytochrome c oxidase activity
YOR293W RPS10A Protein component of the small (40S) ribosomal subunit
YPL178W CDC2 Catalytic subunit of DNA polymerase delta
YDR393W SHE9 Mitochondrial inner membrane protein required for normal mitochondrial morphology
YNL081C SWS2 Putative mitochondrial ribosomal protein of the small subunit, has similarity to E. coli S13 ribosomal protein
YPR069C SPE3 Spermidine synthase, involved in biosynthesis of spermidine and also in biosynthesis of pantothenic acid
YIL054W YIL054W Protein of unknown function; expressed at both mRNA and protein levels
Table 3.3: TMPyP4- and H202-sensitive and -resistant gene deletion strains
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porphyrin structure of TMPyP4, since porphyrins have the ability to produce 




3.2.7   Exposure to light increases toxicity of TMPyP4 
Given that porphyrins can produce ROS upon exposure to light, and that it is this 
property which is potentially causing the sensitivity to TMPyP4, I wanted to test 
whether increasing exposure to light would accelerate or heighten sensitivity to the 
porphyrin. Therefore, I carried out a serial dilution spot test of pentose phosphate 
pathway deletion strains, alongside wild type strains, on media lacking and 
containing 100 μM TMPyP4 and either exposed the plate to light or kept it in the 
dark for 3 days at 30
o
C. As the results in Figure 3.8 demonstrate, exposure to light 
does indeed increase sensitivity of all strains to TMPyP4 treatment, including the 
wild type. The ppp∆ strains exhibited significantly increased sensitivity to TMPyP4 
when incubated in the light in comparison to growth in the dark.  
 
Incubating plates in the dark at the same temperature resulted in an increase in 
growth of all strains when compared to Figure 3.6 and Figure 3.7b, where measures 
were not taken to protect plates from light nor expose them to it. However, several 
of the ppp∆ strains demonstrated TMPyP4-sensitivity even in the dark, especially 
tkl1∆, tkl1∆ rpe1∆ and tal1∆ rpe1∆. The results of this experiment suggest that the 
toxic effects of TMPyP4 can be enhanced upon exposure to light and that deletion of 
key PPP genes can still increase sensitivity to the ligand, even when strains were 










Figure 3.8: Exposure to light increases the sensitivity of yeast strains to TMPyP4 
Spot test for light-activated TMPyP4-sensitivity of ppp∆ strains. Strains were grown to 
saturation in YEPD before a 5-fold serial dilution and pinning onto plates containing and 
lacking 100 μM TMPyP4. All plates were incubated at 30oC for 3 days in an incubator 










CSM 100µM TMPyP4 CSM 100µM TMPyP4












3.2.8   Few yfg∆ strains are sensitive to both TMPyP4 and RHPS4 
As mentioned in the introduction of this chapter, I also screened for differential 
sensitivity to another G-quadruplex binding ligand, RHPS4 (Cookson et al., 2005). 
This ligand is a pentacyclic acridine and binds to G-quadruplexes in a different 
manner and with different specificity and affinity to TMPyP4 (Wei et al., 2006; 
Phan et al., 2005; Gavathiotis et al., 2003; Gavathiotis et al., 2001; Haq et al., 
1999). If the two compounds were operating by similar mechanisms, and exerting 
the same effect, I expected to see a large overlap between the data sets and 
similarities between the screen results in terms of strains defined as having 
differential sensitivity. However, upon comparison of the genome-wide data 
following the TMPyP4 and RHPS4 screens, I found little similarity between the G 
quadruplex binding ligand sensitive strains. Studying the RHPS4 and TMPyP4 data 
more closely, there are only 2 gene deletion strains which are classed as sensitive to 
both G-quadruplex binding ligands, based on the arbitrary cut off of – fre8∆ and 
amd1∆ - whereas there are 16 deletion strains which are RHPS4- and TMPyP4-
resistant (Figure 3.9 and Table 3.4).  
 
In addition to the TMPyP4, H2O2 and RHPS4 screens, I also screened for 
differential sensitivity to hydroxyurea (HU). In clustering all of the fitness (F) data 
from the 6 screens (CSM and 1% DMSO controls, plus 4 treatment conditions) 
together in a heatmap, I found that the fitness profile in response to TMPyP4 
treatment most resembled the profile in response to hydrogen peroxide treatment 
(Figure 3.10). This suggests that TMPyP4 is exerting similar effects and eliciting 
similar phenotypic responses to the presence of hydrogen peroxide, and has little 









Figure 3.9: Only two deletion strains are sensitive to both TMPyP4 and RHPS4 
Correlation plot of fitness differential values from genome-wide screens for TMPyP4- 
and RHPS4-sensitivity (correlation = 0.096). Genes in red (bottom left-hand corner) were 
found to increase sensitivity to both TMPyP4 and RHPS4 when deleted (FD ≤ -0.5). 
Genes in green (top right-hand corner) were found to decrease sensitivity to both 
TMPyP4 and RHPS4 when deleted (FD ≥ 0.5). Blue lines denote FD thresholds. 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fitness Differential (FD) on TMPyP4
ORF Gene SGD Description
Sensitive
YML035C AMD1 AMP deaminase, tetrameric enzyme that catalyzes the deamination of AMP to form IMP and ammonia
YLR047C FRE8 Protein with sequence similarity to iron/copper reductases, involved in iron homeostasis
Resistant
YDL062W YDL062W Dubious open reading frame unlikely to encode a protein; partially overlaps uncharacterized ORF YDL063C
YIL134W FLX1 Protein required for transport of flavin adenine dinucleotide (FAD), a synthesis product of riboflavin, across the mitochondrial membrane
YAL010C MDM10 Subunit of both the ERMES complex and of the mitochondrial sorting and assembly machinery (SAM complex)
YCR028C-ARIM1 Single-stranded DNA-binding protein essential for mitochondrial genome maintenance
YDL104C QRI7 Highly conserved mitochondrial protein, essential for t6A modification of mitochondrial tRNAs that decode ANN codons
YOR033C EXO1 5'-3' exonuclease and flap-endonuclease involved in recombination, double-strand break repair and DNA mismatch repair
YNL003C PET8 S-adenosylmethionine transporter of the mitochondrial inner membrane, member of the mitochondrial carrier family
YIL074C SER33 3-phosphoglycerate dehydrogenase, catalyzes the first step in serine and glycine biosynthesis
YGR101W PCP1 Mitochondrial serine protease required for the processing of mitochondrial proteins and maintenance of mitochondrial DNA and morphology
YDR375C BCS1 Mitochondrial protein of the AAA ATPase family; has ATP-dependent chaperone activity
YJR024C YJR024C 5'-methylthioribulose-1-phosphate dehydratase; acts in the methionine salvage pathway
YBR269C FMP21 Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-throughput studies
YCR071C IMG2 Mitochondrial ribosomal protein of the large subunit
YDR174W HMO1 Chromatin associated high mobility group (HMG) family member involved in genome maintenance
YOR065W CYT1 Cytochrome c1, component of the mitochondrial respiratory chain
YBR122C MRPL36 Mitochondrial ribosomal protein of the large subunit
Table 3.4: TMPyP4- and RHPS4-sensitive and -resistant gene deletion strains
Figure 3.10: Fitnesses of each deletion strain on control and supplemented media
Fitness data for every deletion strain from six genome-wide screens on CSM or CSM 
supplemented with 1% DMSO, 200 μM RHPS4, 100 mM hydroxyurea (HU), 100 μM 
TMPyP4 or 1.5 mM H2O2. Each coloured line represents mean fitness (F) of yfg∆ on the 
indicated medium, coloured according to relative fitness (low F = pale, high F = dark). 
Fitness on each medium was compared for each deletion strain and strains were clustered 
vertically depending on similar fitness changes in response to each treatment. Treatments 








































In this chapter I studied the response of null mutant strains to exposure to a ligand 
which stabilises G-quadruplexes. I carried out a genome-wide screen of yeast single 
deletion strains to examine differential sensitivity to the G-quadruplex binding 
ligand TMPyP4. Previous work demonstrates that TMPyP4 presence can affect 
telomerase activity (Mikami-Terao et al., 2009; Mikami-Terao et al., 2008), so 
therefore I expected to find that deletion of telomerase-, telomere- or DNA damage 
response-associated genes would result in a change in sensitivity to TMPyP4 in 
comparison to wild type strains. However, the conclusions of my genome-wide 
screen revealed little to no evidence for an over-representation of telomere 
associated genes amongst those which were most sensitive to the G-quadruplex 
binding ligand. I did observe, however, that genes associated with the pentose 
phosphate pathway (PPP), the oxidative stress response and tubulin folding 
demonstrated TMPyP4-sensitivity upon deletion. 
 
TMPyP4 is potentially effective against retinoblastoma cell lines, human prostate 
carcinoma and mammary tumours (Mikami-Terao et al., 2008; Grand et al., 2002). 
Interestingly, the PPP also has links with cancer through changes in metabolism 
within tumour cell lines. The main link is named the Warburg effect, in which 
cancer cells rely on aerobic glycolysis to generate energy instead of using 
mitochondrial oxidative phosphorylation (Vander Heiden et al., 2009). Therefore the 
involvement of the PPP in response to TMPyP4 treatment is of particular interest. 
Deletion of ZWF1, RPE1 and TKL1, which encode key enzymes of the PPP, causes 
large increases in sensitivity to TMPyP4. The sensitivity to TMPyP4 displayed by 
ppp∆ strains is most likely the result of a reduction in NADPH production, key for 
antioxidant function and a link to the oxidative stress response. Interestingly, a 
recent paper by Krüger et al. (2011) suggests that the non-oxidative phase of the 
PPP harbours a NADPH-independent role in the oxidative stress response, which is 
proposed to exert its effects through transcriptional alterations. 
 
One could conclude that deletion of PPP genes ZWF1, TKL1 or RPE1 caused 
TMPyP4-sensitivity by affecting flux through the pathway. However, when multiple 
PPP genes were deleted in the same strain, the sensitivity to TMPyP4 remains at 
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similar levels. For instance, tkl1∆ rpe1∆ exhibits the same growth phenotype as the 
single deletion strains of rpe1∆ and tkl1∆. This lack of change following additional 
gene deletions suggests that a change in flux through the PPP is unlikely to be the 
source of the TMPyP4-sensitivity of ppp∆ strains. 
 
In my genome-wide screen for TMPyP4-sensitivity I also found that the oxidative 
stress-linked gene deletion strains ccs1∆ and yap1∆ demonstrated sensitivity to the 
G-quadruplex binding ligand. Therefore I hypothesised that the sensitivity of these 
deletion strains to TMPyP4 is linked to a deficiency in the oxidative stress response. 
I screened the genome-wide response to the presence of hydrogen peroxide (H2O2), 
as well as RHPS4, an alternative G-quadruplex binding molecule (Cookson et al., 
2005). Through these screens I found greater similarity between the responses to 
TMPyP4 and H2O2 than between the two G-quadruplex binding ligands, consistent 
with my hypothesis. 
 
TMPyP4 is a porphyrin, a class of compounds historically used in photodynamic 
therapy, wherein reactive oxygen species (ROS) are produced upon stimulation by 
light (Granville et al., 2001). This property therefore provides a potential 
explanation for our observation that defects in the oxidative stress response results 
in sensitivity to TMPyP4. Grand et al. (2002) noted through transcriptional studies 
that oxidative stress-linked genes were upregulated in response to TMPyP4 
treatment in human cell lines. The results from the transcriptional study by Grand et 
al. (2002) are consistent with our findings in the genome-wide screen, insofar as 
deletion of genes involved in the oxidative stress response results in increased 
sensitivity to TMPyP4. Indeed, upon exposure to light, both wild type and ppp∆ 
strains exhibited significantly increased sensitivity to TMPyP4. Interestingly, the 
ppp∆ strains still demonstrate TMPyP4-sensitivity in spite of incubation in the dark, 
suggesting that low levels of oxidative stress are still occurring in spite of efforts to 
protect the plates against light activation.  
 
cdc13-1 is a mutant form of the telomere binding protein Cdc13 which is deficient 
in telomere capping at restrictive temperatures. Smith et al. (2011) recently 
demonstrated that stabilisation of G-quadruplexes by three different methods has the 
ability to suppress that temperature sensitivity of cdc13-1 at semi-permissive 
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temperatures. This suggests that stable G-quadruplexes can participate in a 
rudimentary telomere cap when natural capping is disrupted. TMPyP4 is predicted 
to bind and stabilise G-quadruplexes, so I tested the effect of the ligand on the 
temperature sensitivity of cdc13-1. I found that TMPyP4 treatment had little effect 
on the growth phenotype of cdc13-1 at semi-permissive temperatures, which 
suggests that the G-quadruplex stabilising effect of TMPyP4 at telomeres is 
insufficient for the suppression of temperature sensitivity, or that the presence of 
TMPyP4 exerts additional effects which affect telomeres, such as oxidative stress 
(von Zglinicki, 2002).  
 
An additional interesting result of the screen is the identification of tubulin-related 
genes as causing TMPyP4-sensitivity upon deletion. Unlike ppp∆ strains, which 
demonstrated sensitivity to both TMPyP4 and H2O2, deletion of tubulin-related 
genes only caused sensitivity to TMPyP4. Certain anti-cancer drugs target 
microtubules, which either act by inhibiting tubulin polymerisation or cause the 
stabilisation of microtubules (Li and Sham, 2002). Since TMPyP4 is not targeted at 
microtubules, the response of tubulin processing mechanisms to G-quadruplex 
stabilisation may be an important area of study with regards to the anti-cancer 



















3.4 Future Work 
 
My studies have identified an important role for the pentose phosphate pathway 
(PPP) in the response to TMPyP4-treatment. The PPP provides a means of 
protection against the effects resulting from treatment with the porphyrin, most 
likely due to the production of NADPH which occurs in the oxidative phase of the 
PPP.  
 
I hypothesise therefore that treatment with TMPyP4 results in ROS generation in 
yeast. In order to test this hypothesis, the production of ROS in TMPyP4-treated 
cells could be monitored using dihydroethidium (DHE), the reduced form of the 
DNA dye ethidium bromide. DHE is commonly used to detect oxidative cellular 
activities, exhibiting blue fluorescence in the cytosol and red fluorescence upon 
oxidation and DNA intercalation. DHE can be used with intact cells and the dye 
would provide an indication as to whether TMPyP4-treatment results in oxidative 
stress.  
 
The role of the PPP in TMPyP4 resistance could also be explored through the 
overexpression of PPP genes. Overexpression of TKL1 can suppress sensitivity of 
sod1∆ to HU and other sod1∆ phenotypes, predicted to be through increasing 
NADPH production (Carter et al., 2005; Slekar et al., 1996). Therefore if ppp∆ 
strains were sensitive to TMPyP4 due to reduced NADPH production and defects in 
the oxidative stress response, increasing expression of key PPP genes may inhibit 
this TMPyP4-sensitivity. 
 
The six genome-wide screens carried out in this chapter generated a lot of data 
which has not been explored here. In particular, the screen for differential sensitivity 
to RHPS4 could be investigated further; for instance, 16 gene deletion strains 
exhibited resistance to both RHPS4 and TMPyP4. These strains could be studied in 
detail to discern whether this response is specific to G-quadruplex binding ligands 






4 The genetic interactions between the response to 




In the previous chapter I demonstrated that deficiencies in the pentose phosphate 
pathway (PPP) led to sensitivity to the G-quadruplex binding ligand TMPyP4 in 
Saccharomyces cerevisiae. I found that the deletion of key PPP genes leads to an 
increase in TMPyP4-sensitivity, which could be attributed to the role of the PPP in 
NADPH production. TMPyP4 is a member of the porphyrin family, a group of 
compounds which have been used historically in photodynamic therapy, in which 
light is used to stimulate the production of reactive oxygen species (ROS) and cause 
apoptosis (Granville et al., 2001). NADPH is key for anti-oxidant function and the 
removal of ROS, and is therefore of high importance for the cellular response to 
oxidative stress. The PPP is required for NADPH production, and therefore this 
could provide some explanation as to why deletion of PPP genes causes TMPyP4-
sensitivity.  
 
Interestingly, deletion of key PPP genes also affects the temperature sensitivity of 
the telomere capping mutant cdc13-1. A genome-wide screen using the same single 
deletion library used in the TMPyP4 screen was carried out in order to study the 
genetic interactions between single deletion mutants and cdc13-1 (Addinall et al., 
2011; Addinall et al., 2008). This screen identified the deletion of key PPP genes, 
TKL1 and TAL1, as being capable of suppressing the temperature sensitivity of 
cdc13-1 to a significant degree (Figure 4.1).  
 
A number of studies have linked telomere biology and oxidative stress, 
predominantly in mammalian systems (Richter and Zglinicki, 2007; Kawanishi and 
Oikawa, 2004; von Zglinicki, 2002). In yeast, a transcriptional study of the response 
to telomere uncapping in cdc13-1 strains demonstrated that genes associated with 
the oxidative stress response, such as MSN4, are upregulated following a shift to 
restrictive temperatures (Greenall et al., 2008). The study also found that the PPP 
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genes SOL4 and GND2 (Reactions 4 and 5 in Figure 1.6) are upregulated in 
response to telomere uncapping (Greenall et al., 2008). 
 
Due to the conclusions of Chapter 3, in which a link between the PPP and TMPyP4-
sensitivity was uncovered, I decided to investigate the interaction between the PPP 
and telomere uncapping further. I hypothesised that, due to the results of the 
transcriptional studies (in which oxidative stress response genes are upregulated), 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.1: Genetic interaction strength comparison between cdc13-1 and yku70∆
Genes which when deleted cause significant suppression of temperature sensitivity of 
both cdc13-1 and yku70∆ appear in the top right-hand corner of the plot. Genes which 
when deleted cause signifcant enhancement of cdc13-1 and yku70∆ temperature  
sensitivity appear in the bottom left-hand corner of the plot. Genes in the centre of the 
plot did not interact with cdc13-1 or yku70∆ and so were removed. Symbols indicate 
genes which are components of selected protein complexes. Genes that interact with both 
cdc13-1 and yku70∆ are open white circles; those that interact with just one mutation are 
crossed boxes. PPP genes are highlighted on the plot using the same colours used in 
Figure 1.6. The dashed black rectangle indicates an arbitrary GIS cutoff of +/- 0.5. Figure 





4.2.1   Deletion of TKL1 and TAL1 suppresses cdc13-1 temperature sensitivity 
Genome-wide screens of the single deletion library (SDL) crossed with a cdc13-1 
strain suggest that temperature sensitivity of the mutant strain can be suppressed 
through deletion of either TKL1 or TAL1 (Figure 4.1; (Addinall et al., 2011; 
Addinall et al., 2008). TKL1 encodes Tkl1, the major transketolase utilised in the 
non-oxidative phase of the pentose phosphate pathway (PPP) (Reactions 8 and 10 in 
Figure 1.6). Tal1 also has a role in this phase of the pathway, in catalysing the 
conversion of erythrose-4-phosphate and sedoheptulose-7-phosphate to 
glyceraldehyde-4-phosphate and fructose-6-phosphate (Reaction 9 in Figure 1.6). 
The genome-wide screen was carried out in the S288C background of 
Saccharomyces cerevisiae. In order to confirm the suppression of cdc13-1 
temperature sensitivity which occurs when either TKL1 or TAL1 are deleted in the 
mutant strain, I carried out a spot test of the equivalent strains in the W303 
background.  Deletion of TKL1 in the cdc13-1 background suppresses sensitivity of 
the capping mutant at temperatures up to 27oC (Figure 4.2a).  TAL1 deletion also has 
a similar effect, but does not improve the growth of cdc13-1 to the same extent as 
TKL1 deletion (Figure 4.2b).  
 
Interestingly, deletion of TKL1 and TAL1 improves the growth of cdc13-1 rad9∆ 
strains. RAD9 encodes an important checkpoint protein which stimulates the DNA 
damage response and cell cycle arrest. When RAD9 is deleted in the cdc13-1 
background, temperature sensitivity is suppressed at temperatures up to 28oC, since 
the uncapped mutant strains continue through the cell cycle (Garvik et al., 1995). 
Eventually the accumulated damage caused by the presence of uncapped telomeres 
results in cell death, which is why the temperature sensitivity of cdc13-1 cannot by 
totally suppressed by RAD9 deletion, which also results in the generation of large 
amounts of ssDNA, at restrictive temperatures (Garvik et al., 1995). As visible in 
Figure 4.2, cdc13-1 tkl1∆ rad9∆ and cdc13-1 tal1∆ rad9∆ strains grow better at 
28oC than cdc13-1 rad9∆. This suggests that the phenotypic suppression exerted by 
TKL1 and TAL1 deletion on cdc13-1 strains is independent of Rad9 activity, since 
the suppression of temperature sensitivity observed in cdc13-1 rad9∆ strains is 
improved by deletion of either gene. 
Figure 4.2: Deletion of TKL1 and TAL1 suppresses cdc13-1 temperature sensitivity
(a) Spot test for temperature sensitivity of cdc13-1, cdc13-1 tkl1∆ and cdc13-1 tkl1∆ 
rad9∆, and a simplified subsection of Figure 1.6, indicating the disrupted step of the PPP 
(red X). Strains were grown to saturation in YEPD before a 5-fold serial dilution and 
pinning onto solid agar plates. Plates were incubated at the indicated temperatures for 3 
days. Numbers in the pathway correspond to those in Figure 1.6 (b) Spot test for 
temperature sensitivity of cdc13-1 and cdc13-1 tal1∆ and cdc13-1 tal1∆ rad9∆. Strains 
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4.2.2   chk1∆ increases suppression of the cdc13-1 phenotype by tkl1∆ and tal1∆ 
The DNA damage response which occurs following telomere uncapping in cdc13-1 
strains is mediated by checkpoint proteins such as Rad9. Rad9 is 
hyperphosphorylated by Mec1 and Tel1 kinases and transmits the DNA damage 
checkpoint signal downstream by activating Rad53 and Chk1 (Ma et al., 2006; 
Sweeney et al., 2005; Blankley and Lydall, 2004; Emili, 1998; Vialard et al., 1998). 
As demonstrated in Chapter 4.2.1, RAD9 deletion can suppress the temperature 
sensitivity of cdc13-1 at semi-permissive temperatures. Deletion of CHK1, which 
acts downstream of Rad9, in the cdc13-1 background can also suppress the 
temperature sensitivity of the mutant strain; chk1∆ mutants are partially defective at 
the metaphase/anaphase checkpoint (Jia et al., 2004; Maringele and Lydall, 2002; 
Sanchez et al., 1999). This is confirmed in Figure 4.3, in which a cdc13-1 chk1∆ 
strain exhibits improved growth at 26.5oC and 27oC when compared to a cdc13-1 
strain at the same temperatures.  
 
Deletion of either TKL1 or TAL1 in the cdc13-1 chk1∆ background improves growth 
further, with increases in temperature tolerance visible for both strains. Since there 
are two different DNA damage checkpoint pathways which are responsible for 
metaphase/anaphase arrest of cdc13-1 mutants (one Rad9/Mec1/Chk1-dependent 
and the other Mec1/Rad53/Dun1-dependent) additive effects to the phenotypic 
suppression of cdc13-1 temperature sensitivity by CHK1 deletion most likely do not 
occur due to effects downstream of this checkpoint. Instead the suppression of 
temperature sensitivity observed in cdc13-1 strains by TKL1 or TAL1 deletion may 
occur due to downstream effects of the Mec1/Rad53/Dun1-dependent checkpoint 
pathway. This is especially interesting considering the Mec1/Rad53/Dun1-
dependent checkpoint pathway affects the expression and activity of ribonucleotide 
reductase (Zhao and Rothstein, 2002; Huang and Elledge, 1997; Elledge, 1996; 










Figure 4.3: Suppression by TKL1 and TAL1 deletion is Chk1-independent 
(a) Spot test for temperature sensitivity of cdc13-1, cdc13-1 tkl1∆ and cdc13-1 tkl1∆ 
chk1∆. Strains were grown to saturation in YEPD before pining onto solid agar plates. 
Plates were incubated at the indicated temperatures for 3 days. (b) Spot test for 
temperature sensitivity of cdc13-1 and cdc13-1 tal1∆ and cdc13-1 tal1∆ chk1∆. Strains 
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4.2.3   Suppression of the cdc13-1 phenotype by tkl1∆ and tal1∆ is rad53∆ sml1∆-           
dependent  
Deletion of TKL1 and TAL1 both resulted in the suppression of temperature 
sensitivity of cdc13-1 chk1∆ strains at semi-permissive temperatures. This led me to 
hypothesise that suppression of cdc13-1 temperature sensitivity in cdc13-1 tkl1∆ and 
cdc13-1 tal1∆ strains is independent of Chk1 activity and is not related to the 
activities of the Rad9/Mec1/Chk1-dependent checkpoint pathway. This suggests that 
the suppression of temperature sensitivity observed in cdc13-1 strains by TKL1 or 
TAL1 deletion may instead occur due to downstream effects of the 
Mec1/Rad53/Dun1-dependent checkpoint pathway. In order to test this hypothesis, I 
created strains in which TKL1 and TAL1 were absent, as well as RAD53. Deletion of 
RAD53 is lethal; however, viable spores can obtained through simultaneous deletion 
of the ribonucleotide reductase (RNR) inhibitor SML1 (Zhao et al., 1998). Therefore 
I examined the temperature sensitivity of cdc13-1 tkl1∆ rad53∆ sml1∆ and cdc13-1 
tal1∆ rad53∆ sml1∆ strains in comparison to cdc13-1 and cdc13-1 rad53∆ sml1∆ 
strains. 
 
As demonstrated in Figure 4.4, cdc13-1 rad53∆ sml1∆ strains are less temperature 
sensitive than cdc13-1 strains. This can be attributed to the defect in the checkpoint 
pathway caused by Rad53 deletion, which leads to partial arrest; Rad53 and its 
downstream target Dun1 are responsible for 50% of the arrest observed in cdc13-1 
mutants (Gardner et al., 1999). Additional deletion of either TKL1 or TAL1 in 
cdc13-1 rad53∆ sml1∆ strains does not increase suppression of temperature 
sensitivity at semi-permissive temperatures (Figure 4.4). Therefore this suggests that 
Tkl1 and Tal1 act downstream of the Mec1/Rad53/Dun1-dependent checkpoint 
pathway in response to telomere uncapping in cdc13-1 strains.  
 
However, it is worth noting that the rad9∆, chk1∆ and rad53∆ sml1∆ strains used in 
these experiments (Figures 4.2 to 4.4) contain a HIS3 auxotrophic maker. 
Introducing this marker into strains with disruptions to carbohydrate metabolism 
through mutation of the pentose phosphate pathway may additionally influence 
metabolism and therefore may affect growth independently of the cdc13-1 mutation. 
 
 
Figure 4.4: Suppression by TKL1 and TAL1 deletion is Rad53-dependent 
(a) Spot test for temperature sensitivity of cdc13-1, cdc13-1 tkl1∆ and cdc13-1 tkl1∆ 
rad53∆ sml1∆. Strains were grown to saturation in YEPD before pining onto solid agar 
plates. Plates were incubated at the indicated temperatures for 3 days. (b) Spot test for 
temperature sensitivity of cdc13-1 and cdc13-1 tal1∆ and cdc13-1 tal1∆ rad53∆ sml1∆. 
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4.2.4   cdc13-1 tkl1∆ tal1∆ does not grow better than single deletion strains 
The deletion of TKL1 and TAL1 both result in the suppression of temperature 
sensitivity of cdc13-1, cdc13-1 rad9∆ and cdc13-1 chk1∆ strains at similar 
temperatures, and neither deletion increases the suppression of temperature 
sensitivity of cdc13-1 rad53∆ sml1∆ strains. Tkl1 and Tal1 both catalyse reactions 
in the non-oxidative phase of the pentose phosphate pathway (PPP). Since both 
enzymes operate in the same pathway, I hypothesised that the suppression of cdc13-
1 temperature sensitivity observed following deletion of TKL1 or TAL1 is due to 
deficiencies in the non-oxidative part of the PPP (see Figure 1.6). In order to test this 
hypothesis, I generated a strain in which both TKL1 and TAL1 were absent, 
alongside the cdc13-1 mutation (Figure 4.5). Growth of this strain is marginally 
improved at 27oC compared to cdc13-1 tkl1∆ (which demonstrated stronger growth 
than cdc13-1 tal1∆), but not to a significant extent. Indeed, at 28oC no growth is 
observed, similar to the single deletion strain alone.  
 
These results suggest that the suppression of cdc13-1 temperature sensitivity 
observed in cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains is due to deficiencies in the 
non-oxidative phase of the PPP, since the majority of the pathway is blocked in 
cdc13-1 tkl1∆ tal1∆ strains (Figure 4.5). However, the activity of Tkl2, the minor 
isoform of transketolase, may allow flux to continue through the non-oxidative 
phase of the PPP, although tests indicate that transketolase activity is undetectable in 
tkl1∆ strains (Schaaff-Gerstenschläger et al., 1993). 
Figure 4.5: Temperature sensitivity of cdc13-1 tkl1∆ is not affected by TAL1 deletion
Spot test for temperature sensitivity of cdc13-1, cdc13-1 tkl1∆, cdc13-1 tal1∆ and 
cdc13-1 tkl1∆ tal1∆, and a simplified subsection of Figure 1.6, indicating the disrupted 
steps of the PPP (red X). Strains were grown to saturation in YEPD before a 5-fold serial 
dilution and pinning onto solid agar plates. Plates were incubated at the indicated 





































4.2.5   The cdc13-1 tal1∆ growth phenotype is dependent on G6PDH activity 
Flux through the pentose phosphate pathway can occur by two different routes, 
depending on the requirements of the cell. The oxidative phase of the PPP produces 
a large amount of the NADPH used in reactions in the cell, whereas the non-
oxidative phase can be used to produce ribose-5-phosphate, the precursor to 
nucleotides and amino acids. The oxidative phase is non-reversible and results in the 
production of ribulose-5-phosphate, which feeds into the fully reversible non-
oxidative phase. Therefore, if there is a requirement for NADPH, flux is 
predominantly directed into the oxidative phase via glucose-6-phosphate and the 
reaction catalysed by Zwf1 (Clasquin et al., 2011; Ralser et al., 2007; Frick and 
Wittmann, 2005). This can also result in ribose-5-phosphate production, but 
evidence suggests that ribose-5-phosphate production can be increased by driving 
flux into the non-oxidative phase via thermodynamic modulation of non-oxidative 
phase enzymes such as Tkl1 (Clasquin et al., 2011).  
 
Zwf1 is a major enzyme which catalyses the first, rate-limiting step of the oxidative 
phase of the PPP. It is constitutively expressed and therefore acts much like a 
housekeeping enzyme (Kletzien et al., 1994). Deletion of ZWF1 in the cdc13-1 
background does not have a large effect on temperature sensitivity in the W303 
background (Figure 4.6). Interestingly, the Addinall et al. (2011) screen found zwf1∆ 
to suppress cdc13-1 temperature sensitivity to a similar extent to TKL1 and TAL1. 
This may be due to a difference in yeast background used, since the screen was 
carried out in S288C. 
 
If the effect that TKL1 and TAL1 deletions exert on the growth of cdc13-1 is entirely 
due to the roles that they play in the non-oxidative phase of the PPP, then I expected 
to observe that deletion of ZWF1 alongside TKL1 and TAL1 deletion in the cdc13-1 
background changes the growth phenotype, either improving or reducing growth in 
comparison to cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains.  Unfortunately, I could not 
test cdc13-1 tkl1∆ zwf1∆ strains, since the double deletion of ZWF1 and TKL1 is 
lethal (Deutscher et al., 2006). In order to test my hypothesis, I therefore crossed a 
zwf1∆ strain with a cdc13-1 tal1∆ strain, which did not result in lethality. As 
demonstrated in Figure 4.6, deletion of ZWF1 actually removes the phenotypic 
suppression caused by TAL1 deletion in the cdc13-1 background at 26.5oC. The  
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temperature sensitivity of cdc13-1 tal1∆ zwf1∆ strains resembled that of cdc13-1 
zwf1∆ strains (and, to some extent, cdc13-1) rather than cdc13-1 tal1∆ strains, which 
grew adequately at 26.5oC. This result suggests that the phenotypic suppression 
observed when TAL1 is deleted in the cdc13-1 background is dependent on Zwf1 
activity. This could either be due to the reduction in NADPH production, since the 
major source of NADPH is the first step of the PPP; alternatively, it may be related 
to the production of ribose-5-phosphate, which can only be produced via the non-




























Figure 4.6: Phenotypic suppression by TAL1 deletion is Zwf1-dependent
Spot test for temperature sensitivity of cdc13-1, cdc13-1 zwf1∆, cdc13-1 tal1∆ and 
cdc13-1 tal1∆ zwf1∆, and a simplified subsection of Figure 1.6, indicating the disrupted 
steps of the PPP (red X). Strains were grown to saturation in YEPD before a 5-fold serial 
dilution and pinning onto solid agar plates. Plates were incubated at the indicated 




































4.2.6   G6PDH activity is not affected by TAL1 or TKL1 deletion 
The deletion of TAL1 could potentially affect Zwf1 activity, which could explain the 
difference observed between suppression of cdc13-1 temperature sensitivity by 
TAL1 deletion and suppression of temperature sensitivity in cdc13-1 tal1∆ zwf1∆ 
strains. For instance, TAL1 deletion may result in an increase in Zwf1 activity 
through directing flux through the oxidative phase of the PPP, which may result in a 
decrease in the temperature sensitivity of cdc13-1. This effect is then absent upon 
deletion of ZWF1. In order to investigate whether deletion of TAL1 had any effect 
on Zwf1 activity, I carried out an enzyme assay (as described in Chapter 2.3). Zwf1 
activity in tal1∆ strains was monitored, as well as in wild type, zwf1∆ and tkl1∆ 
strains.  
 
The activity of Zwf1 does not change upon deletion of tal1∆ or tkl1∆ (Figure 4.7 
and Table 4.1). However, in the zwf1∆ strain, any activity of the enzyme is 
negligible to undetectable, as would be expected. The results suggest that neither 
TAL1 nor TKL1 deletion has a marked effect on Zwf1 activity. I conclude that the 
suppression of cdc13-1 temperature sensitivity by TAL1 deletion is dependent on 





           Table 4.1: Specific activity of Zwf1 in ppp∆ strains 
  Wild Type zwf1∆ tal1∆ tkl1∆ 
Specific Activity 
(μmol/min/mg) 357 ± 34 0 ± 13 317 ± 56 344 ± 34 
Figure 4.7: Deletion of TKL1 or TAL1 does not affect Zwf1 activity
Measurement of Zwf1 (G6PDH) activity in wild type and ppp∆ strains by measuring 
NADPH generation. NADPH generation was determined by measuring absorbance at 
340 nm before and 1, 5 and 10 minutes after the addition of glucose-6-phosphate to the 





















Water  Wild Type (DLY640)
  tal1∆ (DLY5711)
  tkl1∆ (DLY5541)
  zwf1∆ (DLY5557)
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4.2.7   TKL1 deletion suppresses yku70∆ temperature sensitivity 
I decided to investigate the effect of TKL1 and TAL1 deletion on the temperature 
sensitivity of yku70∆ strains in order to establish whether suppression of the 
telomere uncapping phenotype is cdc13-1 specific. The Ku complex is a highly 
conserved complex which binds to the double stranded region of telomeres and 
plays an important role in homologous recombination as well as telomere 
uncapping. In S. cerevisiae, the Ku complex is composed of Yku70 and Yku80, 
which bind together in a heterodimeric ring structure distal from the end of the 
telomere. Telomere uncapping caused by the cdc13-1 mutation and YKU70 deletion 
elicit similar responses but with a number of differences. Whereas uncapping in 
cdc13-1 strains results in extensive degradation of the 5’ strand and the activation of 
the Mec1/Rad53/Dun1-depenent and Rad9/Mec1/Chk1- and Pds1-dependent 
checkpoint pathways, uncapping in yku70∆ strains leads to a shorter 3’ overhang in 
comparison and the activation of only the latter checkpoint pathway (Zubko et al., 
2004; Maringele and Lydall, 2002).  
 
yku70∆ can grow to higher temperatures than cdc13-1 - the temperature-sensitive 
effects can only be observed at temperatures over 36oC. In order to test the effect of 
TKL1 and TAL1 deletion in the yku70∆ background, I crossed tkl1∆ and tal1∆ 
strains with yku70∆ and carried out a serial dilution spot test. The results in Figure 
4.8 demonstrate that the deletion of TKL1 and TAL1 have different effects on the 
temperature sensitivity of yku70∆. TAL1 deletion has minimal effects on yku70∆ 
growth and growth at 37oC may even by slightly inhibited. In contrast, TKL1 
deletion causes a significant improvement in yku70∆ growth at temperatures up to 
37oC. Curiously, this phenotypic suppression disappears upon an increase in 
temperature of just 0.5oC to 37.5oC. This likely to be due to an independent 
temperature sensitivity caused by TKL1 deletion. Indeed, a large-scale study of heat 
sensitivity of null mutants found that tkl1∆ strains demonstrate increased sensitivity 
to temperatures over 37oC (Sinha et al., 2008).  
 
I also tested the growth of yku70∆ tkl1∆ tal1∆ strains. Growth of these strains 
resembled that of yku70∆ tkl1∆ strains, including the sharp reduction in growth at 
37.5oC when compared to growth at 37oC. The genome-wide screen data from the 
Addinall et al. (2011) study suggests that neither TKL1 deletion nor TAL1 deletion 
… 
Figure 4.8: TKL1 deletion suppresses yku70∆ temperature sensitivity
Spot test for temperature sensitivity of yku70∆, yku70∆ tkl1∆, yku70∆ tal1∆ and yku70∆ 
tkl1∆ tal1∆. Strains were grown to saturation in YEPD before a 5-fold serial dilution and 
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has an effect on the temperature sensitivity of yku70∆ (Figure 4.1). My data suggests 
that in the W303 background, the TAL1 result is comparable. However, TKL1 
deletion in the yku70∆ background has a different effect to the one predicted by the 
screen, which was carried out in the S288C background. This could be an effect 

































In this chapter I have demonstrated that deletion of pentose phosphate pathway genes 
TKL1 and TAL1 suppresses the temperature sensitivity of the telomere capping mutant 
strain cdc13-1. The suppression observed upon deletion of either TKL1 or TAL1 is due 
to disruption of the same pathway, namely the non-oxidative phase of the PPP. This 
was confirmed by deletion of both genes in the cdc13-1 background, which did not 
result in an increase in phenotypic suppression; rather, growth of cdc13-1 tkl1∆ tal1∆ 
strains resembled that of cdc13-1 tkl1∆. In addition, suppression of cdc13-1 
temperature sensitivity by TKL1 and TAL1 deletion is independent of the activities of 
the DNA damage-dependent checkpoint protein Rad9 and the DNA damage 
checkpoint effector Chk1. The rad9∆ and chk1∆ null mutations alone cause an 
increase in growth of cdc13-1 strains at semi-permissive temperatures due to 
prevention of the initiation of downstream DNA damage response pathways and cell 
cycle arrest (Jia et al., 2004; Maringele and Lydall, 2002; Sanchez et al., 1999; Garvik 
et al., 1995). I found that deletion of either TKL1 or TAL1 in the cdc13-1 rad9∆ and 
cdc13-1 chk1∆ backgrounds increased the growth of these strains at semi-permissive 
temperatures further, suggesting that the suppression of temperature sensitivity in 
cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains was not part of the Chk1 response pathway. 
Indeed, deletion of either TKL1 or TAL1 in the cdc13-1 rad53∆ sml1∆ background did 
not cause further suppression of the temperature sensitivity of the strain, which further 
reinforces the hypothesis that suppression of cdc13-1 temperature sensitivity by TKL1 
or TAL1 is related to the Mec1/Rad53/Dun1-dependent checkpoint pathway. 
 
ppp∆ strains are sensitive to oxidative stress. For instance, treating ppp∆ strains with 
various agents that cause oxidative stress such as hydrogen peroxide (H2O2), diamide 
and cumene-hydroperoxide (CHP) leads to a reduction in growth when compared to 
untreated strains (Krüger et al., 2011). This is thought to be due to a drop in the 
production of NADPH which is essential for antioxidant function; indeed, in the 
absence of the antioxidant Sod1, overexpression of TKL1 can suppress the sod1∆ 
phenotypes in a manner dependent on the activity of Zwf1 (the yeast G6PDH), which 
suggests that TKL1 overexpression results in an increase in NADPH production 
(Carter et al., 2005; Slekar et al., 1996). However, the oxidative stress sensitivities 
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observed in ppp∆ strains may also be attributable to changes in gene expression 
regulation during the response to oxidative stress (Krüger et al., 2011).  
 
The suppression of the temperature sensitivity of cdc13-1 strains exhibited by TAL1 
deletion is also dependent on the activity of G6PDH, since deletion of ZWF1 in the 
cdc13-1 tal1∆ background removed the observed increase in growth of cdc13-1 at 
semi-permissive temperatures. This suggested that deletion of TAL1 affected Zwf1 
activity and NADPH production. In order to determine whether Zwf1 activity changes 
in response to disruption of the non-oxidative phase of the PPP, I measured NADPH 
production in tkl1∆ and tal1∆ strains. I found that the activity of Zwf1 did not change 
following TKL1 and TAL1 deletion, which agrees with previous measurements of the 
NADPH to NADP+ ratio in these strains (Krüger et al., 2011).  
 
Therefore I concluded that the suppression of cdc13-1 temperature sensitivity by 
TKL1 or TAL1 deletion is independent of NADPH production, and therefore that 
telomere uncapping in cdc13-1 strains does not lead to oxidative stress. Previous 
studies have demonstrated that tkl1∆ and tal1∆ strains are sensitive to the presence of 
ROS, which suggests that cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains should display 
enhanced growth defects if oxidative stress were occurring (Krüger et al., 2011; 
Tucker and Fields, 2004; Juhnke et al., 1996). Here, I have shown that it is in fact the 
opposite and cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains display improved growth 
compared to cdc13-1 strains. 
 
As described in Chapter 1.3.6, the pentose phosphate pathway is important for the 
production of the nucleotide precursor ribose-5-phosphate. Therefore, one 
explanation for the suppression of the temperature-sensitive phenotype of cdc13-1 
by deletion of either TKL1 or TAL1, and suppression of yku70∆ temperature 
sensitivity by TKL1 deletion may be that these null mutations affect the 
concentration of ribose-5-phosphate available for nucleotide biosynthesis. I 
hypothesised that deletion of TKL1, TAL1 and the two genes together increased 
ribose-5-phosphate available for nucleotide biosynthesis due to minimal flux 
through the non-oxidative phase of the PPP, thereby reducing the recycling of 




Studies in bacteria have reported increases in ribose-5-phosphate accumulation in 
transketolase null strains, and the intermediate also accumulates in tkl1∆ and tal1∆ 
S. cerevisiae strains following exposure to hydrogen peroxide (Krüger et al., 2011; 
Park et al., 2006). I suspect that the differences between suppression of cdc13-1 
temperature sensitivity seen in cdc13-1 tkl1∆ and cdc13-1 tal1∆ strains are due to 
the different increases in ribose-5-phosphate levels, where deletion of TKL1 results 
in higher ribose-5-phosphate levels than TAL1 deletion. This difference is also 
observable in the yku70∆ background, in that yku70∆ tkl1∆ strains also grow better 
than yku70∆ tal1∆ strains at semi-permissive temperatures. Since telomere 
uncapping in cdc13-1 strains results in a longer single-stranded 3’ overhang than in 
yku70∆ strains, I suggest that the requirement for nucleotides for repair is greater in 
cdc13-1 strains and that Tkl1 activity has a larger impact on nucleotide production 

























4.4 Future Work 
 
Resulting from this chapter, my hypothesis as to why deletion of TKL1 or TAL1 
causes suppression of the cdc13-1 temperature-sensitive phenotype is based on 
alteration in nucleotide production. Specifically, I concluded that cdc13-1 tkl1∆ and 
cdc13-1 tal1 strains are less temperature sensitive than cdc13-1 strains due to an 
increase in the concentration ribose-5-phosphate, which in turn can aid an increase 
in dNTP levels.  
 
In order to test this hypothesis, the dNTP levels in cdc13-1, cdc13-1 tkl1∆ and 
cdc13-1 tal1∆ strains could be measured to determine whether dNTP concentration 
is affected by telomere uncapping and disruption of the non-oxidative phase of the 
PPP in telomere capping mutants. The equivalent experiments could also be carried 
out in yku70∆, yku70∆ tkl1∆ and yku70∆ tal1∆ strains, since I hypothesise that 
dNTP levels have a smaller effect on yku70∆ strains at restrictive temperatures than 
cdc13-1 strains. 
 
In this chapter I studied Zwf1 activity in tkl1∆ and tal1∆ strains. In order to 
ascertain whether any metabolic changes which occur in response to telomere 
uncapping are affected by TKL1 and TAL1 deletion, the activity of Zwf1 in cdc13-1 
tkl1∆ and cdc13-1 tal1∆ strains could be examined using the same enzyme assay 
used in Chapter 4.2.6. Zwf1 activity in cdc13-1 strains is investigated in Chapter 5. 
 
TKL1 and TAL1 do not encode the only yeast transketolase and transaldolase. 
Therefore the effects of TKL1 and TAL1 deletion explored in this chapter may rely 
on the activities of the secondary transketolase Tkl2 and the putative transaldolase 
Nqm1 (Huang et al., 2008; Schaaff-Gerstenschläger et al., 1993). Strains could be 
generated in which TKL2 and NQM1 are deleted along with TKL1 and TAL1 in the 
cdc13-1 background. This would eliminate all transketolase and transaldolase 
activity and could support the hypothesis that disruption to the non-oxidative phase 







5 Telomere uncapping leads to an increase in pentose 




Metabolic flux is finely regulated and balanced. The increase in expression of a 
single enzyme can alter the chemical balance within a cell, and rapid switching 
between biochemical pathways means that responses to stresses or other 
environmental conditions, such as nutrient levels, are swift and effective. Flux 
through the pentose phosphate pathway under normal conditions in Saccharomyces 
cerevisiae is low, with the majority of glucose entering glycolysis (Frick and 
Wittmann, 2005). As little as 15% of glucose is diverted through the PPP; however, 
stressful conditions can alter this balance (Frick and Wittmann, 2005). One 
important metabolic switch in glucose metabolism is the inhbition of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The presence of oxidative 
species causes inactivation of GAPDH, blocking glycolysis and redirecting glucose 
into the PPP (Ralser et al., 2007).  
 
The enzyme that catalyses the first step of the PPP also responds to environmental 
cues and alters flux into the pathway. Glucose-6-phosphate dehydrogenase (G6PDH, 
Zwf1 in budding yeast) is constitutively expressed in the manner of a housekeeping 
protein. G6PDH activity is regulated post-transcriptionally by various means, most 
significantly the NADP+/NADPH ratio. NADPH is used as a reducing equivalent to 
reduce anti-oxidants which remove potentially harmful reactive oxygen species. 
Under oxidative stress conditions, reduced anti-oxidants become rapidly depleted 
and therefore NADPH levels drop. This change in the NADP+/NADPH ratio 
increases G6PDH activity, which in turn increases NADPH production (Kotaka et 
al., 2005; Au et al., 2000; Luzzatto, 1967).  
 
In a 2010 paper, Cosentino et al. demonstrated that G6PDH activity can also be 
regulated in response to DNA damage through the binding of a heat shock protein to 
the enzyme (Cosentino et al., 2010). Their work with Xenopus laevis and human cell 
lines explored the link between the activity of ATM, the kinase activity of which is 
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key to the DNA damage response and G6PDH activity. The group suggest that 
ATM, through a phosphorylation cascade, can stimulate an increase G6PDH activity 
in response to double strand breaks. This finding is significant, in that it suggests a 
role for the pentose phosphate pathway, or at least G6PDH activity, in the DNA 
damage response, and that increasing flux through the pathway could somehow be 
beneficial.   
 
As I have already explored in previous chapters, the DNA damage response can be 
studied through use of the telomere capping mutant cdc13-1. The temperature-
sensitive cdc13-1 exhibits capping defects at restrictive temperatures which result in 
the initiation of a DNA damage response, leading to extensive resection and cell 
cycle arrest (Garvik et al., 1995). The presence of uncapped telomeres also 
stimulates transcriptional changes. A microarray carried out by Greenall et al. 
(2008) investigated the genome-wide transcriptional response to telomere uncapping 
in cdc13-1. RNA transcript levels in uncapped strains at permissive and restrictive 
temperatures were compared to those of wild type counterparts under the same 
conditions. Changes in transcript levels were monitored over a four-hour time 
course. The analysis revealed that NAD+ metabolism potentially has a link with the 
response to telomere uncapping via increased expression of BNA2, which encodes 
an enzyme with a role in the de novo production of NAD+ (Reaction 1 in Figure 1.6) 
(Panozzo et al., 2002). Interestingly, NAD+ is linked to the pentose phosphate 
pathway via the NADP kinases Utr1 and Yef1 (the latter of which is also 
upregulated following telomere uncapping), which phosphorylate NAD+ to NADP+ 
(Reaction 2 in Figure 1.6) (Li and Shi, 2006). As described in Chapter 1.3.3, NADP+ 
is reduced in the oxidative phase of the PPP to produce NADPH (Figure 1.6). The 
expression of two PPP genes, SOL4 and GND2, also increases greatly upon telomere 
uncapping. Here, I investigate the relationship between telomere uncapping, the 
pentose phosphate pathway and Zwf1 activity further, beginning with additional 
analysis of the published Greenall et al. (2008) microarray data, and with the aim of 
studying flux through the pentose phosphate pathway and the possible mechanisms 







5.2.1   593 genes are differentially regulated following telomere uncapping 
Analysis of microarray data can provide a large amount of information about gene 
regulation in response to changes in conditions or over a particular time period. The 
method by which microarray data is analysed can return different results depending 
on the statistical method used. In addition, other parameters imposed during data 
analysis such as normalisation and pair-wise correction can also alter the results. 
Greenall et al. (2008) investigated the genome-wide response to telomere uncapping 
using a microarray, the data from which was subsequently analysed using 
Bioconductor in R (a statistical programming language) (Gentleman et al., 2004). 
Figure 5.1a, taken from the Greenall et al. (2008) paper, describes the time course 
from which samples were collected for the microarray, where CDC13+ and cdc13-1 
cultures were shifted from permissive to restrictive temperatures and samples taken 
every hour. This analysis identified 647 genes as being differentially regulated upon 
telomere uncapping – the definition of differentially regulated being at least a two-
fold change in expression between CDC13+ and cdc13-1 strains during at least one 
time point in the 4 hour time course (in all three replicates), and a p-value of < 0.05.  
 
In order to determine which genes were most likely to be differentially regulated 
following telomere uncapping, I used this definition and compared the results of 
three different statistical tests on the microarray data associated with the Greenall et 
al. (2008) paper. I analysed the raw CEL files produced following the microarray 
(available via the ArrayExpress website, accession number E-MEXP-1551) in 
GeneSpring and CARMAweb, using the unpaired t-test and the moderated t-statistic 
(limma) respectively (Rainer et al., 2006; Grewal and Conway, 2000). This resulted 
in a list of 664 differentially regulated genes from GeneSpring, and 658 
differentially regulated genes following analysis using CARMAweb. Subsequent 
comparison of the three lists of genes (the results from GeneSpring, CARMAweb 
and the original analysis) gave 593 genes which appeared in all three lists (Figure 
5.1b). Therefore I could be confident that these 593 genes were upregulated 
following telomere uncapping. 
 
 
Figure 5.1: 593 genes are differentially expressed following telomere uncapping
(a) Experimental design of the Greenall et al. microarray (taken from the 2008 paper). 
CDC13+ and cdc13-1 strains were inoculated into liquid culture and grown at 23oC to 
early log phase. Samples were taken (T = 0) and cultures were shifted to 30oC. Samples 
taken every hour after the temperature shift (T = 1 - T = 4) were used for the microarray 
experiment. (b) Three different methods of data analysis identified 593 genes with at 
least two-fold changes in expression level between cdc13-1 and CDC13+ strains (p ≤ 
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5.2.2   PPP-linked terms are over-represented among upregulated genes 
I carried out Gene Ontology (GO) analysis on the genes which were identified as 
differentially regulated following telomere uncapping in my analysis of the 
microarray data. Prior to carrying out GO analysis, cell cycle regulated genes were 
removed from the list of genes identified as being differentially expressed, since a 
number of genes identified as differentially expressed following telomere uncapping 
are likely to be enriched or depleted due to the cell cycle arrest at G2-M, which 
occurs in cdc13-1 strains but not CDC13+ strains (Greenall et al., 2008). GO 
analysis of the remaining 362 genes revealed that overrepresented GO terms related 
to differentially expressed genes following telomere uncapping include 
‘oxidoreductase activity’ and ‘pentose metabolic process’ (Table 5.1).  
 
Further analysis of the upregulated genes and downregulated genes in isolation 
found that many of the over-represented GO terms associated with upregulated 
genes were related to carbohydrate metabolism and the response to oxidative stress, 
whereas many GO terms associated with downregulated genes were related to the 
ribosome and RNA processing (Tables 5.2 and 5.3). A number of the upregulated 
genes related to carbohydrate metabolism were linked with the pentose metabolism, 
including XKS1, GCY1, RBK1, YJR096W, GND2 and SOL4. YEF1 and BNA2 were 
also upregulated in response to telomere uncapping and both encode proteins with 
functions relating to the pentose phosphate pathway (Li and Shi, 2006; Panozzo et 
al., 2002). The GO analysis therefore indicates that the pentose phosphate pathway 















Gene Ontology Term p-value 
Biological Process  
Cellular carbohydrate metabolic process 5.85E-09 
Carbohydrate metabolic process 6.10E-09 
Oxidoreductase activity 9.21E-07 
Monosaccharide metabolic process 8.11E-06 
Generation of precursor metabolites and energy 5.61E-05 
Alcohol metabolic process 1.02E-04 
Energy derivation by oxidation of organic compounds 3.85E-04 
Cellular carbohydrate catabolic process 3.95E-04 
Carbohydrate catabolic process 3.95E-04 
Pentose metabolic process 6.17E-04 
Monosaccharide catabolic process 1.15E-03 
Energy reserve metabolic process 1.94E-03 
Alcohol catabolic process 1.94E-03 
Amino acid biosynthetic process 2.09E-03 
Glucose metabolic process 2.52E-03 
Glutamine family amino acid biosynthetic process 3.11E-03 
Glutamine family amino acid metabolic process 3.11E-03 
Arginine biosynthetic process 4.04E-03 
Amine biosynthetic process 7.34E-03 
Nitrogen compound biosynthetic process 8.34E-03 
Glycogen metabolic process 9.55E-03 
      Table 5.1: GO analysis of differentially expressed genes following telomere uncapping 
 
Gene Ontology Term p-value 
Biological Process  
Carbohydrate metabolic process 7.49E-15 
Cellular carbohydrate metabolic process 7.49E-15 
Oxidoreductase activity 2.34E-10 
Generation of precursor metabolites and energy 3.32E-08 
Alcohol metabolic process 1.56E-06 
Energy derivation by oxidation of organic compounds 2.28E-06 
Monosaccharide metabolic process 8.99E-06 
Cellular carbohydrate catabolic process 1.53E-05 
Carbohydrate catabolic process 1.53E-05 
Pentose metabolic process 4.32E-05 
Energy reserve metabolic process 5.16E-05 
Monosaccharide catabolic process 1.57E-04 
Glucose metabolic process 2.07E-04 
Alcohol catabolic process 2.74E-04 
Glycogen metabolic process 5.84E-04 
Hexose metabolic process 9.11E-04 
Cellular glucan metabolic process 1.36E-03 
Response to oxidative stress 1.92E-03 
Carbohydrate kinase activity 5.45E-03 
Glutamate metabolic process 5.45E-03 
Carbohydrate biosynthetic process 6.20E-03 
Catabolic process 6.50E-03 
Succinate dehydrogenase (ubiquinone) activity 9.61E-03 
Pentose catabolic process 9.61E-03 
Oxidoreductase activity, acting on the CH-CH group of donors, quinone or related 
compound as acceptor 9.61E-03 




Gene Ontology Term p-value 
Biological Process  
Ribosome biogenesis and assembly 1.16E-18 
Ribonucleoprotein complex biogenesis 2.02E-17 
rRNA metabolic process 1.00E-07 
RNA processing 1.61E-07 
rRNA processing 2.19E-07 
Arginine biosynthetic process 1.81E-05 
Cellular amino acid biosynthetic process 7.04E-05 
Arginine metabolic process 1.07E-04 
Urea cycle intermediate metabolic process 1.07E-04 
Amine biosynthetic process 1.27E-04 
Nitrogen compound biosynthetic process 1.30E-04 
Organelle organisation and biogenesis 1.58E-04 
Maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 3.13E-04 
Maturation of SSU-rRNA 3.87E-04 
RNA metabolic process 6.06E-04 
Amino acid and derivative metabolic process 6.87E-04 
Amino acid metabolic process 1.23E-03 
Glutamine family amino acid biosynthetic process 1.60E-03 
Cellular component organisation and biogenesis 4.92E-03 
Nitrogen compound metabolic process 4.92E-03 
Amine metabolic process 7.67E-03 
Nucleobase-containing compound metabolic process 7.67E-03 
  
Cellular Component  
Nucleolus 1.78E-18 
Nuclear lumen 1.78E-10 
Organelle lumen 1.08E-07 
Membrane-enclosed lumen 1.08E-07 
Nuclear part 1.21E-06 
Nucleolar preribosome 3.87E-04 
Non-membrane-bound organelle 3.87E-04 
Intracellular non-membrane-bound organelle 3.87E-04 
90S preribosome 4.13E-04 
Preribosome 4.14E-04 
Nucleus 4.87E-04 
Small subunit processome 2.82E-03 
Preribosome, large subunit precursor 7.18E-03 
     Table 5.3: GO analysis of downregulated following telomere uncapping  
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5.2.3   ZWF1 expression in uncapped strains and genetic interaction with cdc13-1 
The large increases in SOL4 and GND2 levels observed following telomere 
uncapping (Figure 5.2) suggests that Sol4 and Gnd2 are required for the response to 
capping deficiencies. Sol4 and Gnd2 are enzymes which catalyse reactions of the 
oxidative phase of the pentose phosphate pathway (Reactions 4 and 5 in Figure 1.6). 
Therefore, their upregulation suggests that pentose phosphate pathway activity 
increases in response to telomere uncapping. Flux into the PPP in budding yeast is 
regulated in the main by the activity of Zwf1, a glucose-6-phosphate dehydrogenase 
(G6PDH), which catalyses the first step of the pathway (Figure 5.3a and Reaction 3 
in Figure 1.6). Cosentino et al. (2011) demonstrated that G6PDH activity increases 
in response to the presence of double strand breaks (DSBs). Taking this into 
account, I hypothesised that if flux increases through the PPP as a response to 
telomere uncapping, the activity of Zwf1 should increase to facilitate this.  
 
Therefore I decided to study Zwf1 activity in cdc13-1 strains at permissive and 
restrictive temperatures compared with CDC13+ strains. The microarray data from 
the Greenall et al. (2008) study suggests that there is a slight increase in ZWF1 
levels following telomere uncapping (Figure 5.3b); however, Zwf1 expression is 
constitutive and the activity of the enzyme is regulated post-transcriptionally 
(Greenall et al., 2008; Kletzien et al., 1994). The growth phenotype of cdc13-1 
zwf1∆ is not altered in comparison with cdc13-1 alone, which implies that zwf1∆ 
does not affect the growth defect of the mutant strain (Figure 5.4). Interestingly, in 
the S288C background as part of a genome wide screen, cdc13-1 zwf1∆ grows better 
at semi-permissive temperatures than cdc13-1 alone (Figure 4.1 and (Addinall et al., 
2011). However, as shown here, ZWF1 expression does not increase significantly in 
response to telomere uncapping, nor does ZWF1 deletion affect cdc13-1 temperature 








Figure 5.2: The expression of SOL4 and GND2 increases in response to telomere 
uncapping
Change in expression level of SOL4 and GND2 transcripts in cdc13-1 strains in response 
to telomere uncapping, where log2 represents the log-fold change in expression when 
compared with CDC13+ strains under the same conditions (data taken from Greenall et 
al. (2008)). Plotted values represent the means of three independent samples and error 
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Figure 5.3: Change in ZWF1 expression in response to telomere uncapping
(a) Zwf1 catalyses the conversion of glucose-6-phosphate to 6-p-gluconolactone in the 
first step of the oxidative phase of the pentose phosphate pathway, reducing NADP+ to 
NADPH. (b) Change in expression level of ZWF1 transcripts in cdc13-1 strains in 
response to telomere uncapping, where log2 represents the log-fold change in expression 
when compared with CDC13+ strains under the same conditions (data taken from 
Greenall et al. (2008)). Plotted values represent the means of three independent samples 












































cdc13-1 zwf1∆ rad9∆ (5561)
23oC 26.5oC 36oC27oC
Figure 5.4: cdc13-1 temperature sensitivity is not altered by ZWF1 deletion
Spot test for temperature sensitivity of cdc13-1 and cdc13-1 zwf1∆. Strains were grown 
to saturation in YEPD before a 5-fold serial dilution and pinning onto solid agar plates. 
Plates were incubated at the indicated temperatures for 3 days.
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5.2.4   G6PDH activity is absent in zwf1∆ strains 
Zwf1 activity can be monitored by measuring NADPH accumulation in a controlled 
enzyme assay, in which all of the necessary reagents are added to saturation to cell 
lysate isolated from yeast cells. NADPH accumulation can be monitored by 
following changes in absorbance, since NADPH has an absorbance of 340 nm. 
Before testing cdc13-1 strains for Zwf1 activity, I carried out the enzyme assay on a 
wild type strain alongside a zwf1∆ strain and a water control.  
 
As the graph in Figure 5.5 demonstrates, Zwf1 activity can be observed in the wild 
type, but deletion of ZWF1 results in an elimination of NADPH production by the 
particular reaction investigated. When compared to wild type, a ZWF1 delete strain 
has virtually no specific activity whereas the specific activity of the wild type strain 




   
  Table 5.4: Specific activity of Zwf1 in zwf1∆ strains 
 
The results from this experiment therefore suggest that I can be confident that the 
assay is indeed measuring amount of NADPH produced by the reaction catalysed by 
Zwf1, and that deletion of ZWF1 eliminates G6PDH activity. However, since the 
assay cannot be corrected for enzyme co-factors, the enzyme assay can be used to 












  Wild Type zwf1∆ 
Specific Activity 
(μmol/min/mg) 
817 ± 66 9.5 ± 9.6 
   
Figure 5.5: Deletion of ZWF1 eliminates NADPH production in a G6PDH assay
Measurement of Zwf1 (G6PDH) activity in wild type and zwf1∆ strains by measuring 
NADPH generation. NADPH generation was determined by measuring absorbance at 
340 nm before and 1, 5 and 10 minutes after the addition of glucose-6-phosphate to the 
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5.2.5   G6PDH activity in cdc13-1 increases at restrictive temperatures 
I hypothesised that an increase in flux through the pentose phosphate pathway 
occurs following telomere uncapping and that this increase in flux could, in part, be 
identified by an increase in Zwf1 activity. As demonstrated in 5.2.4, Zwf1 activity 
can be monitored using a G6PDH activity assay in which NADPH concentration in 
followed through absorbance measurements. In order to observe the response of 
Zwf1 activity to telomere uncapping, I carried out a time course, represented 
diagrammatically in Figure 5.6. Samples of CDC13+ and cdc13-1 cultures were 
taken at T = 0, then cultures were split and placed at 23oC or 36oC. Further samples 
were taken at 15, 60, 120, 180 and 240 minutes following the shift from permissive 
to non-permissive temperature.  
 
As Figure 5.7 demonstrates, Zwf1 activity remains at a constant level at 23oC in 
both CDC13+ and cdc13-1 strains. At 36oC, Zwf1 activity is elevated after 60 
minutes in both CDC13+ and cdc13-1 strains, when compared to activity at 23oC. 
However, whereas Zwf1 activity in CDC13+ strains remains the same over the 
remainder of the time course, the activity of Zwf1 in uncapped cdc13-1 strains 
continues to rise (Table 5.5).  
  
 Specific Activity (μmol/min/mg) 
Incubation 
Temperature 23oC 36oC 
Time (mins) CDC13+ cdc13-1 CDC13+ cdc13-1 
0 261.5 ± 86 306 ± 66 261.5 ± 86 306 ± 66 
15 252.5 ± 16 277 ± 44 279 ± 54 330.5 ± 32 
60 298 ± 0 264.5 ± 60 457 ± 16 505.5 ± 9 
120 284.5 ± 6 247 ± 16 443.5 ± 35 664.5 ± 32 
180 259 ± 13 270 ± 28 462.5 ± 35 699 ± 85 
240 272.5 ± 25 333 ± 28 404.5 ± 4 873.5 ± 117 
 
       Table 5.5: Specific activity of Zwf1 in CDC13+ and cdc13-1 strains 
 
I determined the cell cycle position of 100 cells from each sample at each time point 
using DAPI staining. The results indicate that after 60 minutes there is little 
difference between the percentage of cells in each stage between wild type and 
cdc13-1 strains (Figure 5.8). However, as the time course progresses the number of 
cdc13-1 cells arrested at G2-M increases significantly, peaking at almost 90% of 
cells after four hours at 36oC. The cdc13-1 strains kept at 23oC, along with the wild 
… 
Figure 5.6: Experimental design of Zwf1 activity measurement time-course 
CDC13+ and cdc13-1 strains were inoculated into liquid culture and grown at 23oC for 
four hours, samples taken then the cultures were diluted with fresh YEPD and divided 
into two separate flasks. One flask of each culture was placed at 23oC and the other at 
36oC. Samples were taken after 15, 60, 120, 180 and 240 minutes.
cdc13-1CDC13+
23oC









DLY640 DLY3001 DLY1108 DLY1195
cdc13-1CDC13+
Figure 5.7: Change in the specific activity of Zwf1 in wild type and cdc13-1 strains
Measurement of Zwf1 (G6PDH) activity in wild type and cdc13-1 strains by measuring 
NADPH generation. NADPH generation was determined as in Figure 5.5. Change in 
absorbance over 5 minutes was used to calculate specific activity. Plotted values indicate 
mean specific activities of Zwf1 in three independent measurements of each sample and 





































Figure 5.8: Cell cycle arrest of cdc13-1 cells correlates with increase in Zwf1 
activity 
Cell cycle position of strains tested in Figure 5.7, determined using DAPI staining. 
Samples were taken at the same time as enzyme activity analysis samples. % cells 
indicates the proportion of cells in the indicated stage of the cell cycle (see Chapter 
2.3.4 for cell classifications).
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type strains at both temperatures, demonstrate an even distribution of cells in each 
cell cycle stage at all time points. The data therefore indicates that the increase in 
Zwf1 activity observed in cdc13-1 strains at restrictive temperatures correlates with 




5.2.6   G6PDH activity increase in cdc13-1 is dependent on Rad9 activity 
An increase in Zwf1 activity in cdc13-1 strains appears to correspond with cell cycle 
arrest at G2-M. The proportion of arrested cells increases throughout the time 
course, following a shift to a restrictive temperature (Figure 5.8). Similarly, as the 
time course continues, the specific activity of Zwf1 in cdc13-1 cultures gradually 
increases. Cell cycle arrest in cdc13-1 strains at restrictive temperatures is dependent 
on Rad9 activity (Garvik et al., 1995). Rad9 activity initiates cell cycle checkpoints 
and stimulates downstream effectors which bring about the arrest. Therefore, 
deleting RAD9 in the cdc13-1 background prevents the cell cycle arrest aspect of the 
response to telomere uncapping. In cdc13-1 rad9∆ strains, cells progress through the 
G2-M checkpoint and continue to divide for several generations, in spite of the 
presence of uncapped telomeres (Garvik et al., 1995). This means that cdc13-1 
rad9∆ strains display improved growth at non-permissive temperatures compared to 
cdc13-1 alone; however, the problems which stem from the presence of uncapped 
telomeres, such as loss of essential genes, accumulation of single-stranded DNA and 
homologous recombination, eventually result in too much damage to sustain growth, 
and as a consequence, cdc13-1 rad9∆ strains do not grow over 28oC (Garvik et al., 
1995).  
 
 Since an increase in Zwf1 activity in cdc13-1 strains appears to correspond with 
cell cycle arrest at G2-M, I investigated whether preventing arrest from occurring 
would prevent the observed Zwf1 activity increase. Following the same 4-hour time 
course utilised in 5.2.6, the activity of Zwf1 in cdc13-1 rad9∆ strains was measured, 
alongside Zwf1 activity in CDC13+ RAD9+ strains (Figure 5.9 and Table 5.6).  
 
 Specific Activity (μmol/min/mg) 
Incubation 
Temperature 23oC 36oC 
Time (mins) CDC13+ RAD9 cdc13-1 rad9∆ CDC13+ RAD9 cdc13-1 rad9∆ 
0 201 ± 54 121 ± 174 259.5 ± 22 241.5 ± 4 
15 252.5 ± 6 217 ± 38 201 ± 54 174.5 ± 22 
60 274.5 ± 19 301.5 ± 32 457.5 ± 45 384 ± 16 
120 174 ± 92 225 ± 25 379.5 ± 168 473 ± 54 
180 233 ± 0 240 ± 66 441 ± 117 432 ± 35 
240 236 ± 41 327 ± 18 474.5 ± 57 497 ± 25 
 
       Table 5.6: Specific activity of Zwf1 in CDC13+ RAD9 and cdc13-1 rad9∆ strains 
 
Figure 5.9: Specific activity of Zwf1 in wild type and cdc13-1 rad9∆ strains
Measurement of Zwf1 (G6PDH) activity in wild type and cdc13-1 rad9∆ strains by 
measuring NADPH generation. NADPH generation was determined as in Figure 5.5. 
Change in absorbance over 5 minutes was used to calculate specific activity. Plotted 
values indicate mean specific activities of Zwf1 in three independent measurements of 
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As noted in 5.2.5, Zwf1 activity in wild type strains remains fairly constant over the 
4 hour time course. An increase in Zwf1 activity after 60 minutes is again observed 
in both CDC13+ RAD9+ and cdc13-1 rad9∆ strains. As reported previously, the 
activity of Zwf1 in wild type strains at 36oC remains at a constant level for the 
remainder of the time course. Interestingly, unlike in cdc13-1 strains (Figure 5.7 and 
Table 5.5), Zwf1 activity in cdc13-1 rad9∆ strains is similar to that in wild type. 
Where the activity of the enzyme increases further as the time course progresses in 
cdc13-1 strains, in cdc13-1 rad9∆, enzyme activity remains at a similar level.  
 
This result suggests that the increase in Zwf1 activity observed following telomere 
uncapping in cdc13-1 strains incubated at restrictive temperatures is due to cell 
cycle arrest and is dependent on Rad9 activity. As the determination of cell cycle 
position in the samples shows, no cell cycle arrest is occurring in cdc13-1 rad9∆ 
strains. (Figure 5.10) Both wild type and cdc13-1 rad9∆ strains demonstrate even 
distribution of cells in each cell cycle stage at each time point across the time 
course. Therefore I conclude that the increase in Zwf1 activity observed in cdc13-1 
strains is due to cell cycle arrest, which does not occur in cdc13-1 rad9∆ strains and 







Figure 5.10: Cell cycle arrest did not occur in cdc13-1 rad9∆ cells
Cell cycle position of strains tested in Figure 5.9, determined using DAPI staining. 
Samples were taken at the same time as enzyme activity analysis samples. % cells 
indicates the proportion of cells in the indicated stage of the cell cycle (see Chapter 
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5.2.7   Cell-cycle arrest affects G6PDH activity 
The above results suggest that the increase in Zwf1 activity observed in cdc13-1 
strains is due to Rad9 activity and the cell cycle arrest which occurs in response to 
telomere uncapping. If the cause of the increase in Zwf1 activity were due primarily 
to the G2-M cell cycle arrest rather than telomere uncapping, Zwf1 activity in other 
strains which arrest in the cell cycle may display similar changes. Mutations in other 
CDC genes can cause arrest at different points in the cell cycle. For example, cdc15-
2 arrests in late mitosis at restrictive temperatures (Jaspersen et al., 1998). Using the 
same time course experiment, I studied Zwf1 activity in wild type and cdc15-2 
strains over a 4-hour period following a shift to restrictive temperatures (Figure 5.11 
and Table 5.7).  
 
 Specific Activity (μmol/min/mg) 
Incubation 
Temperature 23oC 36oC 
Time (mins) CDC15+ cdc15-2 CDC15+ cdc15-2 
0 212 ± 13 301 ± 25 156 ± 66 301 ± 25 
15 192 ± 41 230 ±  95 194 ± 95 227.5 ± 35 
60 291.5 ± 32 262.5 ± 47 441 ± 16 392 ± 98 
120 240 ± 16 331 ± 0 401 ± 41 715.5 ± 94 
180 307 ± 31 340.5 ± 16 582 ± 110 923.5 ± 57 
240 337 ± 42 329.5 ± 50 501 ± 28 1064 ± 54 
 
        Table 5.7: Specific activity of Zwf1 in CDC15+ and cdc15-2 strains 
 
Zwf1 activity in cdc15-2 strains increases significantly over the time course, 
compared to wild type, in which Zwf1 activity increases within the first 60 minutes 
then remains at the same level for the remaining 3 hours. Comparing changes in the 
specific activity of Zwf1 in cdc15-2 to those in cdc13-1, the increase observed in 
activity in the former is greater than in the latter. And as the cell cycle position 
results indicate, a majority (over 90%) of cells in cdc15-2 strains at restrictive 
temperatures are arrested in late anaphase/cytokinesis (Figure 5.12). 
 
Cells can also be arrested in the G1 phase of the cell cycle using the mating 
pheromone α-factor. Exposure of strains containing the bar1∆ mutation to low 
levels of α-factor results in arrest in the G1 phase of the cell cycle, since BAR1 
encodes a protease which can cleave and inactivate the mating pheromone. Since I 
… 
Figure 5.11: The change in the specific activity of Zwf1 in wild type and cdc15-2 
strains
Measurement of Zwf1 (G6PDH) activity in wild type and cdc15-2 strains by measuring 
NADPH generation. NADPH generation was determined as in Figure 5.5. Change in 
absorbance over 5 minutes was used to calculate specific activity. Plotted values indicate 
mean specific activities of Zwf1 in three independent measurements of each sample and 






































Figure 5.12: Cell cycle arrest of cdc15-2 cells correlates with increase in Zwf1 
activity 
Cell cycle position of strains tested in Figure 5.11, determined using DAPI staining. 
Samples were taken at the same time as enzyme activity analysis samples. % cells 
indicates the proportion of cells in the indicated stage of the cell cycle (see Chapter 
2.3.4 for cell classifications).






















































































had previously only tested strains arrested later on the cell cycle, I decided to study 
the effect of arresting cells in G1. I wanted to determine whether the effect on Zwf1 
activity seen in the previous experiments was specific to cells arrested later on in 
the cell cycle, or whether it was part of a general cell cycle arrest response. A 
similar assay to those above was carried out, but instead of shifting half of the 
cultures to a restrictive temperature, half of the cultures were incubated with α-
factor and half without, both at 23oC. As demonstrated in Figure 5.13, Zwf1 activity 
remains similar between strains incubated with α-factor and those without across 
the 4-hour time course (Table 5.6).  
 
 Specific Activity (μmol/min/mg) 
α-factor - + 
Time (mins) bar1∆ bar1∆ 
0 447 ± 136 447 ± 136 
15 407 ± 3 342 ± 64 
60 442 ± 23 406 ± 54 
120 339.5 ± 101 366.5 ± 19 
180 373 ± 41 460 ± 13 
240 362 ± 25 500.5 ± 6 
 
          Table 5.8: Specific activity of Zwf1 in α-factor arrested strains 
 
Cell cycle position determination indicates that, in one strain at least, virtually all of 
cells in the cultures incubated with α-factor were arrested in G1 by 4 hours (Figure 
5.14), which suggests that in spite of cell cycle arrest taking place, there is no 
alteration in Zwf1 activity in response, as viewed in arrested cdc13-1 and cdc15-2 
strains. Therefore it appears that the increase in Zwf1 activity seen in cdc13-1 and 











Figure 5.13: Change in the specific activity of Zwf1 in α-factor arrested strains
Measurement of Zwf1 (G6PDH) activity in wild type and α-factor arrested strains by 
measuring NADPH generation. NADPH generation was determined as in Figure 5.5. 
Change in absorbance over 5 minutes was used to calculate specific activity. Plotted 
values indicate mean specific activities of Zwf1 in three independent measurements of 





























Figure 5.14: Cell cycle arrest of α-factor treated strains
Cell cycle position of strains tested in Figure 5.13, determined using DAPI staining. 
Samples were taken at the same time as enzyme activity analysis samples. % cells 
indicates the proportion of cells in the indicated stage of the cell cycle (see Chapter 
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In this chapter I have demonstrated that Zwf1 activity increases in cdc13-1 strains 
incubated at restrictive temperatures over a 4-hour time period. I studied Zwf1 
activity with the aim of discerning whether flux through the pentose phosphate 
pathway (PPP) increases in cdc13-1 strains, as suggested by transcription data. The 
results from the Greenall et al. (2008) microarray indicated that telomere uncapping 
in cdc13-1 strains results in an increase in pentose phosphate pathway activity. The 
transcript abundance of SOL4 and GND2 (Reactions 4 and 5 in Figure 1.6), along 
with the transcript levels of other PPP-related genes, increased upon shifting 
temperature-sensitive cdc13-1 mutants to restrictive temperatures. However, the 
expression of ZWF1 did not increase to a significant extent, which I attributed to the 
constitutive expression of the gene. Zwf1 activity is instead regulated post-
transcriptionally, and it is this activity which I aimed to investigate.  
 
My original hypothesis was that the observed increase in Zwf1 activity was due to 
the DNA damage response which occurs following telomere uncapping in cdc13-1, 
similar to the findings of Cosentino et al. (2010) in their study of G6PDH activity in 
Xenopus and human cell lines in response to double strand breaks. However, upon 
study of other cell cycle arrest mutants I found that the increase in Zwf1 activity 
observed in cdc13-1 strains arrested at G2-M was also observable in cdc15-2 strains, 
which arrest later in the cell cycle during late anaphase. Zwf1 activity in cells 
arrested in G1, such as those treated with α-factor, did not increase in a similar 
fashion which led me to conclude that the stage of the cell cycle in which cells are 
arrested is the important factor when studying Zwf1 activity.  
 
Without studying the flux through the PPP, it is hard to conclude whether activity of 
the pentose phosphate pathway as a whole increases in response to cell cycle arrest 
in these strains. However, given the main roles of the PPP in generation of NADPH 
and ribose-5-phosphate, it is conceivable that an increase in PPP flux in cells 
arrested at G2-M and late anaphase would aid defence against oxidative stress and 
contribute to repair following DNA damage. Alternatively, cell cycle arrest may 
lead to an increase in flux through glycolysis and therefore an increase in flux 
through the PPP, in a metabolic change similar to that seen in cancer cells as part of 
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the Warburg effect (Dickens, 1938; Warburg and Christian, 1937; Lipmann, 1936; 
Warburg et al., 1935). Indeed, carbohydrate metabolism features prominently 
amongst the GO terms linked to genes upregulated following telomere uncapping 
(Table 5.2). 
 
And so the increase in Zwf1 activity observed in cdc13-1 and cdc15-2 strains may 
be part of a generic stress response or metabolic change. However, it still remains 
unclear as to why this effect is dependent upon the stage of the cell cycle in which 
arrest is occurring, since Zwf1 displayed similar activity in both cells arrested in G1 

























5.4 Future Work 
 
My research found that cell cycle arrest in G2-M and late anaphase results in 
increased glucose-6-phosphate dehydrogenase (Zwf1) activity. The data suggests 
that this increase is only observed when cells are arrested later on the cell cycle, as a 
change in activity is not seen in cells arrested in G1. I hypothesise that this increase 
is due to a stress response or a metabolic change caused by the arrest.  
 
The change in G6PDH activity observed appears to be dependent on the stage of the 
cell cycle in which cells are arrested. In order to confirm my results, Zwf1 activity 
could be explored in a number of other strains which arrest at different stages in the 
cell cycle. Here, I have only tested 3 strains which arrest at specific points; the 
investigation of Zwf1 in other strains could further support my hypothesis and 
provide information as to how Zwf1 activity changes throughout the cell cycle.  
 
The work by Cosentino et al. (2010) indicates that G6PDH activity can be regulated 
by means other than NADP/NADPH ratio, such as ATM activity in response to 
DNA damage. Therefore the regulation of Zwf1 activity in response to cell cycle 
arrest could be explored. This could be carried out by genetic means, such as 
deletion of the ATM homolog, Tel1, followed by monitoring of Zwf1 activity. 
 
Studying Zwf1 activity does not give a complete picture of flux through the PPP. 
Therefore to investigate whether the increase in Zwf1 activity translates into an 
increase in flux through the PPP in response to cell cycle arrest, the concentrations 
of PPP intermediates in arrested strains could be measured using liquid 















6 General Discussion 
 
In this thesis I set out to examine the cellular response of yeast to treatment with a 
G-quadruplex binding ligand through utilising a single gene deletion library and 
monitoring strain fitness. Due to the relationship between the G-rich telomeres, G-
quadruplexes and telomerase, I expected to find that mutants with deficiencies in 
telomere-, telomerase- and DNA damage-related genes had differential sensitivity 
to the ligand tested, TMPyP4. However, the results of my screen indicated that the 
greatest sensitivity to TMPyP4 occurs when there are deficiencies in the oxidative 
stress response, and in particular, the pentose phosphate pathway (PPP). Further 
investigations into the TMPyP4-sensitive strains revealed that the sensitivity of the 
strains to the porphyrin was most likely due to the inability to remove reactive 
oxygen species efficiently. TMPyP4 treatment of mammalian cell lines results in 
the upregulation of oxidative stress response genes, and is a member of the 
porphyrin family, a group of compounds which are capable of generating ROS upon 
exposure to light (Grand et al., 2002; Granville et al., 2001). Porphyrins are also 
used in the treatment of cancer, whereby the photosensitising agent is administered 
intravenously, accumulates in most cells and is exposed to light in the target region, 
producing ROS and inducing apoptosis (Granville et al., 2001). Therefore the 
efficacy of TMPyP4 against cancer cell lines could be attributed to either its G-
quadruplex binding ability or relationship with the porphyrin family. 
 
High-throughput screening of the yeast gene deletion collection has also been used 
to determine genetic interactions between deletion strains and the telomere capping 
mutant cdc13-1 (Addinall et al., 2011; Addinall et al., 2008). The deletion of TKL1 
and TAL1, genes which encode key enzyme in the non-oxidative phase of the PPP, 
suppresses the temperature sensitivity of cdc13-1 strains. I originally hypothesised 
that this suppression was attributable to alterations in NADPH levels and that 
telomere uncapping in cdc13-1 strains were causing oxidative stress. However, 
further investigations into the effects of deleting TAL1 and TKL1 on Zwf1 activity 
suggested that NADPH production and a response to oxidative stress were unlikely 
to be the cause of the observed phenotypic suppression. Instead I hypothesise that 
deletion of TKL1 and TAL1 cause an accumulation of the nucleotide precursor 
ribose-5-phosphate and that this increase enhances growth of cdc13-1 at semi-
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permissive temperatures. Other data suggests that nucleotide production increases 
in cdc13-1 strains and that this is beneficial to the telomere capping mutants, 
including transcription data which demonstrates an increase in the expression of 
RNR subunits, the relocation of RNR subunits following telomere uncapping and 
the suppression of temperature sensitivity of cdc13-1 strains by deletion of the RNR 
inhibitor SML1 (Greenall et al., 2008; Tsolou and Lydall, 2007; Yao et al., 2003). 
 
I also hypothesised that flux through the pentose phosphate pathway changes in 
response to telomere uncapping. Studies into transcript expression changes in 
cdc13-1 in response to a shift to restrictive temperatures indicate that there is an 
increase in the expression of several PPP and PPP-related genes. A recently study 
by Cosentino et al. (2010) has also indicated that G6PDH activity can be altered in 
response to the presence of double strand breaks via the activity of ATM. Taking 
this data into account, I sought to monitor the activity of the enzyme which 
catalyses the first rate limiting step of the PPP – Zwf1. I found that while Zwf1 
activity did indeed increase in cdc13-1 strains following telomere uncapping, it also 
increased in strains arrested in late anaphase (cdc15-2). Since this increase was not 
observed in cells arrested in G1, I concluded that increase in Zwf1 is caused by 
arrest late in the cell cycle. It is likely that Zwf1 activity and NADPH production 
increases in G2-M and late anaphase due to a general alteration in cellular 
metabolism or in order to protect against oxidative damage, as a result of a general 
stress response to cell cycle arrest. 
 
Overall I have demonstrated that the pentose phosphate pathway is key for the 
response to environmental changes that cells may encounter, from effect of drug 
treatment to telomere uncapping and cell cycle arrest. The methods by which 
pentose phosphate pathway activity is regulated and modified have in recent times 
been revealed to be more complex than previously thought. Indeed, recent studies 
into the effect of the upregulation of the PPP have also revealed a transcriptional 
role for the non-oxidative phase of the pathway, particularly in the response to 
oxidative stress (Krüger et al., 2011). Since the PPP is intrinsically linked to cancer 
cell metabolism and tumour proliferation, any further knowledge on its regulation 
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